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Abstract 
I 
Like growth and guidance of developing axons, regeneration after axonal injury is 
predominantly influenced by factors located in a neuron's extracellular environment. 
These factors include neurotrophins, such as Nerve Growth Factor (NGF), and adhesion 
molecules, such as laminin. However, how these factors interact to stimulate optimal 
levels of neurite growth is largely unknown. In this thesis, I initially investigated whether 
attachment to permissive culture substrates is sufficient to promote neurite outgrowth 
from DRG neurons, and whether this interaction is able to enhance the response of 
neurons to added neurotrophic factors, such as NGF. Adult Dorsal Root Ganglion (DRG) 
neurons plated on surfaces coated with a thin film of laminin exhibited increased neurite 
outgrowth, this growth was correlated with increased expression of laminin binding 
integrin subunits. Laminin-induced neurite growth was integrin,..dependent as it was 
attenuated by treatment with either a cyclic Arg-Gly-Asp (RGD) peptide or a j31 integrin-
blocking antibody (!:Hi). The addition of NGF to cells plated on laminin resulted in a 
significant and synergistic increase in the integrin-dependent outgrowth. 
In performing these experiments it was observed that not all DRG neurons were 
responding to laminin and NGF with increased neurite growth. As neurons in the adult 
rat DRG can be classified into at least three separate subpopulations based on 
morphologic and phenotypic differences, a cell selection approach was utilized to show 
that laminin-induced neurite growth occurs in the absence of added trophic factors only 
in heavy chain neurofilament positive and calcitonin gene related peptide positive DRG 
neurons (NGF-responsive population). In contrast, laminin alone is not sufficient to 
stimulate significant neurite growth from lectin Griffonia Simplicifolia IB4 positive 
-1-
neurons (IB4+ve), although it is still required to elicit a growth response from these cells 
in the presence of Glial Cell Line Derived Neurotrophic Factor (GDNF) (eg., neurite 
I 
growth occurred only when cells were plated on laminin in the presence of GDNF). By 
using chemical inhibitors;we demonstrated that only the PI 3-K/Akt pathway was 
required for neurite growth from the NGF-responsive cell population. However, both the 
PI 3-K/Akt and MEK/MAPK signalling pathways were required for neurite growth from 
the IB4+ve cell population. Further analysis indicated that Src was potentially a key 
point of collaboration between NGF and laminin induced neurite growth in NGF-
responsive adult DRG neurons. Src appeared to be located upstream of the PI 3-K/ Akt 
signalling pathway and was responsible for increased neurite growth induced by the 
addition of laminin and NGF together. 
In this series of studies we have identified specific signalling events and 
environmental requirements associated with neurite growth for different subpopulations 
of adult DRG neurons, pointing to potential therapeutic targets while identifying why any 
one treatment alone may ·be insufficient to totally repair peripheral nerve damage. 
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CHAPTERl 
I 
INTRODUCTION 
1.1 Neuronal regeneration of the adult nervous system 
1.1.1 The regenerative response 
In order for a nerve cell to undergo axonal regeneration and stimulate functional 
recovery, it must first survive the initial insult. Once this is achieved, the cell has to 
mount a regenerative response in which the severed axon must grow from its remaining 
proximal segment, across the injury site, and back to the appropriate target, where it must 
reform its original synaptic connections. In order for this regenerative response to occur, 
the cell body must receive signals from its injured axon telling it to switch from the 
normal operating mode, whereby information in the form of action potentials is sent 
along the length of its axon, to a mode where axonal growth becomes its main priority 
(Fu and Gordon, 1997). Thus, axonal injury causes neurons to revert back to a state 
similar to that seen early in development, where attempts to form the appropriate terminal 
connections are made. 
During nervous system development, axons are required to travel great distances 
with accuracy in order to make the required synaptic connections. For instance, a 
pseudounipolar DRG neuron extends a single axon from its cell body, which bifurcates 
sending one process centrally, to the spinal cord, while the other process is sent 
peripherally to the skin, muscle, or visceral organs. For axon growth and accurate target 
innervation to occur, a number of excitatory and inhibitory growth and guidance cues 
must be utilized. 
-1-
The growth cone is a specialized structure located at the leading end of an axon 
and acts as the major sensory-motor component for the detection of growth and guidance 
I 
cues in the extracellular environment. The growth cone is made up of 2 major domains 
consisting of a centr(ll domain surrounded by a peripheral domain (Dent and Gertler, 
2003 ). The central domain has an abundance of microtubules and membranous 
organelles, whereas the peripheral domain is made up of two actin rich structures. These 
structures include the lamellipodium, which is made up of a dense meshwork of actin 
filaments and directly surrounds the central domain, and the filopodia, which are longer 
finger-like projections of actin that extend from the outer edge of the lamellopodium 
(Dent and Gertler, 2003; Forscher and Smith, 1988; Krause et al., 2003; Lebrand et al., 
2004; Letourneau et al., 1986; Letourneau et al., 1987). Axon elongation has been shown 
to occur in three stages and is critically dependent on the presence of these filament 
structures. The first stage of axon growth is protrusion where the growth cone quickly 
extends lamellopodia and filopodia, which begin to probe their environment. The second 
stage is engorgement where the organelles and cytoplasm move forward into the central 
domain of the growth cone. The third and final step is consolidation where a new section 
of axon is formed by the collapse of the proximal portion of the newly elongated growth 
cone (Dent and Gertler, 2003; Krause et al., 2003; Lebrand et al., 2004). 
Thus, both lamellopodia and filopodia extending from the growth cone act as 
sensors which undergo continuous cycles of extension and collapse while probing their 
environment (Burmeister and Goldberg, 1988; Goldberg and Burmeister, 1 986; Goldberg 
and Burmeister, 1988; Goldberg and Burmeister, 1989). Filopodia, for example, act as 
fingers that probe the environment, transducing signals from both excitatory and 
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inhibitory cues. These cues are considered to be short or long range, stimulating specific 
cell surface receptors and indudng advancement, retraction, turning, or collapse of the 
growth cone. The short-range cues include those that are attached to either cellular 
membranes or the extracellular matrix and typically exert precise control over growth 
cone movement. The long-range cues, however, are typically secreted, soluble factors 
that act on growth cones a distance from the source of production. These factors 
typically exert less precise control over growth cone movement. 
Like the processes involved in nervous system development, growth cone 
interaction with the extracellular environment is essential to the regenerative response 
following axonal injury. Being interested in these processes the fundamental goal of my 
research was to identify the key environmental conditions and subsequent cellular 
signalling components required to stimulate optimal levels of neurite growth from adult 
sensory neurons. Knowing that both short- and long-range growth and guidance cues are 
important developmentally, these factors became my main focus. Initially I was 
concerned with the role of neurotrophins, specifically NGF, in axon growth. However, 
during early collaborative studies between David Jones (a former MSc student in the lab) 
and myself, the observation was made that adult DRG neurons plated on the extracellular 
matrix molecule laminin were extending neurites in the absence of added trophic factors. 
This led us to suspect that the extracellular matrix on which the neurons were plated was 
having a positive effect on neurite outgrowth. Thus, my key interest became the 
interactions between laminin activated signalling pathways and NGF activated signalling 
pathways in stimulating axonal regeneration in adult DRG neurons. The reasons for 
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focusing on the extracellular matrix molecule laminin and the neurotrophin NGF are 
numerous and will be discussed in great detail in the upcoming sections. 
1.1.1.1 Signalling at the gr~wth cone 
As suggested in Section 1.1.1, both lamellopodia and filopodia extending from the 
growth cone are responsible for sensing and transducing cues from a cell's environment 
that are required for growth and elongation of axons. The ability of an axon to respond to 
external growth and guidance cues is largely the function of a group of proteins 
belonging to the Rho family of small GTPases (Luo, 2002; Ng et al., 2002). These 
proteins have been shown to directly regulate actin filament dynamics, thus regulating 
growth cone motility (Luo, 2002; Ng et al., 2002). Members of this family of proteins 
(including RhoA, Rock, Rae, Pak, and Cdc42) are important in the regulation of growth 
cone extension and retraction, and are also important in the promotion or inhibition of 
axon growth. As shown in Fig 1.1 Rho GTPase activity is regulated by two distinct 
classes of molecules, the Rho GAPs, or GTPase activating proteins, and the Rho GEFs, 
or guanine nucleotide exchange factors (Huber et al., 2003). The Rho GAPs function to 
inhibit Rho GTPase activity, while the Rho GEFs function to activate Rho GTPase 
activity (Huber et al., 2003). In general, activation of Rho A stimulates the activation of 
ROCK, which induces the retrograde flow of actin (Huber et al., 2003). This stimulates 
growth cone retraction and inhibition of axon extension. Activation of Rae, and Cdc42 
act in opposition to RhoA and inhibit the retrograde flow of actin and stimulate actin 
polymerization and branching (Huber et al., 2003). This stimulates growth 
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Figure 1.1 Schematic illustration indicating how the family of small Rho GTPases 
are utilized at the growth cone for axon extension and guidance. GEF, guanine 
nucleotide exchange factor; GAP, GTPase activating protein. Adapted from Huber et al., 
2003. 
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cone protrusion and axon extension. Thus, external cues can have direct effects on GAPs 
and GEFs that act to either stimlilate or inhibit axonal regeneration. 
1.1.2 Regeneration in the CNS vs. PNS 
Following axotomy, the distal segment of the severed axon undergoes Wallerian 
degeneration. This is the process by which the distal part of the severed axon, which no 
longer has contact with its cell body, undergoes degeneration and subsequent removal 
(Stoll et al., 2002). During this process, there is an immune response that stimulates the 
infiltration of leukocytes and macrophages, which act to remove the degenerating myelin 
sheet via phagocytosis (Stoll et al., 2002). 
Although the presence and rate of Wallerian degeneration is roughly the same in 
both the CNS and PNS, differences exist in this process that are very important to axonal 
regeneration. In the CNS, myelin removal is slow and inefficient, and myelin debris, 
which contains a variety of inhibitory proteins, remains in the injury site for extended 
periods of time (George and Griffin, 1994). The injury site in the CNS is also plagued by 
the formation of a glial scar, which has also been shown to contain growth inhibitory 
molecules (Klapka et al., 2005; Ribotta et al., 2004). In contrast, axotomy of PNS 
neurons stimulates the complete removal of the myelin sheet, and Schwann cells change 
from their normal state of myelination, begin to proliferate, and form bands of Bungner, 
which act as basal lamina tubes providing guidance tracts for regenerating axons (Fu and 
Gordon, 1997). The Schwann cells of the distal nerve stump begin to release a variety of 
cell adhesion, extracellular matrix, and neurotrophic molecules in an attempt to provide a 
permissive environment for axonal regeneration (Fu and Gordon, 1997; Stoll et al., 
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2002). In the CNS du~ing Wallerian degeneration, oligodendrocytes do not change from 
a myelinating to a proliferating state and the formation of structures like the bands of 
Bungner does not occur. Unlike the PNS, there is a lack of permissive molecules such as 
' 
NGF and laminin that are secreted after CNS injury in the adult (Fenrich and Gordon, 
2004; Stoll et al., 2002). 
It has long been known that CNS neurons, unlike PNS neurons, lack the ability to 
achieve significant amounts of axonal regeneration following injury (Aguayo et al., 1981; 
Aguayo et al., 1991; David and Aguayo, 1981; Filbin, 2003). However, when provided 
with the appropriate environmental conditions, CNS neurons have been shown to 
regenerate (Azanchi et al., 2004; David and Aguayo, 1981; Fairless and Barnett, 2005; 
Klapka and Muller, 2006; Kuffler, 2000). These findings suggest that the marked 
difference in regenerative capacity between CNS and PNS neurons is largely due to 
different environmental factors. Specifically, the adult CNS is faced with an inhibitory 
environment, which is created by the presence of inhibitory molecules associated with the 
myelin sheath and glial· scar, and a lack of permissive molecules such as laminin and 
NGF associated with the Schwann cells of the PNS (Azanchi et al., 2004; Fouad et al., 
2005; Kuffler, 2000). 
1.1.2.1 The CNS environment 
As noted in Section 1.1.2, it is postulated that the extracellular environment of the 
CNS is unfavourable for axonal regeneration, making functional recovery after CNS 
injury limited. The major inhibitory components of the CNS environment are derived 
from either the myelin sheath or the glial scar. I will first discuss the inhibitory 
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molecules Nogo, Myelin Associated Glycoprotein (MAG), and Oligodendrocyte Myelin 
Glycoprotein (OMgp) that are fdund in myelin and act as potent inhibitors to approaching 
axons. I will then discuss how both the physical properties of the glial scar and its 
molecular components act to inhibit neurite growth. 
The inhibitory Nogo molecule was first identified as an antigen for the IN-1 
antibody, which was shown by Schwab and colleagues to block the inhibitory action of 
myelin on the growth of corticospinal tract axons in young adult rats (Chen et al., 2000; 
GrandPre et al., 2000; Prinjha et al., 2000; Schnell and Schwab, 1990). Three major 
isoforms of the Nogo molecule have been reported, including Nogo-A, Nogo-B, and 
Nogo-C (Schweigreiter and Bandtlow, 2006). While Nogo-B and Nogo-C are expressed 
outside the nervous system, Nogo-A is specific to the mammalian CNS and is located on 
both the surface of oligodendrocytes and in the lumen of the endoplasmic reticulum 
(Filbin, 2000; Hunt et al., 2002). Nogo-A has been shown to contain two functional 
components, an internal amino-Nogo, and the external Nogo66. The Nogo66 region has 
been identified on all Nogo isoforms and acts as the major inhibitory component of 
axonal regeneration (Fournier et al., 2001; GrandPre et al., 2000). Strittmatter and 
colleagues identified a GPI linked receptor that is predominantly expressed on neuronal 
surfaces, which they termed the No go receptor (NgR). Inhibition of this receptor via GPI 
protein cleavage blocked Nogo66 binding and subsequent growth cone collapse and 
stimulated axon growth from CNS spinal explants (Fournier et al., 2001). 
MAG, a member of the Ig superfamily of molecules, was the first of the myelin-
derived proteins to be identified as an inhibitor of axon growth (McKerracher et al., 
1994; Mukhopadhyay et al., 1994 ). Early in development, like other members of the Ig 
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super family of protei'ns, MAG functions to promote axon growth and guidance. The 
switch to axonal inhibition occurs at different times in different neurons; for instance, 
I 
retinal ganglion cells have been shown to switch from MAG induced attraction to 
inhibition embryonically (Salzer et al., 1990). This switch to inhibition of axon growth 
by MAG was later shown to be dependent on cellular expression of cAMP and activation 
of its downstream effector PKA; the embryonic switch to MAG inhibition in retinal 
ganglion cells occurs between E18 and PS, which coincides perfectly with a decrease in 
cAMP expression (Cai et al., 2001). Activation of the cAMP/PKA pathway before MAG 
stimulation, via neurotrophin pre-treatment, blocks MAG induced growth inhibition (Cai 
et al., 1999). Similarly, inhibiting cAMP embryonically, prior to MAG induced 
inhibition, causes growth cone collapse (Cai et al., 2001). 
Of the three myelin-derived inhibitory proteins, OMgp is the most recently 
identified. This protein was initially called arretin and was identified from 
chromatographic fractionation of MAG (Kottis et al., 2002). Like NogoA and MAG, 
OMgp also acts to inhibit neurite growth from regenerating neurons. The addition of 
OMgp inhibited neurite growth from both cerebellar granule and hippocampal neurons in 
vitro (Kottis et al., 2002). 
Like Nogo, MAG and OMgp have also been found to bind to the NgR. NgR 
transfection into neurons that do not normally express the receptor causes OMgp to 
stimulate growth cone collapse, and similarly, dominant negative expression of NgR 
blocks MAG induced growth inhibition (Domeniconi et al., 2002; Wang et al., 2002). 
However, as indicated, NgR is a GPI linked receptor, meaning that it does not extend into 
the cytoplasm and, thus, cannot exert a direct influence on internal signalling cascades. 
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Rather, NgR was found to function as a co-receptor with the low affinity neurotrophin 
receptor p75 and lingo-1 (Bandtlow and Dechant, 2004; Ceni and Barker, 2005; Mi et al., 
2004; Yamashita et al., 2002). Neurons that lack the p75 receptor or were transfected 
with a dominant negative lingo-1 protein do not undergo MAG-induced growth cone 
inhibition (Mi et al., 2004; Yamashita et al., 2002). Together, this signalling complex 
functions as a regulator of the Rho family of GTPases. Upon binding, myelin activates 
the NgR complex and stimulates RhoA activation which in turn inhibits neurite growth 
from a variety of different cell types in the adult CNS (Bandtlow, 2003; Domeniconi et 
al., 2005). Conversely inhibition of Rho A or its downstream signalling intermediates 
with the C3 exoenzyme or a dominant negative form of the Rho A protein has been shown 
to stimulate axon growth and regeneration (Ellezam et al., 2002; Lehmann et al., 1999; 
Winton et al., 2002; Yamashita et al., 2002). Thus, negative regulation of Rho and its 
downstream effectors has a positive effect on neurite growth in a variety of CNS cell 
types including, retinal ganglion, cerebellar, spinal, and cortical neurons (Bandtlow, 
2003; Domeniconi et al., 2005; Ellezam et al., 2002; Hunt et al., 2002; Lehmann et al., 
1999; Logan et al., 2006; Mi et al., 2004; Winton et al., 2002; Yamashita et al., 2002). 
The formation of the glial scar is a relatively late occurrence after CNS injury and 
if myelin inhibition can be overcome, allowing the regenerating axon to traverse the 
injury site before the scar forms, then this event becomes less concerning. The glial scar 
is formed in a process called reactive gliosis, whereby the infiltration of reactive 
astrocytes into the injury site causes the formation of a physical barrier along with the 
accumulation of chondroitin sulfate proteoglycans (McKeon et al., 1999; McKeon et al., 
1991). These molecules, which include neurocan, brevican, phosphocan, NG2, tenascin 
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and chondroitin sulfate, are known to inhibit axonal regeneration. For instance, NG2 has 
been shown to be responsible for inhibiting sensory neuron regeneration into the dorsal 
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root entry zone (Zhang et al., 2001 ), while neurocan and phosphocan inhibit the 
regeneration of adult cortical and retinal ganglion neurons (McKeon et al., 1999; 
Monnier et al., 2003) (see Fig 1.1). Like the myelin-associated inhibitors, chondroitin 
sulfates exert their inhibitory effects on neurite growth via activation of RhoA and its 
downstream effector Rho Kinase ROCK (Monnier et al., 2003). Inhibition of this 
signalling pathway via the C3 exoenzyme, or the use of the chemical inhibitor specific to 
ROCK, Y-27632, allows the axon to overcome chondroitin sulfate induced inhibitory 
effects (Dergham et al., 2002; Monnier et al., 2003). Many other attempts to overcome 
axonal inhibition by chondroitin sulfates have also been explored. For instance, the use 
of Chondroitinase ABC, an enzyme that removes the glycosaminoglycan side chains of 
chondroitin sulfates rendering them inactive, has seen some success in stimulating 
regeneration in both corticospinal tract and dorsal column neurons (Bradbury et al., 
2002). To date, specific receptors for this class of molecules are elusive, and thus, 
experimental attempts to stimulate regeneration via receptor inhibition have not been 
possible. 
1.1.2.2 The PNS environment 
As suggested in Section 1.1.2, the PNS environment is much more favourable for 
axonal regrowth than the CNS environment. However, this is not because the PNS does 
not express the inhibitory myelin proteins or the receptors required for binding to these 
molecules. Many studies have shown that myelin-associated inhibitors have the ability to 
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inhibit axonal regeneration from PNS neurons. For example, Stritmatter's group found 
that Nogo stimulates growth cohe collapse from sensory neurons (Fournier eta/., 2001). 
Thus, peripheral neurons express the receptors required for binding to inhibitory myelin 
molecules and react to contact in the same way as CNS neurons. Therefore, the 
permissive growth environment of the PNS may be due to the efficient removal of myelin 
and its associated inhibitory molecules by proliferating Schwann cells and macrophages 
during Wallerian degeneration (Fenrich and Gordon, 2004; Stoll et al., 2002). However, 
the removal of these inhibitory substances is only a part of the reason why the PNS 
environment is more favourable for axon growth than the CNS environment. For 
instance, unlike the CNS, axotomy in the PNS stimulates the increased expression of a 
variety of permissive growth and guidance molecules (Fenrich and Gordon, 2004). 
Schwann cells are the prominent producers of the permissive PNS growth 
environment; these cells normally form the myelin sheet and have a one to one 
relationship with peripheral axons (Bunge, 1994a; Bunge and Bunge, 1986; Bunge, 1987; 
Bunge, 1993; Bunge, 1994b; Bunge and Wood, 1987; Dezawa, 2002; Fenrich and 
Gordon, 2004 ). As previously noted, axotomy stimulates Schwann cell proliferation, 
which in turn, induces the expression of a wide range of cell adhesion molecules, 
neurotrophic factors, and extracellular matrix molecules, all of which have been shown to 
promote growth during nervous system development. For example, following axotomy, 
Schwann cells upregulate their expression of cell adhesion molecules, such as Neural 
Cell Adhesion Molecule (NCAM) and L1 (Jessen et al., 1987; Martini and Schachner, 
1988), they deposit extracellular matrix molecules, such as laminin, collagen, and 
fibronectin, which make up the basement membrane (Chernousov et al., 1999; 
-13-
Kuecherer-Ehret et al.,' 1990; Lefcort et al., 1992), and they produce growth factors, such 
as Nerve Growth Factor (NGF), Brain Derived Neurotrophic Factor (BDNF), and Glial 
Cell Line Derived Neurotrophic Factor (GDNF) (Acheson et al., 1991; Bandtlow et al., 
' 
1987; Matheson et al., 1997; Meyer et al., 1992; Saika et al., 1991a; Saika et al., 1991b). 
The process of Schwann cell proliferation and the presence of these factors act to 
stimulate axonal regeneration and functional recovery; inhibition of this process by 
depletion of Schwann cells after nerve injury impaired axonal elongation (Fugleholm et 
al., 1994). 
1.1.3 Anatomy of the peripheral nerve 
The PNS encompasses all nerves that lie peripheral to the pial covering of the 
CNS and include the craniospinal and autonomic nerves. Peripheral nerves are made up 
of both afferent and efferent nerve fibers. Afferent nerve fibers connect external 
receptors to the central nervous system, bringing information in from the periphery, and 
include, the peripheral process of the sensory DRG neurons projecting from the skin, 
muscle and visceral organs to the central process which projects to the dorsal aspect of 
the spinal cord. Efferent nerve fibers, include the primary motor neurons which have 
their cell bodies located in the grey matter of the spinal cord, and send information 
through their axons to muscle fibers in the periphery. In higher vertebrates, these afferent 
and efferent fibers join just outside the spinal cord to make up peripheral spinal nerves 
(Fig 1.2). Peripheral spinal nerves are covered by the epineurium, which is a tough 
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Figure 1.2. Location and structure of the DRG. Ag stained cross section of a rat spinal 
Cord with Dorsal Root Ganglion attached, this image has been adapted form 
http://biology.clc. uc.edu/fankhauser/Labs/ Anatomy & Physiology/ A&P20? /CNS Histol 
ogy/Spinal Cord/Spinal Cord Histology.htm. 
Dorsal root entry zone 
Doraal root 
Pig 1.2 
connective tissue layer derived from the mesoderm. Inside the epineurium, another layer 
called the perineurium covers bundles of individual fibers called fasciculi, which are 
filled with an intrafascicular connective tissue called the endoneurium. The epineurium 
provides the major structural support for the peripheral nerve and is made up of 
fibroblasts, collagen and fat. The perineurial layer is made up of alternating layers of 
flattened polygonal cells derived from fibroblast and collagen; between these layers is the 
basal lamina that contains important growth promoting molecules that will be discussed 
in later sections of this study. The endoneurium is made of mostly type 1 collagen fibers 
and is found adjacent to individual Schwann cell-axon units; between these units and the 
endoneurium lies another basal lamina layer (Fig 1.3). 
1.1.3.1 Anatomy of the dorsal root ganglion 
Although spinal nerves contain both motor and sensory fibers, my studies have 
focused on the sensory portion of the PNS, in order to study the processes involved in 
axonal regeneration. I will now describe the anatomy of the sensory dorsal root ganglion 
neuron, on which all of my studies have been performed. 
Sensory neurons that convey information from peripheral sensory organs to the 
dorsal aspect of the spinal cord are housed in connective tissue similar to the 
perineurium, known as the dorsal root ganglion (DRG) (Fig 1.2) (Gray et al., 1995). 
DRG neurons are pseudounipolar with spherical cell bodies that vary in diameter and are 
surrounded by small round satellite cells (Devor, 1999; Yoshida and Matsuda, 1979). A 
single axon that arises from these neurons exits the cell body and bifurcates, sending one 
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Figure 1.3. Anatomy of the peripheral nerve. A: Illustration of the typical structure of 
a peripheral nerve. B: Histological section of a sciatic nerve. The peripheral nerve is 
made up of three connective tissue layers, the outermost epineurium, the middle 
perineurium, and the innermost endoneurium. The endoneurium surrounds individual 
nerve bundles that house axons, Schwann cells, and the basal lamina. Adapted from 
http://science.nhmccd.edu/biollnervous/nervous.htm and http://www.apsu.edu /thompsonj 
I Anatomy%20&%20Physiologv /2010/201 0%20Exam%20Reviews/Exam%204%20Revi 
ew/CH%2013%20Peripheral%20Nerve%20Histology.htm. 
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Fig 1.3 
process centrally to fdrm a synapse in the dorsal aspect of the spinal cord via the dorsal 
root entry zone, while the other process goes peripherally to the sensory receptors located 
in the skin, muscle, and visceral organs (Devor, 1999). Thus, the sensory message is 
carried from the periphery to the CNS via an extremely long axon that essentially 
bypasses the cell body, which makes up less than 1% of the cell's cytoplasm, and acts to 
supply protein and energy to the enormous length of axon (Devor, 1999). 
The adult rat DRG is made up of a heterogeneous population of cells subdivided 
on the basis of neurochemistry, morphology, trophic requirements, and sensory 
modalities (Averill et al., 1995; Gavazzi et al., 1999; Ishikawa et al., 2005; Petruska et 
al., 2000; Priestley et al., 2002a). Three major cell groups have been identified with 
potential for further subclassification. To aid in the explanation of the different cellular 
subpopulations within the DRG, a schematic illustration adapted from Priestley and 
colleagues has been included (Fig 1.4). As shown in Fig 1.4, the first group (denoted in 
red) contains roughly 30-40% of the cells within the DRG. This population comprises 
the large and medium diameter neurons, and can be identified based on their expression 
of the heavy chain neurofilament (NF200+ve ). These neurons typically have large 
myelinated axons, and function as mechanoreceptors and proprioceptors that have the 
ability to rapidly conduct action potentials. With regards to receptor expression, the 
NF200+ve neurons express the p75 neurotrophin receptor and TrkC, although TrkA and 
TrkB receptors are also reported (Averill et al., 1995; Ishikawa et al., 2005; Priestley et 
al., 2002a). Therefore, these neurons are able to respond to NT-3 (binds TrkC), NGF 
(binds TrkA), and BDNF (binds TrkB). The next two major groups consist of mainly 
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Figure 1.4 Pie chart summarising the three major populations of neurons that 
are found in the DRG. Large diameter myelinated Proprioceptive and 
Mechanoreceptive neurons are NF200+ve; small and media diameter nociceptive 
peptidergic neurons are CGRP+ve; small diameter non-peptidergic nociceptive neurons 
bind the lectin Grifjonia Simplicifolia IB4. This figure has been adapted from Priestley 
et. al. 2002. 
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small diameter neurons and are considered to be either peptidergic, expressing calcitonin 
gene related peptide (CGRP+ve, denoted in yellow), or non-peptidergic, binding the 
lectin Griffonia Simplicifolia IB4 (denoted in green) (Averill et al., 1995; Ishikawa et al., 
2005; Priestley et al., 2002a). These groups are considered to be unmyelinated or thinly 
myelinated nociceptive afferents. The CGRP+ve population contains roughly 30% of the 
cells within the DRG and also expresses a high level of both the p75 neurotrophin 
receptor and TrkA, thus these neurons preferentially respond to NGF (Averill et al., 1995; 
Ishikawa et al., 2005; Priestley et al., 2002a). The IB4-binding population also contains 
roughly 30% of the cells within the DRG. These neurons do not express either the p75 
nor Trk receptors, but instead express the receptor tyrosine kinase RET and the GFRa 1 
subunit, which makes these cells responsive to GDNF and unresponsive to the 
neurotrophins NGF, NT3, and BDNF (Bennett et al., 1998; Kashiba et al., 2001; Molliver 
et al., 1997). 
The internal complexity of the DRG coupled with the fact that each neuron 
extends a single axon a great distance to its periphery gives the DRG the unique 
morphological properties that make it a great candidate for the study of axonal 
regeneration. 
Another important property of adult DRG neurons that make them ideal for 
studying axonal regeneration is that, unlike neonatal DRG neurons that show a 
dependence on neurotrophic factors for their survival, postnatal DRG neurons are 
neurotrophin independent and are able to survive both in vitro and in vivo in the absence 
of exogenous trophic factors (Dodge et al., 2002; Dodge et al., 2006). This property 
allows neurotrophin-induced growth effects to be clearly distinguished from neurotrophin 
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induced survival effects. Studies that focus on regeneration in embryonic or neonatal 
neurons are always plagued by the fact that neurotrophins have to be present. Thus, the 
interaction between extracellular matrix molecules and neurotrophins on axon growth can 
be difficult to determine. ' 
1.1.4 Classification of nerve injury 
Functional recovery after axonal injury is limited, and in many cases, reliant on 
the type and severity of nerve injury. Seddon identified three major categories for the 
classification of peripheral nerve injury, which include neuropraxia, axonotmesis, and 
neurotmesis, brief descriptions of each of these injuries are as follows (Seddon, 1975). 
Neuropraxia is the least severe type of nerve injury and is the result of a mild 
insult, such as local ischemia, which induces a block in impulse conduction. Although 
this type of injury can result in both motor and sensory loss, axonal continuity remains 
intact, and, Wallerian degeneration does not occur. Such pathology is usually the result 
of a myelin sheet injury and patients undergo full functional recovery within a relatively 
short period of time (Seddon, 1975). 
Axonotmesis is a more severe condition in which axonal continuity is lost while 
the connective tissue, including the Schwann tubes, endoneuria!, and perineurial 
structures, remain intact. This condition is commonly seen in crush/compression, stretch 
and percussion injuries, and results in a less favourable prognosis. Unlike neuropraxia 
where the axon remains intact, axonotmesis results in the proximal portion of the severed 
axon dying back to the node of ranvier adjacent to the injury site, while the distal portion, 
due to the loss of cell body contact, undergoes Wallerian degeneration. For regeneration 
to occur, the axon has to leave the proximal stump and grow a substantial distance across 
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the site of injury back to the original target. In this situation, the remaining endoneuria! 
tube provides a path for regenerating axons, and thus, functional recovery is possible and 
depends on the degree of internal disorganization of the nerve, severity of damage to the 
cell body, and the distance required for target innervation (Seddon, 197 5). 
Neurotmesis is the most severe type of nerve injury, resulting in the poorest 
prognosis. This type of injury occurs when there is a complete loss of continuity of the 
entire nerve and is usually the result of a laceration or severe nerve crush, whereby all 
axons and connective layers, including the perineurium and endoneurium, are severed. In 
this situation, spontaneous functional recovery is poor; not only does the nerve have to 
grow large distances to reach its target, but is has to do so without any guidance from the 
original connective structures (Seddon, 1975). Although functional recovery is rare after 
this type of insult, clinical attempts are still made to repair sites of injury and stimulate 
axonal regeneration. For instance, a variety of surgical techniques, including coaptation 
by epineurial suture, fascicular suture, and glue, have been used, to essentially bring the 
distal and proximal nerve stumps together while trying to reduce the extent of scar 
formation and provide a path for nerve growth (Chen, 2002). In many cases, the amount 
of damage inflicted by the injury is so severe that sections of the nerve are lost or have to 
be removed. In such a situation, coaptation without stretching and inflicting further 
damage to the proximal and distal aspects of the remaining nerve becomes impossible. 
Intervention in this case requires that a bridge be formed between the two nerve stumps. 
A variety of materials have been used to bridge the gap, including both natural 
biologically active materials, such as skeletal muscle, blood vessels, and autogenous 
nerve, and non-biological materials, such as silicone, nylon fiber, and polyurethanes 
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(Chen, 2002; Hall, 1997; Hall and Kent, 1996; Meek and Coert, 2002; Strauch, 2000). 
Both types of materials have their own benefits and shortcomings. For instance, the 
biological materials have good compatibility, and thus, a low rejection rate, but they tend 
to collapse and promote scar tissue proliferation, resulting in poor regeneration. The non-
biological materials provide much better support and can be laden with growth promoting 
molecules like growth factors and extracellular matrix proteins, but, they are foreign 
objects and can be subject to rejection. 
1.1.5 Models of injury and disease affecting the PNS 
Peripheral neuropathy refers to an injury or degeneration of peripheral axon 
fibers. In general, peripheral neuropathies can be mononeuropathies, or a 
polyneuropathies (Marrs and Newton, 2003). Mononeuropathies affect a single nerve 
root or peripheral nerve fiber and are usually caused by a direct injury or insult to the 
axon. Polyneuropathies affect more then one peripheral nerve and are usually the result 
of a disease. Both of the~e types of nerve injury result in substantial disability and loss of 
function; and spontaneous full functional recovery is limited. 
1.1.5.1 Physical nerve insults 
Traumatic peripheral nerve injury is a relatively common occurrence, seen in 
upwards of 5% of the people admitted to trauma centers. Currently, one of the most 
common causes of peripheral nerve injury are motor vehicle accidents, although, many of 
the early clinical cases occurred during the first and second world wars (Noble et al., 
1998; Woodhall, 1951). In many occurrences, peripheral nerve damage is the result of 
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fractures to adjacent bones; for instance, upper extremity nerve injuries such as radial, 
ulnar, and median nerve damage may be due to broken radial and/or ulnar bones, and 
similarly, femoral nerve injuries commonly result from fractures of the femur (Noble et 
a!., 1998). Although mononeuropathies of this nature result in substantial functional 
impairment, these types of physical injuries are asymmetric, affecting one body area 
only. For instance, a severed right radial nerve would result in a partial loss of function 
of the right hand. As suggested previously, regeneration and functional recovery after 
physical nerve injury is dependent on the severity of the nerve injury. For example, in 
severe crush/transection injuries, where no real organized distal stump remains, the 
connective tissue and immature nerve fibers form a neuroma, which is a disorganized 
bundle of fibers that prevents any further regeneration (Young, 1948). 
1.1.5.2 Diabetes 
Diabetes is a disease that results from either a deficiency of insulin or an insulin 
receptor malfunction. In either case, glucose accumulates in the extracellular fluid and 
exerts negative effects on a number of sensitive cell populations. Alterations in glucose 
levels induce diabetic polyneuropathies, which are the most common complication, and 
in many cases, the first indicator, associated with diabetes (Feldman et al., 1997; 
Polydefkis et a!., 2004 ). Unlike physical nerve injury, diabetic polyneuropathies are 
symmetric and readily affect the sensory nerves of the DRG. DRG neurons are 
especially susceptible to glycemic regulation because the cell body and long peripheral 
axons are located outside of the protective blood nerve barrier (Arvidson, 1979). 
Hyperglycemia associated with diabetes induces a variety of functional and structural 
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abnormalities in these' cells, including decreased axonal caliber and conduction velocity, 
dying back and dwindling of axons, disruption of the cell membrane, and possible cell 
death. Many of these abnormalities are associated with alterations in structural proteins 
such as tubulin and neurofllament (Pierson et al., 2002; Scott et al., 1999; Yagihashi et 
al., 1990). These changes may lead to a loss of sensation for pressure, temperature, and 
vibration. Eventually reflexes carried by large sensory neurons are diminished, and the 
patient can experience pain or numbness (Feldman et al., 1999). A major complication 
associated with this disease has been termed the diabetic foot. The diabetic foot is a 
condition where the loss of pain sensation, through disruption of distal sensory contacts, 
predisposes diabetics to foot ulcerations. Foot ulcers go undetected for extended periods 
of time, and failing to heal, they become gangerous and result in foot amputation, or 
potentially patient death (Le Quesne and Fowler, 1986). 
Although peripheral neuropathies are a major problem associated with diabetes, 
little effort has gone into promoting regeneration of injured axons (McHugh and 
McHugh, 2004). This is a concern as many environmental alterations associated with 
diabetes have been reported. As suggested in section 1.1.2, in the normal PNS, injury 
results in rapid macrophage infiltration and phagocytosis of the inhibitory myelin sheet. 
Schwann cells take on a proliferative nature forming guidance tubes for regenerating 
axons and increasing their expression of permissive extracellular matrix molecules, 
which help to produce a new basement membrane. In diabetic nerves, these regeneration 
promoting processes are delayed or interrupted, producing an environment that more 
closely resembles that of the CNS (Cheng and Zochodne, 2002; Kennedy and Zochodne, 
2000; Levy et al., 2001). For example, delayed macrophage infiltration results in the 
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prolonged presence of inhibitory myelin proteins (Kennedy and Zochodne, 2000; Levy et 
al., 2001 ), and the failure of Schwann cells to migrate out of the distal stump results in 
poor basement membrane production and the absence of bands of Bungner (Cheng and 
Zochodne, 2002). These events make the normal permissive environment of the PNS 
inhibitory, resulting in poor axonal regeneration and prolonged degeneration. 
In addition to the altered immune and Schwann cell responses, diabetes also 
produces alterations in the expression of both growth factor molecules and their 
corresponding cell surface receptors. For instance, decreased NGF production, as well as 
reduced Trk A expression and NGF retrograde signalling have been found in DRG 
neurons and their targets in diabetic models (Brewster et al., 1994; Hellweg and Hartung, 
1990; Jakobsen et al., 1981; Pierson et al., 2003). An increase in p75 expression, which 
has been reported to stimulate sensory neuron cell death, has been found in diabetic 
peripheral nerves (Jiang and Jakobsen, 2004; Scarpini et al., 1996). Alterations in 
neurotrophin signalling and expression may contribute to the impaired nerve function 
associated with diabetes, as it has been shown that NGF treatment has the potential to 
reverse diabetes-related nerve alterations (Unger et al., 1998). 
These findings indicate that the extracellular environment is critically important in 
peripheral nerve regeneration regardless of whether the loss of function comes from 
direct physical insult or disease. 
1.1.6 Models for the study of axonal regeneration in the PNS 
A variety of different models, both in vivo and in vitro, have been utilized to study 
the processes involved in axonal regeneration. Each of these model systems has its 
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advantages and disadvantages. For my studies, I have chosen to use an in vitro model to 
study aspects related to sensory nerve regeneration. I will briefly discuss the widely used 
ner've crush model for the study of axonal regeneration and explain why I have chosen to 
use dissociated DRG neurons instead. 
1.1.6.1 In vivo vs. in vitro 
Nerve crush is one of the most commonly used in vivo models for the study of 
axonal regeneration. In the use of this model, animals are anaesthetized, the nerve of 
interest is exposed, and a mechanical crush is performed. The crush induces axotomy 
and stimulates Wallerian degeneration and die back of the distal and proximal axons 
respectively. This allows the researcher to study a number of different experimental 
questions. For instance, early studies by Ramon Cajal that expanded on Waller's original 
work utilized nerve crush to identify fine details associated with Wallerian degeneration 
(Stoll et al., 2002). Years later, this technique is still being used to study the effects of 
axotomy on gene expression in both neurons and support cells, in an attempt to 
understand regenerative conditions. For example, axotomy has recently been shown to 
stimulate the upregulation of the cell surface adhesion receptors, or integrins, in the 
proximal axon (Wallquist et al., 2004). So why have I chosen to use an in vitro cell 
culture model to study the aspects of peripheral nerve regeneration? 
The research that I have conducted has focused on the effects of environmental 
factors on sensory nerve regeneration. Thus, it made more sense to be able to study 
individual cells in isolation without confounding extraneous variables found in the 
surrounding peripheral nerve. By removing the non-neuronal cells and all of the support 
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structures found in the dorsal root ganglion, I was able to exert precise experimental 
control by adding the factors ot interest to the neurons one at a time while looking for 
potential interactions. This method of study also allowed me to investigate fine details at 
the cellular level associated with sensory axon regeneration. 
I realize that in vitro models such as this are not the same as the nerve crush 
models of real physiological conditions, as the peripheral environment is made up of 
more than just one or two components, in a three dimensional space. However, valuable 
data that would be difficult to collect using in vivo methods can be obtained, and applied 
to in vivo models of regeneration using in vitro models. 
1.1.7 Growth factors and their role in neurite growth 
Trophic factors are well known mediators of differentiation, survival, and growth 
of both CNS and PNS neurons during development and regeneration (Airaksinen and 
Saarma, 2002; Allen and Dawbarn, 2006; Chao et al., 2006; Kaplan and Miller, 2000; Lu 
et al., 2005; Markus et al., 2002a; Snider et al., 2002). Of the various trophic factors 
available, I will discuss members of two distinct families that are critically important to 
DRG neurons. The first group consists of the classical neurotrophins NGF, BDNF, 
Neurotrophin-4/5 (NT4/5), and Neurotrophin-3 (NT3), while the second group is closely 
related to members of the transforming growth factor~ superfamily and includes GDNF, 
neurturin (NTN), persephin (PSP) and artemin (ART). Both groups of molecules are 
secreted, soluble factors that have a noncovalent homodimer structure consisting of two 
pairs of non-parallel ~ subunits (McDonald and Blundell, 1991; McDonald and Chao, 
1995; McDonald et al., 1990; McDonald et al., 1991; Yano and Chao, 2000). Thus, 
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trophic factors are veiy similar in structure and differ mainly by amino acid sequences 
found in three distinct loops that join the j) strands (McDonald and Chao, 1995). Of these 
I 
trophic factors, I will first discuss the neurotrophin NGF, its receptors, and subsequent 
signalling mechanisms, f~llowed by GDNF, its receptors and subsequent signalling 
mechanisms (the populations of DRG neurons that do not respond to NGF, express the 
receptors for and respond to GDNF). 
1.1.7.1 NGF and its receptors 
NGF was the first member of the neurotrophin family to be identified and has 
become the prototypical member of the neurotrophins. This molecule was first 
discovered by Rita Levi-Montalcini and Viktor Hamburger in the early 1950s as a 
stimulant of survival and differentiation in embryonic sensory and sympathetic neurons 
(Aloe, 2004; Cowan, 2001; Hamburger, 1993; Levi-Montalcini et al., 1995). As 
suggested previously, NGF exerts its effects by binding to two separate classes of 
receptors, the low affinity p75 neurotrophin receptor (p75NTR) and the high affinity 
tropomyosin receptor kinase A (TrkA). The p75NTR receptor is a member of the tumor 
necrosis factor family and has the ability to bind all neurotrophins with the same affinity 
(Yano and Chao, 2000). As noted above, p75NTR functions as a component of the 
Nogo, Lingo receptor complex and aids in the activation of RhoA and subsequent 
inhibition of neurite growth following growth cone binding to inhibitory myelin 
molecules. Aside from this function, p75NTR also acts as a co-receptor for Trk, altering 
the binding kinetics ofNGF (Hempstead et al., 1991; Mahadeo et al., 1994; Yano and 
Chao, 2000). For instance, the use of I 125 -NGF indicates that binding to, and release of 
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NGF from TrkA happens at a much slower rate when p75NTR is absent than when 
p75NTR is present (Mahadeo et al., 1994). Similarly, removal of the p75NTR receptor 
decreases the sensitivity of sensory neurons to NGF (Lee et al., 1994). The signalling 
components downstream of p75NTR following NGF binding are essentially the same as 
those found following myelin binding. However, instead of stimulating the activation of 
RhoA and inhibiting neurite growth, NGF binding inhibits RhoA activation, which acts to 
enhance neurite growth (Blochl et al., 2004; Gallo and Letourneau, 2004). Thus, 
p75NTR can act as both a positive and negative regulator of neuronal regeneration. 
Unlike the p75 receptor that binds all neurotrophins with the same low affinity, 
Trk receptors act by binding with a high affinity to specific members of the neurotrophin 
family. For instance, TrkA preferentially binds NGF, TrkB preferentially binds BDNF 
and NT4/5, and TrkC preferentially binds NT3. As shown in Fig 1.5 three major 
signalling pathways stimulated by NGF binding to TrkA have been identified, these 
pathways consist of the PI 3-K/Akt, Ras/MAPK, and PLC-y signalling intermediates. 
Upon NGF binding, TrkA dimerizes and autophosphorylates its cytoplasmic tyrosine 
residues Y490 and Y785. The phosphorylation of these residues stimulates the 
recruitment and binding of adaptor proteins, which in turn, activate downstream 
-33-
Figure 1.5. Schematic illustration summarizing proposed signalling intermediates 
involved in NGF induce neurite growth of adult DRG neurons. 
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signalling intermediates (Cunningham and Greene, 1998; Kaplan and Miller, 1997; 
Kaplan and Miller, 2000; MarRus et al., 2002a; Snider et al., 2002; Yano and Chao, 
2000). Phosphorylation of Y 490 stimulates the activation of both Ras/MAPK and PI 3-
K/Akt signalling pathways, whereas phosphorylation ofY785 activates PLC-y, which in 
tum, stimulates PKC activation (Kaplan and Miller, 1997; Kaplan and Miller, 2000). 
Stimulation of these pathways has been shown to play significant roles in cellular 
differentiation, survival and neurite outgrowth in a variety of different cell types. For 
example, inhibition of the Ras/MAPK pathway blocks NGF-induced differentiation in 
PC12 cells, while inhibition of the PI 3-K/Akt pathway has a negative impact on cell 
survival (Kaplan and Miller, 2000; Kim et al., 2004; Klesse et al., 1999). Conversely, 
activation of the PI 3-K/ Akt signalling pathway in these cells has been shown to inhibit 
neurite branch formation and aid in neurite elongation (Higuchi eta/., 2003). Similarly, 
neurite growth stimulated by the addition of NGF is dependent on the PI 3-K/Akt 
signalling pathway in both DRG and sympathetic neurons, and the inhibition of either of 
PI 3-K or Akt has a negative effect on axonal regeneration (Atwal et al., 2000; Edstrom 
and Ekstrom, 2003; Jones et al., 2003; Kimpinski and Mearow, 2001; Markus et al., 
2002b; Zhou et al., 2004). 
Although the above signalling intermediates have been identified as important 
components for axonal regeneration, how these pathways actually regulate axon growth 
in not well understood. 
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1.1.7.2 GDNF and its 'receptors 
GDNF was the first member of the GDNF family of trophic factors to be 
I 
discovered and has been identified as a molecule that could promote survival in a variety 
of cell types including PC12 cells, mesencephalic dopaminergic neurons, motor neurons, 
sympathetic neurons, locus coeruleus noradrenergic neurons, and subpopulations of 
sensory neurons (Airaksinen and Saarma, 2002; Arenas et al., 1995; Coulpier and Ibanez, 
2004; Henderson et al., 1994; Lin et al., 1993; Oppenheim et al., 1995; Park et al., 2005). 
Shortly after the discovery of GDNF, the other family members NTN, PSP and ART 
were identified. Like NGF, the GDNF family of trophic factors exerts its actions by 
binding to two separate cell surface receptors. The first receptor GFR-a., like Trk, is the 
high affinity growth factor receptor responsible for ligand specificity (Airaksinen and 
Saarma, 2002). For instance, although some overlap exists, GFR-a.l preferentially binds 
GDNF, GFR-a.2 preferentially binds NTN, GFR-a3 preferentially binds PSP, and GFR- · 
a.4 preferentially binds ART. Although binding to the GFR-a. receptor alone has been 
shown to stimulate internal signalling cascades, it is commonly accepted that this GPI 
linked receptor signals via activation of the second GDNF receptor, RET (Durbec et al., 
1996; Treanor et al., 1996; Trupp et al., 1996). Like Trk, RET is a transmembrane 
tyrosine kinase receptor, which upon activation, has the ability to stimulate internal 
signalling cascades (Sariola and Saarma, 2003). Signalling pathways are activated by 
initial GDNF binding to the GFR-a.l receptor, which stimulates the recruitment and 
dimerization of two RET receptor subunits, the combination of which stimulates 
transphosphorylation of specific tyrosine residues on the receptors' cytoplasmic tails 
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(Airaksinen and Saarma, 2002). GDNF induced phosphorylation of the cytoplasmic 
tyrosine residues on RET stimul~tes the recruitment of specific adaptor proteins, which in 
turn, activate specific signalling cascades. As shown in Fig 1.6, Like NGF, RET 
phosphorylation has the ability to activate the MEK/MAPK, PI 3-K/ Akt and PLC-y 
pathways (Sariola and Saarma, 2003). For instance, phosphorylation ofY1015 stimulates 
the activation of PLC-y (Borrello et al., 1996; Trupp et al., 1999), phosphorylation of 
Y1062 stimulates the activation of MEK/MAPK (Trupp et al., 1999), and 
phosphorylation of Y1 096 stimulates the activation of PI 3-K/ AKT (Soler et al., 1999; 
Trupp et al., 1999). Aside from stimulating survival in various cell types, activation of 
these signalling intermediates via GDNF can also stimulate neurite growth. For instance, 
GDNF-induced activation of PI 3-K, but not MAPK, is required for lamellopodia 
formation and process extension in both neuroepithelioma SK-N-MC cells and enteric 
neuroblasts (Maeda et al., 2004; Srinivasan et al., 2005; van Weering and Bos, 1997). 
GDNF-induced activation of MAPK, but not PI 3-K, stimulates differentiation and 
neurite outgrowth in PC12 cells (Creedon et al., 1997; Park et al., 2005; Xing et al., 
1998). However, in sympathetic neurons GDNF has been shown to stimulate neurite 
growth by activating both PI 3-K and MAPK signalling pathways (Coulpier and Ibanez, 
2004). These results not only show the importance of the different signalling 
intermediates in neurite growth and cellular survival but they also illustrate that many of 
the results are cell type specific, and what is important in one cell type may not be 
important in another. 
To date most of the studies on trophic factor-induced neurite growth have been 
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Figure 1.6. Schematic illustration summarizing proposed signalling intermediates 
involved in GDNF induced neurite growth of adult DRG neurons. 
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carried out using different cell types with cells cultured in the presence of extracellular 
matrix molecules, with the result that the influence of these molecules are often 
I 
overlooked. Therefore, the complex interplay between neurotrophin and extracellular 
matrix receptors that lead to neurite growth are not well understood. 
1.1.8 Extracellular matrix molecules and their role in neurite growth 
The ability of a neuron to extend a process over a biological substrate requires 
there to be a direct interaction with an insoluble network of proteins called the 
extracellular matrix, or basement membrane. Depending on the different cellular 
locations, this matrix consists of a number of different molecules; for example, laminin, 
collagen, and fibronectin have all been identified in the PNS (Guo and Giancotti, 2004). 
Extracellular matrix molecules (ECM) exert their effect by binding to a class of cell 
surface adhesion receptors called integrins (Aplin et al., 1999; Giancotti and Ruoslahti, 
1999; Guo and Giancotti, 2004). Integrin receptors are abundant on the leading edge of 
growth cones peripheral domains, and on the leading edge of migrating cells. Here these 
receptors act as sensors for ECM molecules and stimulate internal signalling cascades 
upon binding. Of the extracellular matrix molecules, we are most interested in the effects 
of laminin and the corresponding integrin receptors on neurite growth. In early studies 
on basal lamina composition, it was found that laminin is the most highly expressed ECM 
molecule in the basement membrane (Martin and Timpl, 1987). This molecule is 
detected earlier than any other ECM molecule during development and persists into 
adulthood (Martin and Timpl, 1987). More recent studies have confirmed these results, 
for example, studies by Matesz et al. on the role extracellular matrix molecules in 
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nervous system regeneration, have found that laminin is highly expressed in the PNS of 
the common water frog Rana Bsculenta and is upregulated after PNS injury (Matesz et 
a/., 2005). Although other ECM molecules are present at lower levels in the PNS, 
laminin has been shown to be a stronger promoter of neurite growth from DRG neurons 
than collagen or fibronectin (Gundersen, 1988). 
As suggested previously, the lack of ECM proteins in the adult CNS provides a 
partial reason why little or no axonal regeneration occurs from CNS neurons after injury 
(Matesz et al., 2005). The presence of these molecules has been shown to be able to 
overcome the inhibitory influences of CNS myelin and CSPGs on neurite growth (Condie 
et al., 1999; David et al., 1995). For example, recent studies by Laforest et al, show that 
PC 12 cells plated on MAG normally have little neurite growth, poor cellular adhesion, 
and little cell spreading, but, when laminin was added to these cultures the inhibitory 
MAG induced effects were overcome. By using specific integrin inhibitors, the authors 
found that these effects were integrin dependent and that a laminin specific integrin was 
involved (Laforest et al., 2005). 
The following section will provide a brief discussion of laminins, their structure, 
and corresponding function; I will then discuss the laminin-binding integrin receptors and 
known downstream signalling cascades. 
1.1.8.1 Laminins 
The ECM molecule laminin was initially isolated from basement membranes 
produced by mouse tumor cells called Engelbreth-Holm-Swarm or EHS cells (Timpl et 
al., 1979). Individual laminin molecules are large trimeric proteins with a,~, and y 
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subunits that predominantly bind to cell surface adhesion receptors called integrins 
(Luckenbill-Edds, 1997; Malinda and Kleinman, 1996). The three separate laminin 
I 
subunits bind together to form a cross-like structure and each domain has been suggested 
to serve specific cellular fu~ctions, such as attachment, migration, and neurite growth and 
elongation (Luckenbill-Edds, 1997). At least 10 different laminin isoforms have been 
identified, which are expressed in various regions of the mammalian body and by 
different cell types. These isoforms vary only by their expression of a, ~, and y subunits, 
and have been termed laminin-1 to laminin-15 (Colognato et al., 2005; Luckenbill-Edds, 
1997). 
In the PNS, laminin is a molecule that is synthesized and secreted by a variety of 
cell types. Schwann cells, being a major producer of laminin in the peripheral nerve, 
deposit these molecules within the basal lamina. This basal lamina and subsequently 
laminins have been shown to be involved in many different processes, and have been 
shown to function in different stages of development. For example, their function is 
required for proper neural crest cell migration (Previtali et al., 2001; Tarone et al., 2000) 
and in the attraction and stimulation of neurite growth (Luckenbill-Edds, 1997). 
Laminins have also been shown to play important roles in Schwann cell-induced 
myelination of PNS axons. In normal developmental and regenerative processes, 
myelinating Schwann cells are surrounded by a basal lamina rich in larninin-2, and 
laminin-8 which have both been shown to be required for normal myelin formation; 
disruption of Schwann cell production of either of these laminin isoforrns results in 
defects in synthesis of myelin proteins and an abundance of unsorted, unmyelinated 
axons (Chen and Strickland, 2003; Oguievetskaia et al., 2005; Yang et al., 2005). 
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As suggested previously, laminin production is increased after PNS injury and is 
prominent during bands of Bungner formation, which are important for forming growth 
and guidance tubes for regenerating axons. Studies indicated that these molecules could 
play a positive role in neurite growth. The addition of an anti-laminin antibody prevents 
axon growth into peripheral basal lamina tubes of rat sciatic nerves (Wang et al., 1992), 
while laminin availability is able to override the inhibitory influences of myelin on both 
CNS and PNS neurons (David eta!., 1995; Matesz eta!., 2005). As suggested above, the 
major laminin receptors are the integrins, and although these receptors have been shown 
to bind different laminin isoforms, laminin-1 is a predominant mediator of neurite 
outgrowth in the PNS (Luckenbill-Edds, 1997). Therefore, in my studies this was the 
main laminin isoform that was used. 
1.1.8.2 Integrin receptors 
Growth cone attachment to laminin and subsequent activation of internal 
signalling cascades, are mediated through integrins. Integrins are a class of heterodimeric 
transmembrane cell surface adhesion receptors that are composed of a and (3 subunits, 
the cytoplasmic tails of which are short and have no intrinsic enzymatic activity 
(Giancotti, 2003). To date, 18 a and 8 (3 mammalian subunits have been identified, and 
different combinations of these subunits allow for the creation of at least 24 different 
integrin receptors (Guo and Giancotti, 2004). Each of these receptors have been shown 
to bind different ECM molecules with partial overlap between ligands, and most integrins 
recognize more than one ECM molecule (Giancotti, 2003; Giancotti and Ruoslahti, 1999; 
Hynes, 2002). For instance, a1(31 binds both laminin and collagen; however, laminin 
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also acts as a ligand for a2131, a3131, a6131, a6134, and a 7131 (Archelos et al., 1999; 
Hynes, 1992; Previtali et al., 2001). Much of the work performed on integrin receptors 
has focused on their role in cell migration, angiogenesis, wound healing, and metastasis 
(Caswell and Norman, 2006; Eble and Haier, 2006; Lenz, 2005; Sato, 2001; Serini et al., 
2006). However, the importance of these receptors in growth and repair of PNS neurons 
has also been identified (Previtali et al., 2001). As with laminin, integrin receptors have 
been shown to be upregulated after injury to PNS neurons. For example, upon injury of 
the peripheral processes of the DRG, the laminin-associated integrin receptors a6131 and 
a 7131 are upregulated, and this has been suggested to play an important role in 
regeneration after PNS injury (Wallquist et a!., 2004 ). Similarly it has been shown that 
DRG neurons receiving a preconditioning lesion prior to severe injury have significantly 
better regeneration in the presence of laminin than neurons that did not receive a 
preconditioning lesion. This effect was suggested to be due to an upregulation of the 
a7131 integrin receptor after the initial injury, and inhibition of this receptor was shown to 
inhibit the precondition growth effect (Ekstrom et al., 2003). 
Although integrins have short cytoplasmic tails with no intrinsic enzymatic 
activity, they have been shown to function by signalling across the membrane in two 
distinct directions: via "inside-out" signalling, molecular intermediates within the cell act 
to alter receptor affinity and activation state by altering the conformation of its 
cytoplasmic tails. In "outside-in" signalling, ligand binding activates the integrin 
receptor which stimulates a conformational change within the extracellular component of 
the receptor, which in turn mobilizes complexes of molecules that transmit a variety of 
intracellular signals (Aplin et al., 1999; Clark and Brugge, 1995; Clark and Hynes, 1997; 
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Giancotti, 2003; Giancotti and Ruoslahti, 1999; Ginsberg et al., 2005; Guo and Giancotti, 
2004; Schwartz et al., 1995; TraVis et al., 2003). 
As I am most interested in the effects of laminin binding on axonal regeneration, I 
will focus my discussion on the "outside-in" signalling processes involved in integrin 
activation. The mechanisms involved in "outside-in" signalling have been most widely 
studied in non-neuronal cells and are associated with proliferation, survival, and 
migration of different cell types. Integrin binding to the ECM has been shown to 
stimulate a conformational change in the cytoplasmic tail of the receptor, such that the 
tails straighten and stimulate the recruitment of adaptor proteins such as talin and 
vinculin. These proteins then act to link integrins to the actin cytoskeleton and stimulate 
the recruitment of a number of different cytoplasmic protein kinases (Giancotti, 2003; 
Giancotti and Ruoslahti, 1999). Coupled with ligand-induced integrin clustering these 
events stimulate the formation of aggregates at the cell surface called focal adhesions 
(Giancotti, 2003; Giancotti and Ruoslahti, 1999). The kinases associated with these focal 
adhesions include focal adhesion kinase (F AK), integrin-linked kinase (ILK), and the 
Src-family kinases (such as Src, Fyn, and Yes) (Chen et al., 1996; Guo and Giancotti, 
2004; Hannigan et al., 1996; Howe et al., 1998; Kornberg et al., 1992; Schaller and 
Parsons, 1994; Schlaepfer and Hunter, 1998; Wary et al., 1996; Wary et al., 1998). 
Activation ofthese early integrin-linked intermediates has also been suggested to activate 
the downstream signalling components Ras, MAPK, and PI 3-K, all of which have been 
shown to be activated by growth factor receptors in different cell types (Giancotti and 
Ruoslahti, 1999; Guo and Giancotti, 2004) 
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The processes associated with focal adhesion formation and actin dynamics are 
regulated by the Rho family of small GTPases. As suggested earlier this family of 
proteins plays an essential role in growth cone remodeling and axonal extension, and thus 
these intermediates are potentially very important in axon growth during regeneration 
(Brunton et al., 2004; Wiesner et al., 2005). 
For both neurotrophin and integrin signalling, I have suggested that the Rho 
family of small GTPases are important for axon growth, but the complex interactions 
between the potential activators and effectors within the cell are poorly understood. For 
example, it has been suggested that activation ofthe PI 3-K/Akt pathway is important for 
NGF- induced neurite growth in adult DRG neurons (Jones et al., 2003; Kimpinski et al., 
1997; Kimpinski and Mearow, 2001), yet how this is linked to growth cone remodeling 
and axon extension is poorly understood. Similarly the connection between integrin-
activated signalling events and axon growth are even more elusive. As noted previously, 
much of the work investigating integrin-mediated signalling has been performed in non-
neuronal cells. This is· important because many of the above mentioned signalling 
intermediates have been suggested to be cell type and behavior dependent (Brunton et al., 
2004; ffrench-Constant and Colognato, 2004). The potential role of integrins in 
regeneration of sensory neuron axons and the complex interactions between integrin- and 
growth factor-activated signalling pathways responsible for axonal regeneration in adult 
sensory neurons are not well understood. 
To summarize the signalling cascades that were suggested to be downstream of 
integrin activation at the time that I started these studies, I have included a schematic 
diagram as an illustration of the possible chain of events (Fig 1. 7). 
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Figure 1.7. Schematic illustration summarizing proposed signalling 
intermediates involved in integrin induced neurite growth of adult DRG neurons. 
a/jl lntegrin 
NEURITE GROWTH 
Fig 1.7 
1.2 Hypothesis and objectives 
The main objective of my thdis was to investigate the mechanisms involved in the 
regulation of neurite growth of adult sensory DRG neurons. My focus was on the effects 
of environmental factors, specifically laminin and NGF, on axonal regeneration. 
Although it is becoming clear that laminin and subsequent integrin binding are important 
processes for axon growth and regeneration, when I began my experiments very little 
information with regards to integrin signalling in neurons was available. At the time, it 
had been suggested that various intermediates in the NGF-induced Trk activated 
signalling pathways were important for neurite growth; however, most of the in vitro 
studies had been performed with cells plated on various extracellular matrix molecules 
such as laminin, and thus the potential interactions and dependence on integrin-induced 
intermediates had been overlooked. Therefore, I became interested in the interactions 
between laminin and NGF signalling intermediates responsible for axonal regeneration 
within the peripheral sensory nervous system. In this study, it was hypothesized that the 
activation of laminin-induced signalling intermediates was sufficient to promote 
significant neurite growth from adult rat DRG neurons in the absence of exogenous NGF, 
and that the addition ofNGF acted to potentiate laminin-induced signalling, stimulating a 
level of neurite growth not achievable by the presence of either factor alone. Thus, 
integrin-activated signalling pathways could synergize with NGF-activated signalling 
pathways to stimulate optimal levels of axonal regeneration in peripheral sensory DRG 
neurons. 
To study this hypothesis, three specific objectives were developed. 
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Objective 1: Test whether integrin activation via binding the ECM molecule 
laminin could stimulate significant neurite growth from adult rat DRG neurons in 
I 
the absence of added neurotrophins. In initial experiments, dissociated adult DRG 
neurons were cultured on 'substrates coated with either poly-D-lysine (a neutral non-
integrin binding molecule) or laminin (an ECM molecule that binds and activates integrin 
receptors), in the presence or absence of added NGF. Using a camera lucida imaging unit 
and corresponding software, the quantity and pattern of neurite growth were assessed. To 
ensure that growth results were due to the engagement of the integrins, these experiments 
were performed in the presence and absence of integrin blocking peptides and antibodies 
(Chapter 2). 
Objective 2: To characterize the signalling pathways stimulated by laminin-
induced integrin activation and NGF-induced Trk activation responsible for neurite 
growth in adult rat DRG neurons. To study the signalling events responsible for 
neurite growth, dissociated DRG neurons were plated on either poly-D-lysine, or laminin 
± added NGF, ±pathway specific pharmacological inhibitors. At 24 hr, cells were 
harvested, lysed, and Western blot analyses were performed. These experiments were 
initially performed in a heterogeneous population of cells (Chapter 2). However, 
differential growth responses were observed in different neurons, so a similar series of 
experiments was performed on specific cell populations (Chapter 4, and 5). To carry out 
these experiments, I developed a cell isolation technique that utilized magnetic beads to 
select, release, and plate homogeneous populations of neurons (Chapter 3). 
Objective 3: To identify key points of collaboration between laminin-induced 
signalling pathways and NGF -induced signalling pathways responsible for optimal 
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levels of neurite growth in adult rat DRG neurons. To identify potential points of 
collaboration between integrin 1 and Trk induced signalling pathways responsible for 
neurite growth, homogeneous populations of dissociated DRG neurons were plated on 
poly-D-lysine ± pathway specific pharmacological inhibitors for 2 h prior to treatment 
with media containing NGF, laminin, or laminin plus NGF. Neurons were subsequently 
harvested and lysed at 1 0 min, 1 hr, or 6 hrs after treatment, and Western blot analyses 
were performed (Chapter 5). 
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CHAPTER2 
INTEGRIN ACTIVATION AND NEUROTROPHIN SIGNALLING 
COOPERATE TO ENHANCE NEURITE OUTGROWTH IN 
' 
SENSORY NEURONS 
(Published in the Journal of Comparative Neurology, 2005, 486(3):267-80) 
2.1 Introduction 
We know that various elements can influence and promote regeneration of 
peripheral axons. In addition to soluble factors (neurotrophins, cytokines and other 
growth factors), the extracellular environment in which growth occurs is critically 
important. In the CNS, axonal regeneration does not occur to any great extent, and while 
this is due to a number of factors, the most prominent is a non-permissive growth 
environment as well as an unavailability of appropriate growth-promoting factors. In the 
PNS, on the other hand, peripheral axons (both motor and sensory) generally regenerate 
quite well relative to CNS axons. We have recently characterized signalling pathways 
activated by NGF and IGF-1 in promoting neuronal survival and neurite growth from 
adult DRG sensory neurons in vitro (Dodge et al., 2002; Jones et al., 2003; Kimpinski 
and Mearow, 2001). While our results show that the provision of both NGF and IGF 
supports the most extensive growth, this enhancement is dependent upon the availability 
of a permissive culture substrate. 
In the PNS, components ofthe basal lamina, such as laminin, collagen IV and 
entactin are well known to promote neurite growth both in vivo and in vitro. In this 
regard, the integrins play a key role, as they are the cell surface receptors for ECM 
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molecules such as laminin. The integrin receptors consist of heterodimers of a and j3 
subunits, the cytoplasmic tails of which are short and have no intrinsic enzymatic activity 
(Giancotti and Ruoslahti, 1999; Howe et al., 1998). Different combinations of these 
receptors bind to different substrate molecules; for instance, integrin a 1131 binds to 
specific domains of the laminin molecule and has been shown to mediate the binding of 
neurons and neuronal cell lines to laminin (Tomaselli et al., 1993 ). Embryonic and 
neonatal chick and rat DRG neurons are reported to express high levels of alj)l and 
a3j31, and lower levels of a5j31 and a6j31 (Condie, 2001; Condie and Letourneau, 1997; 
Lefcort et al., 1992; Tomaselli et al., 1993; Toyota et al., 1990; Yanagida et al., 1999). 
Similarly, adult DRG neurons and their axons express integrins that allow for interaction 
with ECM and basal lamina molecules like laminin, collagen and fibronectin, although 
the level of expression is reported to be much lower than in developing neurons (Condie, 
2001; Condie and Letourneau, 1997). 
Integrin signalling mechanisms have been most widely studied in non-neuronal 
cells, where it has been shown that integrin-mediated events activate a number of 
cytoplasmic protein kinases, in particular F AK (focal adhesion kinase), ILK (integrin 
linked kinase), and the Src-family kinases (Aplin et al., 1998; Giancotti and Ruoslahti, 
1999; Sastry and Burridge, 2000). These intermediates are recruited to the sites of 
integrin-mediated cellular attachment along with other structural proteins such as 
paxillin, talin and vinculin to form focal adhesions, leading to morphological changes 
contributing to events such as cell spreading, survival and migration (Attwell et al., 2003; 
Ivankovic-Dikic et al., 2000; Park et al., 2000). 
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Our objective was to investigate how integrin-activated signalling pathways interact 
with growth factor-activated pathways, and to determine whether integrin signalling 
would be sufficient in the absence ofNGF to promote neurite growth. 
2.2 Materials and methods 
2.2.1 Neuronal cultures 
Dorsal root ganglia (DRG) from young adult (4-6 wk) Sprague-Dawley rats 
(Memorial University of Newfoundland Vivarium and Charles River Canada, Montreal, 
QC) were dissected and dissociated. In accordance with University Animal Care 
guidelines, animals were live decapitated, ganglia from all spinal levels were removed, 
and the roots were trimmed. To isolate individual DRG neurons, both enzymatic and 
mechanical dissociation was used. Enzymatic dissociation was carried out first and 
performed by incubating the ganglia in 0.25% collagenase for 45 min, and 0.25% trypsin 
for 40 min (Invitrogen/ Gibco BRL, Burlington, Ont). Mechanical dissociation was 
carried out next and petformed by repeated cycles of aspiration and expulsion of the 
DRG fragments through a flame narrowed pasture pipette. Upon completion, dissociated 
DRG neurons were suspended in serum-free Neurobasal medium (NB, Invitrogen) 
supplemented with 1 OOU penicillin/streptomycin, B27 supplement (Invitrogen), and 
20mM cytosine arabinoside (modified NB). This suspension was then layered on top of a 
30% Percoll solution (Amersham Bioscience, Baie d'Urfe, QC) in 15ml conical tubes and 
centrifuged at 400g for 20 min at room temperature. Pellets were then carefully extracted 
with a sterile pasture pipette, placed in a fresh 15ml tube, washed with the previous 
suspension media, and centrifuged to remove any remaining Percoll. Neurons were 
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plated in either Lab-Tek 16-well chamber slides (Nunc International, Naperville, NC) for 
neurite growth assessment or I:Z-well plates for Western blot analysis, and incubated at 
37°C with 95% 0 2 and 5% C02 for 24 and 48 hrs. Slides and culture plates were coated 
twice with poly-lysine (PL, 1 mg/ml, BD Bioscience, Bedford, MA) laminin, (LN, 50 
mg/ml, Invitrogen) or Matrigel (MG, BD Bioscience; 1:100 dilution in ice-cold NB). 
Surface coating for MG was similar to that used for laminin, and not at all like the MG 
gels used for ganglionic explants (Tonge et al., 1997). Coating with these extracellular 
matrix molecules resulted in a thin film of LN or MG on the plating surfaces. The 
neurons were cultured in modified serum-free NB alone or supplemented with NGF (25 
ng/ml, Cedarlane Labs, Hornby, ON). 
2.2.2 Immunocytochemistry 
Neurons were fixed in 4% paraformaldehyde (pH 7-7.4) in PBS for 15 minutes, 
permeabilized with 0.1% Triton-X-I 00 and blocked with 10% normal goat serum in PBS. 
For neuronal and neuritic identification, TRITC-labeled Phalloidin (1: 100, Sigma), and 
antibodies directed against peripherin were employed (1 :250, Chemicon, Temucula, CA). 
For analyses ofintegrin signalling components, antibodies directed against ~1 (Chemicon 
AB 1952) and al(Chemicon AB 1934) integrin subunits; pFAK (pY 397, Biosource 
Inc), ILK (Upstate Biotech Inc, Lake Placid, NY), and pAkt (Cell Signalling 
Technology, Beverly, MA) were employed. Cells were incubated with the primary 
antibodies at 4°C for 16-20 hrs, followed by Cy2- or Cy5-tagged secondary antibodies 
(Jackson Immunoresearch Labs, West Grove, PA). These slides were cover slipped with 
glycerol and imaged with confocal laser scanning microscopy. For neuronal tracing 
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analyses, HRP-tagged secondary antibodies were used followed by visualization with the 
ABC system and diamino-benzidine (DAB) as the developing agent (Vector 
Laboratories, Burlingame, CA). 
2.2.3 Measurements ofNeurite Growth 
Neurite initiation (neuritogenesis) was first quantified by determining the 
percentage of total phase bright neurons with neurites twice the length of their cell 
bodies. Growth was assessed at both 24 and 48 hrs. Individual neuron tracings of DAB-
stained neurons were carried out using the Neurolucida® (MicroBrightField, VT) tracing 
program. Only neurons for which we were able to identify unambiguously the associated 
neurites or neuritic networks were chosen for tracing analysis. Data analyses were 
carried out with the NeuroExplorer® software package; here Scholl analysis (intersection 
point and length) and total neurite length data were collected. Scholl analysis measures 
both the number of intersection points of axons crossing 20 ~-tm concentric circles 
radiating from the cell body and the length of the neurites within each concentric circle, 
thus giving a measure of both elaboration and total growth of the neurites. Total neurite 
length is a measure of the cumulative length of neurites produced. Data were imported 
into a graphing and statistical analysis software program (Prism 3, GraphPad Corp) for 
further analyses. For each condition examined (control (PL) +NGF or -NGF, LM +NGF 
or -NGF, and MG + NGF or -NGF) 50 neurons were completely traced, with cells 
pooled from approximately 3-6 different plating experiments. 
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2.2.4 Integrin Blocking 
Integrin activation was /blocked by the use of a synthetic cyclic RGD peptide 
(Arg-Gly-Asp, 0.1 mg/ml, Chemicon), which had been added to culture media two hours 
after plating and replenished every 24 hrs where applicable. In some experiments a !)1-
integrin blocking antibody (131i) (Chemicon) was used; results were similar to those 
obtained with the RGD peptide. 
2.2.5 Immunoblotting 
For Western analyses, neurons were plated in 12-well plates that had been coated 
with PL, LN (25 ~g/ml, Invitrogen) or MG in the presence or absence ofNGF (25 ng/ml, 
Cedarlane Labs). Neurons were subsequently processed at 24 hrs after stimulation by 
removing the original plating media, adding 300 ~~ of PBS containing 0.5 mM 
Orthovanadate to each well, and scraping the cells off the plating surface using a beveled 
tip rubber scrapper. Collected samples were briefly centrifuged to pellet the cells, 
supernatant was removed, and the cells were lysed by gentle rotation overnight using 50 
~~ of lysis buffer containing TBS with 1% NP-40, 10% glycerol, 1 mM phenylmethyl 
sulphonyl fluoride (PMSF), 10 mg/ml aprotinin, 1 mg/mlleupeptin, and 0.5 mM sodium 
orthovanadate. Following cell lysis and centrifugation (1 0,000 rpm, 5 min), the 
supernatants were used to determine protein concentrations using a BCA protein assay 
(Pierce Chemicals, Rockford, IL.). Equivalent amounts of protein (50 ~g) were subjected 
to SDS-PAGE (8%-10% acrylamide). Following transfer to nitrocellulose, the blots were 
stained with Ponceau Red, photographed, assessed for the equivalency of protein loading, 
and cut to allow the top and bottom portions of the blot to be probed simultaneously. 
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Ponceau Red was sub'sequently removed using Tris-Buffered Saline and the blots were 
blocked with 3% milk in Tris-Buffered Saline with 0.2% Tween-20, and subsequently 
I 
incubated with the following antibodies (1: 1 ,000) overnight at 4°C: phospho-p44/42 
MAPK, (NEB/Cell Signalling Technology); F AK, phosphotyrosine 4G 10 (Upstate 
Biotech Inc); pFAKY397 (Biosource Inc); al integrin (Chemicon); ERK (MAPK), f:H 
integrin (Santa Cruz Biotech, SC8978); pAkt, Akt (NEB/Cell Signalling Technology); 
Src (Santa Cruz Biotech); pSrc PY216 (Biosource Inc). The next day, blots were washed, 
incubated in the appropriate horseradish peroxidase conjugated secondary antibody (anti-
rabbit or anti-mouse lgG- HRP; Boehringer Mannheim, 1 :5,000), and visualized using 
chemiluminence reagents (ECL, NEN, Boston, MA) and exposure to X-ray film (Cronex 
MRF Clear base, Agfa Corp, Greenville, SC). Developed films were subsequently 
digitized and densitometrically analyzed using the Image J software (NIH image 
downloadable software). Phosphorylated substrates were normalized against their non-
phosphorylated forms, for non-phosphorylated substrates, actin, or MAPK were used. 
Digital images of the blots were used to make composite figures with Adobe Photoshop 
graphics software (Adobe Corp, Mountain View CA). 
2.2.6 Src inhibition 
PP2 (25 !lM, Chemicon), a potent and selective inhibitor of the Src family of 
tyrosine kinases (SFK) was used to inhibit Src intermediates in the integrin-signalling 
pathway. The inhibitor was added to the culture media 2 hrs after plating, and 24 hrs 
later cells were harvested and lysed for use in lmmunoblotting. 
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2.2. 7 Adhesion assay 
Cells were plated on 11 well plates and allowed to sit for 2 hrs before initial 
counts were performed. Prior to counting, cells were washed with Modified Neural Basal 
media to simulate normal feedings. To ensure that the same population of cells was 
counted each time, an X was drawn on the bottom of each well separating the area into 
four equal quadrants. A quadrant was initially chosen at random and cells in this area 
were counted at 2, 24, 48, and 72 hrs after plating. Once completed the percent of cells 
that remained attached was calculated and plotted in a bar graph, whereby initial count at 
2 hrs after plating was considered to be 100 percent adhesion. 
2.2.8 Statistical Analysis 
All reported data analyses are based on a minimum of 3 separate experiments for 
each manipulation. Data are plotted as mean ± SEM and significance is noted only if 
p<0.05 as determined by ANOVA using Tukey testing for post hoc comparisons for 
multiple group analyses. 
2.3 Results 
2.3.1 Effects of poly lysine, laminin and matrigel extracellular matrix on neurite 
growth and signalling 
In these experiments, we were interested in how neurite growth could be 
promoted by extracellular matrix (ECM) molecules in the absence ofNGF, and whether 
this growth, ifpresent, would be potentiated by the presence ofNGF. However, we first 
compared the adherence of neurons plated on poly-lysine (PL) or a thin film of growth 
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factor-reduced MG to 'determine whether differences in adhesion would confound effects 
on neurite outgrowth. Adhesion assays were carried out as noted in the Methods section. 
Cells were plated on either PL or MG coated 12-well dishes, an 'X' was inscribed on the 
outside bottom of the wells, and the number of cells adhering to the substrate within the 
chosen quadrant of this 'X' were counted at 2 hrs after plating; this number was taken as 
t=O. Subsequently, the medium in the cultures was exchanged every 24 hrs and the 
number of neurons still adherent in the quadrants was counted at 24, 48 and 72 hrs 
postplating. The data were expressed as a percentage of the counts at t=O and are 
presented in Fig 2.1 for neurons plated on PL (Fig 2.1 A, B) or MG (Fig 2.1 C, D). There 
was no significant difference within the groups or between the groups plated on PL or 
MG, nor did NGF appear to have any influence on adherence. Although we did not 
directly test adhesion to LN in this experiment, our observations indicate that neuronal 
adherence to LN and MG, and PL are similar. 
In our initial series of experiments we examined several combinations of ECM, 
including collagen, laminin (LN) and, growth factor reduced Matrigel (MG). In these 
experiments, all substrates were capable of eliciting neurite growth in the absence of 
added growth factors. The first series of growth quantitation results were carried out with 
MG, but we also tested whether the effects we observed with MG were comparable to 
equivalent concentrations of LN. We observed little difference between the LN- and 
MG-coated substrates in both percentage of neurite growth and expression of down 
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Figure 2.1. Neuron adherence is similar on polylysine and Matrigel-coated 
substrates. Neurons were plated on PL (A, B) or MG (C, D) coated slides, and the 
number of adhering neurons counted over 72 hrs according to the methods outlined in the 
Results section. There is no significant difference between the substrates in terms of 
adherent neurons. 
A 
PL -NGF Ohr 
!l'll!lll PL -NGF 24hr 
• PL -NGF 48hr 
• PL -NGF 72hr 
Condition 
B 
~ 1 PL +NGF Ohr 
PL+NGF 24hr 
- PL +NGF 48hr 
• PL +NGF 72hr 
100
i, ll 751 ! 
::111 
Condition 
c 
100 
75 
50 
_ J MG -NGF Ohr 
MG -NGF 24hr 
- MG -NGF 48hr 
• MG -NGF 72hr 
"1 II ol 
Condition 
D 
MG+NGF Ohr 
IIIII MG +NGF 24hr 
• MG +NGF 48hr 
• MG+NGF 72hr 
Condition 
Fig 2.1 
stream signalling intermediates (data not shown). For instance, Fig 2.2A shows that, 
although the addition of NGF produced a significant increase in the percentage of cells 
with neurites in both conditions, there was no significant difference between LN and MG 
conditions (Fig 2.2 A, p>0.05). However, cells plated on LN or MG ± NGF showed a 
significant increase in the percentage of cells with neurites compared to cells plated on 
PL (Fig 2.2 A, p<O.OOl). While it is possible that the other components of the MG (such 
as collagen IV) may have a role in the growth responses we have observed, our 
preliminary studies and previous reports indicate that laminin is the major growth effector 
in MG as previously reported by Tonge and colleagues (Tonge et al., 1997). 
To determine the influence of ECM molecules on growth from young adult DRG 
sensory neurons, we plated dissociated DRG neurons on plastic or glass surfaces coated 
with one of two substrates, either PL (lacking any sequences required to produce integrin 
activation) or a thin film of growth factor-reduced MG (which will activate integrins). 
Fig 2.2 B-E presents representative micrographs of neurite growth 24 hrs after plating on 
either PL or MG in the presence or absence ofNGF. Neurons plated on PL showed little 
or no neurite outgrowth in the absence of NGF (Fig 2.2 B), although addition of NGF 
resulted in the appearance of some short neurites (Fig 2.2 D). In contrast, neurons plated 
on the MG coating displayed substantial neurite outgrowth in the absence of NGF (Fig 
2.2 C), which was further enhanced by the addition ofNGF (Fig 2.2 E). 
2.3.2 Integrin activation enhances neurite growth 
Differences in neurite growth as observed in the representative images in Fig 2.2 
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Figure 2.2. Comparison of the effects of Polylysine, laminin and Matrigel on 
neuronal growth. A: Cells were plated on polylysine (PL), laminin (LN) or growth 
factor reduced matrigel (MG), and the number of cells with neurites were counted 24 hrs 
after plating. There was no significant difference in the percentage of neurite-bearing 
cells on LN or MG ± NGF. However, the addition ofNGF in both substrate conditions 
produced a significant increase in the percentage of cells with neurite growth. ** 
p<O.OOl. B-E: Neurons were plated on PL (B,D) or MG (C,E) coated culture plates. B, 
neurons cultured on PL in absence of added NGF; D, neurons cultured on PL in the 
presence of added NGF, 25 ng/ml. C, neurons were cultured on MG in the absence of 
added NGF; E, neurons cultured on MG in the presence of added NGF, 25 ng/ml. 
Neurite growth on MG is greater than on PL even in absence of added NGF. Addition of 
NGF enhances growth on both PL and MG. Scale bar- 50 !J-ffi (applies to A-D). 
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were quantified as noted below. In order to evaluate the contribution of integrin 
activation to growth, some cultures were treated with a synthetic cyclic RGD peptide. 
This sequence (Arginine-Glycine-Aspartate, RGD) is recognized by the majority of 
known integrins, and plays a key role in integrin-mediated adhesion; extracellular matrix 
molecules such as laminin contain one or more RGD sites (Aplin et al., 1998; Ruoslahti, 
1996). The RGD peptides can block integrin-dependent interactions with the substrate 
and cell-surface receptors. Neurite growth was assessed following fixation and 
immunostaining with peripherin. Individual neurons were traced at 24 hr and 48 hrs after 
plating, using image analysis computer software (Neurolucida® tracing program). Data 
were extracted and analyzed using the NeuroExplorer® component of this software as 
outlined in the Methods and as previously reported (Jones et al., 2003). 
The results of these analyses are presented in Fig 2.3; the panels on the left side of 
the figure present total neurite growth, while the panels on the right side of the figure 
present the numbers of intersections using Scholl analysis. It is obvious that neurons 
plated on MG have much more extensive neurite growth than· cells plated on PL, 
regardless of whether NGF is present or not (panels A, C vs. E, G). On PL, addition of 
NGF resulted in approximately a 45% increase in growth by 24 hrs, which was not 
significantly altered by the RGD peptide (panel A). On MG, the addition of NGF 
resulted in about a 35% increase in growth by 24 hrs; the RGD peptide decreased the 
growth on MG by about 35% regardless of whether NGF was present or not (panel E). 
By 48 hrs, growth on PL in the presence ofNGF remained similar to the 24 hr results; 
again the RGD peptide did not have a significant effect on growth (panel C). In contrast, 
neurites continued to 
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Figure 2.3. lntegrin activation enhances neurite growth - quantitation of neurite 
growth and branching. Neurons were plated on PL or MG coated dishes in the 
presence or absence ofNGF. Panel A, B- PL, 24 hrs; Panel C, 0- PL, 48 hrs; Panels E, 
F- MG, 24 hrs; Panel G, H- MG, 48 hrs. In addition, some cultures were treated with 
the cyclic peptide RGD (0.1 !J-glml) two hours after plating. Cultures were tlxed and 
stained with antibodies to peripherin followed by HRP-DAB detection. Quantitation of 
growth and branching was assessed using the Neurolucida® tracing program, and as 
described in the Methods. Left hand panels: total neurite length (in !J-m); data are 
presented as mean:± SEM. Right panels: the number of intersections (an indication of 
neurite branching and complexity); data are presented as the mean of the number of 
intersection points in 20 1--lm radial increments from the cell body (see Methods for 
details). Significance was tested using one-way ANOV A with Tukey post-hoc testing. * 
p< 0.05, ** p<O.OOl. 
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neurites continued to extend on the MG increasing the amount of growth by almost 3-fold 
at 48 hrs (panel G). At 48 hrs, the apparent NGF-dependent growth was somewhat less 
than that observed at 24 hrs, with the addition ofNGF resulting in about a 25% increase 
in growth compared to MG alone (panel G). In the presence of the RGD peptide, NGF 
effect was limited to an increase of only 1 0%. 
The results of the Sholl analyses indicate that the effect of integrin and NGF 
signalling on total growth seems to be not necessarily a result of increased extension but 
rather an increase in the complexity of the growth patterns, eg., an increased number of 
branches (Fig 2.3 F, H). This effect appears to be synergistic in that the number of 
intersections in the MG+NGF conditions (at both 24 and 48 hrs) is greater than an 
additive effect of either condition alone. In vivo these neurons have rather extensive 
peripheral fields of innervation and the ability to respond to both ECM signals and 
growth factor signal may provide for optimal re-establishment of reinnervation patterns 
after nerve injury. The ability of these neurons to respond to substrate and growth factor 
in the manner shown may provide a basis for the observations of increased collateral 
sprouting that occurs in the intact peripheral processes ofNGF-responsive neurons after 
denervation of adjacent receptive fields (Diamond et al., 1992; Mearow, 1998). 
These data support the notion that integrin engagement by ECM molecules and 
subsequent activation are sufficient for neurite growth from DRG neurons in the absence 
of added neurotrophins like NGF, and that this growth can be further enhanced by the 
addition of trophic factors such as NGF. However, the observation that the RGD peptide 
appears to almost completely block the effect of NGF by 48 hours was not expected and 
points to a potentially more complex interaction between NGF-dependent and the 
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integrin-dependent signalling pathways. Indeed, one interpretation is that integrin 
activation may be required to respond to growth factors, although numerous studies 
I 
indicate that cultured neurons are still able to respond to growth factors when plated on 
synthetic substrates. Since integrin signalling can be influenced by outside-in and inside-
out signalling events (Giancotti, 2003), it is possible that in addition to the outside-in 
signalling evoked by integrin-LN interactions, there may also be important inside-out 
events evoked by NGF-dependent signalling that could contribute to the results. Our data 
also support the interpretation that while growth factors alone can elicit a certain amount 
of neurite growth, interactions with permissive ECM substrates can clearly enhance this 
response. 
2.3.3 Enhancement of growth of adult DRG neurons correlates with increased 
expression of integrin subunits 
Although growth patterns and signalling at 24 hours between cells plated on LN 
and MG were identical, to avoid problems with potential confounding components found 
in MG, LN (see Methods) was used to further study the signalling mechanisms involved 
in integrin activation. Neurons were plated on PL or LN in the presence or absence of 
NGF, and 24 hrs later either cell lysates were prepared and processed for Western 
blotting analyses, or cells were fixed and immunostained for confocal microscopy, (as 
described in Methods section). 
As shown by Western blot analysis (Fig 2.4 A) a significant increase in ~ 1 
integrin expression was seen when cells were plated on LN as compared to cells plated 
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Figure 2.4. Expression of ~1 integrin in adult DRG neurons in the presence or 
absence of a ~-1 blocking antibody (~1i). Adult DRG neurons were plated on either PL 
or LN coated dishes for 24 hrs ::t NGF :±: ~ 1 i, followed by Western blotting of celllysates 
(A) or immunocytochemistry (B-I); when applicable ~ 1i was added two hours after 
plating. A: Expression of~ 1 integrin subunit was increased in adult neurons plated on 
LN, but not significantly influenced by the addition ofNGF. This increase was abolished 
when media was supplemented with a ~ 1 inhibitor. MAPK was used as a loading 
control, and the values for ~ 1 are expressed relative to MAPK expression. B-I: Cells 
were fixed and immunostained with anti-~1 antibody, followed by Cy2-tagged secondary 
antibodies. Confocal laser scanning microscopy was used to visualize the stained 
neurons. Cells plated on LN (D: LN-NGF, E: LN +NGF) show increased staining 
intensity for~ 1 when compared to cells plated on PL (B: PL -NGF, C: PL +NGF), where 
expression was unaffected by the presence ofNGF. Cells plated on LN in the presence 
of a ~1 inhibitor (H: LN -NGF +~1i, I: LN +NGF +~1i) show decreased growth, with no 
significant effect of NGF above control levels. Cells plated on PL in the presence of the 
[31 inhibitor (F: PL -NGF +[31 i, G: PL +NGF +[31 i) were not significantly affected. 
Scale bar- 20 [.lm. Graphs represent the mean± SEM of relative densitometric data of 3 
blots from 3 experiments; data are expressed as percentages with the control value (PL) 
for each experiment taken as 100 %. Significance was tested using one-way ANOV A 
with Tukey post-hoc testing. * p< 0.05, ** p<O.OOl. 
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on PL (* *p<O .001 ). This effect was abolished with the addition of a functional blocking 
131 integrin antibody (131 i). Examining expression at the cellular level, (Fig 2.4 B-E) a 
modest increase in 131 was observed for cells plated on LN (D, E) when compared to cells 
plated on PL (B, C). Patterns of staining for 131 were different between substrate 
conditions with LN substrates punctuate staining of the cell body, neurites and growth 
cones. Fig 2.4 F-1 shows that when l31i was added to the culture media, the LN-induced 
increase in 131 (H, I) was reduced to levels detected on PL (B, C). More importantly the 
addition of 131 i reduced neurite growth seen in integrin-activated LN conditions to control 
non-integrin activated PL conditions. 
As shown by Western blot analysis (Fig 2.5 A) a significant increase in a.1 
integrin was also observed when cells were plated on LN as compared to cells plated on 
PL (*p<0.05, **p<O.OOl). As with 131, this effect was abolished with the addition of a 
functional blocking 131 integrin antibody (131 i). At the cellular level (Fig 2.5 B-E) an 
increase in a.l was seen for cells plated on LN (D, E) compared to cells plated on PL (B, 
C). Patterns of staining for a.l were also different between substrate conditions with LN 
substrates showing staining at points of bifurcation, growth cones, and throughout the cell 
body, whereas cells plated on PL displayed lower a. I expression apparently concentrated 
at the edges of the cell membrane (B, C, F, G). Fig 2.5 F-1 shows that when l3li was 
added to the culture media there was no increase in a.1. As noted above, the addition of 
131 i reduced neurite growth on LN, supporting the interpretation that this is integrin-
mediated growth. These data support the role of a.ll3l integrin as a laminin receptor. We 
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Figure 2.5. Expression of al integrin in adult DRG neurons in the presence and 
absence of a ~1 blocking antibody (~li). Adult DRG neurons were plated on either PL 
or LN coated dishes for 24 hrs ::t NGF ± ~ 1 i followed by Western blotting of celllysates 
(A) and immunocytochemistry (B-I). A: Expression of a 1 integrin subunit was increased 
in adult neurons plated on LN, but not significantly influenced by the addition of NGF. 
This increase was abolished when media was supplemented with the j31 antibody. MAPK 
was used as a loading control, and cd relative expression. 8-I: Cells were fixed and 
immunostained with anti-a.l antibody followed by Cy2-tagged secondary antibodies. 
Confocal laser scanning microscopy was used to visualize the stained neurons. Cells 
plated on LN (D: LN-NGF, E: LN +NGF) show an increase in staining intensity for a l 
when compared to cells plated on PL (B: PL -NGF, C: PL +NGF) whereas expression 
was unaffected by the presence of NGF. Cells plated on LN in the presence of a ~I 
inhibitor (H: LN -NGF +~ 1 i, 1: LN +NGF +~ 1 i) show decreased growth and staining 
intensity for a.l, with no significant effect of NGF above control levels. Cells plated on 
PL in the presence of the ~1 inhibitor (F: PL -NGF +~1i, G: PL +NGF +~li) were not 
signiticantly affected. Scale bar- 20 !J.m. Graphs represent the mean ::t SEM of relative 
densitometric data from 3 blots from 3 experiments; data are expressed as percentages 
with the control value (PL) for each experiment taken as l 00 %. Significance was tested 
using one-way ANOVA with Tukey post-hoc testing. * p< 0.05, ** p<O.OO I. 
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also attempted analysis of a.3 and a.6 integrin subunits, however, commercially available 
antibodies did not provide consistent results for either Western or immunocytochemical 
analysis. 
2.3.4 Cellular expression of downstream signalling intermediates in the integrin and 
NGF signalling pathways 
Expression of pFak, ILK, and pAkt, was examined using immunocytochemistry 
and confocal microscopy on adult neurons plated on PL or LN. Representative results 
are presented in Fig 2.6. As shown in Fig 2.6 A-D, Fak phosphorylation was increased in 
cells plated on LN (C, D) when compared to cells plated on PL (A, B). There was also a 
trend toward a further increase in pFak levels with the addition ofNGF. Similarly, ILK 
expression (Fig 2.6 E-H) was increased when cells were plated on LN (A, B) as 
compared to those plated on PL (E, F). Notable was the large increase in membrane and 
neurite localization with very bright staining at branching points. As our growth 
observations noted a significant increase in the complexity of groWth (Fig 2.3) for cells 
plated on MG in the presence and absence of NGF, it is tempting to speculate that the 
local accumulation of both Fak and ILK (along with apparent accumulation of the 
integrins (Fig 2.4, D, E, & Fig 2.5 D, E) at branching points may play a role in pathway 
decision-making. We were unable to obtain a phospho-specific ILK antibody for these 
studies. In Fig 2.6 I-J it is apparent that Akt phosphorylation is increased with the 
addition of NGF and that pAkt expression was higher in LN conditions than in PL 
conditions. 
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Figure 2.6. Neuronal expression of signalling intermediates in the integrin and NGF 
pathways. Adult DRG neurons were plated on either PL or LN. in the presence or 
absence of NGF. Cells were fixed and immunostained with anti- pFak (A: PL-NGF. B: 
PL +NGF, C: LN -NGF, 0: LN +NGF), anti-fLK (E: PL -NGF. F: PL +NGF, G: LN 
-NGF, H: LN +NGF), and anti-pAkt (I: PL-NGF, .J: PL +NGF. K: LN -NGF, L: LN 
... NGF) followed by Cy2-tagged secondary antibodies. Confocal laser scanning 
microscopy was used to visualize the stained neurons. Note increased growth of neurons 
plated on LN with a further increase when plated in the presence of NGF. A-0: Cells 
plated on laminin show increased expression of pfak with no obvious effect ofNGF. E-
H: Cells plated on laminin show increased expression of fLK with no obvious effect of 
NGF. 1-L: Cells in the presence of NGF show increased phosphorylation of Akt when 
plated on either substrate condition. Slight increases in pAkt are seen in cells plated on 
laminin in the absence ofNGF compared to controls. Scale bar- 20 !J.rn. 
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2.3.5 Analysis of downstream signalling intermediates common to both integrin and 
NGF signalling pathways. 
To quantitatively analyse activation and expression of downstream signalling 
components, we employed Western blotting of celllysates as described in Methods. To 
further examine the relationship between integrin and growth factor signalling, a selective 
inhibitor of the Src family of tyrosine kinases, PP2 (Hanke et al., 1996), and a functional 
blocking ~-1 integrin antibody, ~ 1 i, was used. Neurons were plated on PL or LN in the 
presence or absence of NGF for 2 hours, then media was aspirated and supplemented 
with new media of the same composition (Fig 2. 7, control condition), media with PP2 
(Fig 2.8), or with ~1i (Fig 2.9). Cells were then incubated for a further 24 hrs at 37°C, 
after which time lysates were processed for Western blotting analyses. 
As shown in Fig 2.7 A, a significant increase in Src activation (as assessed by 
phospho-Src antibody) was observed in cells plated on LN compared to those plated on 
PL (** p<0.001), and this was further enhanced by the addition ofNGF (** p<0.001). 
LN-induced increases in Src activity were abolished with the addition of PP2 (Fig 2.8 A) 
and j31i (Fig 2.9 A). In the case of Akt, LN alone had little effect on pAkt, although the 
combination of LN and NGF resulted in increased activation. The addition of PP2 
abolished both the NGF- and LN-induced increases in active Akt (Fig 2.8 B), although 
little or no effect was seen with the addition of j31i (Fig 2.9 B). Activation ofFAK (Fig 
2. 7 C) was observed primarily in the LN conditions with no further increase with the 
addition ofNGF, (** p<0.001). As with Src activation, FAK activation was abolished 
with the addition of both PP2 (Fig 2.8 C) and j31i (Fig 2.9 C). We also examined the 
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Figure 2.7. Western blot analysis of downstream signalling intermediates in the 
integrin and NGF signalling pathways. Adult DRG neurons were plated on either PL 
or LN coated dishes for 24 hrs ±. NGF, and Western blotting of cell lysates was 
subsequently carried out. A: Activation of Src (as assessed by p-Src) was significantly 
increased in cells plated on laminin in both the presence and absence of NGF (Fig 8A, 
p<O.OOl), with a further significant increase when NGF is present (Fig 8A, p<O.OOl). B: 
Phosphorylation of Akt was significantly increased with the addition of NGF (Fig 8B. 
p<O.OOl), with a slight but non-significant influence from the ECM. C: Activation of 
Fak was significantly increased in cells plated on laminin in both the presence and 
absence ofNGF, with no further increase when NGF is present (Fig 8C, p<O.OOl). 0: 
Phosphorylation of MAPK was significantly increased with the addition ofNGF (Fig 80, 
p<O.OO l ), but not significantly influenced by the ECM. Graphs represent the mean .± 
SEM of densitometric data from at least 3 blots from at least 3 experiments. Significance 
was tested using one-way ANOV A with Tukey post-hoc testing. ** p<O.OO l. 
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Figure 2.8. Western blot analysis of downstream signalling intermediates in the 
integrin and NGF signalling pathways in the presence of a specific Src family kinase 
(SFK) inhibitor (PP2). Adult DRG neurons were plated on either PL or LN coated 
dishes for 24 hrs ±. NGF +PP2 and Western blotting of cell lysates was subsequently 
carried out. A: Increased activation of Src by LN and NGF was reduced to control levels 
in the presence of SFK inhibitor. B: Increased phosphorylation of Akt with the addition 
of NGF was reduced to control levels in the presence of the SFK inhibitor. C: Increased 
activation of Fak in the LN conditions in both the presence and absence of NGF, was 
reduced to control levels in the presence of the SFK inhibitor. D: Phosphorylation of 
MAPK was not influenced by the addition of the SFK inhibitor. Graphs represent the 
mean ± SEM of densitometric data from at least 3 blots from at least 3 experiments. 
Significance was tested using one-way ANOV A with Tukey post-hoc testing. * p< 0.05, 
** p<O.OOl. 
LN 
PL 
NGF 
A 
pSrc 
Src 
B 
pAkt 
Akt 
c 
pfak 
Fak 
D 
pMAPK 
MAPK 
+ + 
+ 
+ + 
+ 
-----
....... 
• 
- -
---....... ..... 
225 
_1 
~ 
~1 
i:1 
~ 
c. 
c 
Q. 
.2 
~ 
c::=J PL -NGF +PP2 
c::=J PL +NGF +PP2 
111111 LN -NGF +PP2 
- LN +NGF +PP2 
Treatment 
c::=J PL -NGF +PP2 
c::=J PL +NGF +PP2 
111111 LN -NGF +PP2 
- LN +NGF +PP2 
Treatment 
c::=J PL -NGF +PP2 
c::=J PL +NGF +PP2 
111111 LN -NGF +PP2 
- LN +NGF +PP2 
Treatment 
c:::J PL -NGF +PP2 
c:::J PL +NGF +PP2 
lBillll LN -NGF +PP2 
- LN +NGF +PP2 
** 
Treatment 
** 
Fig 2.8 
Figure 2.9. Western blot analysis of downstream signalling intermediates in the 
integrin and NG F signalling pathways in the presence of a fH blocking antibody 
(~li). Adult DRG neurons were plated on either PL or LN coated dishes for 24 hrs ± 
N G F +~ 1 i and Western blotting of cell lysates were subsequently carried out. A: 
Increased activation of Src by LN and NGF was reduced to control levels in the presence 
of the ~ 1 inhibitor. B: Increased phosphorylation of Akt with the addition of NGF was 
unaffected by the presence of the~ 1 inhibitor. C: Increased activation of Fak in the LN 
conditions in both the presence and absence of NGF was reduced to control levels in the 
presence of the ~1 inhibitor. D: Phosphorylation of MAPK was not influenced by the 
addition of the ~ 1 inhibitor. Graphs represent the mean ± SEM of densitometric data 
from at least 3 blots from at least 3 experiments. Significance was tested using one-way 
AN OVA with Tukey post-hoc testing. * p< 0.05, ** p<O.OO l. 
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activation of MAPK, which has been reported to be activated by integrin engagement in 
other cell types. In these neurons LN had no obvious effect on MAPK activation 
I 
measured at 24hrs, although it was obvious that NGF treatment resulted in MAPK 
activation. Neither PP2 (Fig 2.8 D) nor ~li (Fig 2.9 D) had any effect on MAPK 
activation. These results suggest that any integrin-growth factor convergence is not 
occurring through the Ras-MAPK pathway in these neurons, but rather through a Src-
mediated pathway, with subsequent downstream activation of PI3K. 
2.4 Discussion 
We are interested in understanding how integrin-activated signalling pathways 
interact with those activated by growth factors like NGF to result in optimal axonal 
regeneration. In the present study we have investigated how ECM molecules such as LN 
can act to enhance neurite growth from adult DRG neurons compared to an adhesive, but 
non-integrin activating, substrate (PL). Our results demonstrate that neurons plated on 
ECM exhibit significantly more outgrowth than those plated on PL, and that this growth 
can be further enhanced by NGF, suggesting convergence of these signalling pathways. 
We also investigated activation of signalling intermediates in NGF- and integrin-
dependent growth and our findings are summarized in Table 2.1. NGF-dependent 
signalling in the absence of integrin activation (eg., PL+N) resulted in the sustained 
activation of Akt and MAPK above baseline, but not F AK or Src. With integrin 
activation alone ( eg., LN), pF AK and pSrc were elevated above baseline, and pAkt also 
increased, although as noted previously this increase did not reach significance; 
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Table 2.1. Summary of signalling intermediates in integrin and growth factor signalling 
pathways 
Signalling component 
Substrate condition FAK Src Akt MAPK (31 al Neurite Growth 
PL 
PL+N + + + 
LN + + + + + ++ 
LN+N + ++ ++ + + + +++ 
PL+N+PP2 + ND ND 
LN+PP2 ND ND 
LN+N+PP2 + ND ND 
PL+N+f31i + + 
LN+f31i 
LN+N+f31i + + + 
- Base line, + increase over baseline, ++ increase over N or Lalone, ND not determined 
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activation ofMAPK w'as not observed. We also examined ILK expression and observed 
an increase in cellular expression and localization in the LN condition. However, due to 
I 
the lack of phospho-specific antibodies we were unable to determine the activation state 
of ILK. In both these exp~rimental conditions, our data indicated that these signalling 
events correlated with increased neurite growth. 
In the conditions where both integrin- and NGF-evoked signalling pathways come 
into play, pFAK, pSrc, pAkt and pMAPK were again elevated above baseline. However, 
only the Src activation appeared to be significantly enhanced above either the NGF- or 
LN-elicited activation. This observation suggests that Src may be the point of 
convergence of the two pathways. 
Use of the ~ 1-integrin blocking antibody and the SFK selective inhibitor PP2 
allowed us to further dissect the signalling events. ~ 1 i-treatment resulted in the 
attenuation of F AK and Src activation, but had no detectable influence on pAkt or 
pMAPK, indicating that the latter two events were NGF-dependent. ~li also blocked the 
LN-dependent increase 'in expression of a.l and ~ 1 integrin subunits. Similarly, PP2 
treatment resulted in the inhibition ofF AK and Src activation, but in contrast to ~ 1 i, PP2 
also blocked the NGF-dependent Akt activation. PP2 had no effect on NGF-dependent 
MAPK activation. Both these inhibitors also blocked neurite outgrowth, with PP2 being 
more effective than ~li in inhibiting growth in the presence ofboth NGF and LN. 
Our data suggest that the enhanced growth on the ECM was at least partially due 
to modestly increased integrin expression, as well as increased intracellular signalling via 
integrin engagement. We have not examined expression of other integrins in our culture 
system, but it is also possible that other a. integrins such as a.6 or a.7 may be involved in 
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the regulation of neurite outgrowth (Belkin and Stepp, 2000; Previtali et al., 2001 ). For 
example, the a.4~1 integrin is upregulated during peripheral nerve regeneration and has 
been shown to enhance DRG neurite growth on fibronectin (Vogelezang et al., 2001). 
How growth factor and integrin activated signalling actually regulate 
neuritogenesis is not clear. Data from the integrin-signalling field indicate that complex 
interactions between many of these co-ordinately activated pathways modulate both 
cellular adhesion and the reorganization of cytoskeletal elements required for cellular 
motility (and by analogy, neuritic extension and growth). Our results point to a 
convergence of NGF and integrin activated signalling pathways along with the potential 
requirement for integrin signalling to elicit a response to specific neurotrophins. For 
instance, neurons that have been plated on MG in the presence of the RGD peptide for 48 
hours show not only inhibition of the integrin-dependent neurite outgrowth, but inhibition 
ofNGF dependent outgrowth as well. How this NGF-induced outgrowth inhibition takes 
place is unclear. But, because both integrin and NGF contribute to activation of common 
signalling components such as Src it is possible that when inhibited (eg. Fig 2.8 and Fig 
2.9), added NGF can no longer stimulate the required level of activation resulting in 
lower amounts of growth. Thus, not only are there convergent interactions between 
integrin and NGF signalling pathways, but it is also possible that activation of 
components downstream of integrin signalling may be necessary to achieve an effective 
cellular responses to neurotrophins such as NGF. 
Integrin engagement can trigger a number of different intracellular pathways that 
would appear to use the same intermediates as the neurotrophin-trk cascades. Some of 
these intermediates are primarily activated by integrins, such as F AK, while others like 
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Ras-MAPK appear to be more reliant on growth factor receptor signalling ( Giancotti and 
Tarone, 2003). For example, F AK is activated by integrin engagement, and can interact 
either directly or via adapter proteins talin or paxillin with the cytoplasmic tail of integrin 
j3 subunits (de Curtis and Malanchini, 1997; Giancotti and Ruoslahti, 1999). FAK has 
been suggested to be the central coordinator of signalling downstream from integrins, 
since it plays a key role in cell motility, migration and survival (Schwartz and Ginsberg, 
2002). A number of proteins can bind phosphorylated F AK, including paxillin, Src, 
CAS, Grb2 and PI 3-kinase, pointing to roles not only in cellular motility but also in 
promotion of survival (Schwartz and Ginsberg, 2002; Vuori et al., 1996). We have 
shown that there was a significant increase in FAK activation when adult neurons were 
plated on LN, although this did not appear to increase further with the addition ofNGF. 
Src activation has also been reported to be integrin-dependent, although whether this is 
upstream or downstream of F AK activation seems to depend upon the experimental 
system (Giancotti and Tarone, 2003; Jones et al., 2000). Our data suggest that Src 
activation is upstream ofF AK and potentially PI 3-K signalling, since PP2 treatment 
blocked both Fak and Akt activation. NGF-dependent TrkA signalling also results in Src 
activation in PC12 and neuroblastoma cells (Gatti, 2003; Tsuruda et al., 2004; Wooten et 
al., 2001; Altun-Gultekin, 1996; Rankin and Mearow, unpublished observations). 
Transactivation of TrkA via G-protein coupled receptors and src activation has also been 
observed (Lee et al., 2002). In ongoing experiments, we have observed that NGF-
mediated Src phosphorylation can be blocked by K252a and appears to require the Y 490 
site in TrkA; however, we have found no evidence that PP2 inhibits NGF-TrkA 
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signalling or at least via traditional PI 3-K ~ Akt, Ras~ MAPK pathways (Rankin and 
Mearow, unpublished observatidns). 
We have previously reported that the PI 3-K~Akt, rather than Ras~MAPK, 
signalling pathway plays a primary role in NGF-dependent growth from adult DRG 
neurons (Jones et al., 2003; Kimpinski and Mearow, 2001). Use of the PI 3-K inhibitor, 
L Y200928 resulted in inhibition of neurite growth, while the MEK inhibitor, U0126, 
actually appear to enhance growth somewhat (Jones et al., 2003). The fact that NGF, but 
not LN, resulted in sustained MAPK activation is consistent with our previous 
observations in these sensory neurons, where even in short-term stimulation experiments 
we have not observed significant LN-dependent phosphorylation of MAPK. These data 
also point to differences between cellular systems. For example, in our experiments with 
PC12 cells, both LN- and NGF-evoked activation of MAPK are detectable within 
minutes but are not sustained and disappear within 30 minutes of treatment (unpublished 
observations). 
Both the extracellular environment through which axons grow and the availability 
and action of neurotrophic factors play key roles in regulating axonal growth and 
regeneration. Our data suggest that potentiation of similar signalling pathways or 
convergence of distinctly-activated pathways could underlie the observed enhancing 
effects of laminin or other ECM molecules on growth factor-dependent cellular 
responses. 
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CHAPTER3 
A PROCEDURE FOR SELECTING AND CULTURING SUB-
POPULATIONS OF NEURONS FROM RAT DORSAL ROOT 
GANGLIA USING MAGNETIC BEADS 
(Published in Brain Research Protocols, 2005, 16 (1-3):50-7) 
3.1 Type of research 
Sensory neurons of the DRG consist of a heterogeneous population of cells that 
can be classified on the basis of neurochemistry, morphology, trophic requirements, and 
sensory modalities (Averill et al., 1995; Gavazzi et al., 1999; Petruska et al., 2000; 
Priestley et al., 2002a). Three major cell groups have been identified. These include 
large and medium diameter neurons identified based on their expression. of 
phosphorylated heavy chain neurofilament NF200, p75 Neurotrophin Receptor 
(p75NTR), and tyrosine kinase receptors Trk A, B, or C, and typkally have myelinated 
axons and function as peripheral mechanoreceptors (Priestley et al., 2002a). The next 
group consists of mainly small diameter neurons, express calcitonin gene related peptide 
(CGRP), p75NTR and TrkA, and are thought to have unmyelinated or thinly myelinated 
axons and function as peripheral nociceptive neurons (Molliver et al., 1997; Priestley et 
al., 2002a). The final group are also mainly small diameter neurons, bind the lectin 
Griffonia Simplicifolia IB4, express the receptor tyrosine kinase RET and at least one of 
the Glial Cell Line-derived neurotrophic factor family receptor subunits (GFRa), are 
considered to have unmyelinated or thinly myelinated axons and function as peripheral 
nociceptive neurons (Averill et al., 1995; Bennett et al., 1998; Kashiba et al., 2001; 
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Molliver et al., 1997; Snider and McMahon, 1998). These differences have been shown 
to be important when considering diseases such as diabetes that affect the peripheral 
nervous system. For instance, it has been shown that the small diameter nociceptive 
nerve fibres of the IB4 and CGRP positive populations (IB4+ve, CGRP+ve) are the first 
affected and most susceptible neurons to diabetic environments (Le Quesne and Fowler, 
1986; Polydefkis et al., 2003). Thus, it is important that we be able to study different 
treatments on specific subpopulations of DRG neurons in isolation. Here we describe a 
procedure that uses magnetic beads for preparing viable homogenous cultures of DRG 
neurons based on their expression of previously mentioned cell surface markers. 
Specifically, here we have used the lectin IB4 to select out the population of non-peptide 
noceciptive neurons, leaving the CGRP and NF200 expressing populations behind 
(NF200+ve). However, this protocol can easily be adapted to select cells that express any 
cell surface marker with the appropriate antibody by the use of monoclonal or polyclonal 
lgG-coated magnetic beads. 
3.2 Time required 
Step 1. Dissection of 4-6 week old Sprague-Dawley rat DRGs (2-3 rats): 30 min. 
Step 2. Enzymatic and mechanical dissociation: 1 hr and 20 min. 
Step 3. Removal of non-neuronal debris via 30% Percol gradient: 30 min. 
Step 4. Magnetic bead selection and separation: 30 min. 
Step 5. Plate selected cells: 5 min. 
Step 6. Growth ofDRG cultures: 24 hr. 
Step 7. Immunocytochemistry: 24 hr. 
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Step 8. Confocal micro'scopy: 4 hr. 
Total: 54- 60 hr 
3.3 Materials 
3.3.1 Animals 
Male Sprague-Dawley rats 4-6 weeks old (Memorial University ofNewfoundland 
Animal Care Facility) were used. 
3.3.2 Dissection and Special equipment 
- Small animal guillotine 
- Large sharp tip scissors 
- Large notch tip forceps 
- 45 degree curved fine-tipped jeweler's forceps 
- 45 degree curved fine-tipped micro-surgical scissors 
- Autoclaved 9" Pasteur pipets 
15 ml conical tubes 
1.5 ml eppendorf tubes 
- 3 7° C water bath 
- Variable speed swinging bucket centrifuge 
- Adams Nutator single speed orbital mixer (Fisher, Ottawa, ON) 
- Stereo dissection microscope 
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- Poly-D-Lysine (BD Bioscience, Canada), and Laminin (Gibco/Invitrogen, Grand 
Island, NY) coated Lab-Tee 16 well chamber slides (Nalge NUNC international, 
VWR, Mississauga, ON) 
- 22x74mm glass cover-slip (Nalge NUNC international) 
- Dynal Magnetic Separator (Dynal, Product# 120.20) 
3.3.3 Chemicals and reagents for preparing viable selected DRG cultures. 
- Neurobasal (NB) media containing 100 units/ml penicillin, 100mg/ml 
streptomycin 
- Modified Neurobasal media (ModNB) containing 100 units/ml penicillin, 
1 OOmg/ml streptomycin, 29 .2mg/ml L-glutamine (Gibco/Invitrogen), 
supplemented with 500~1/50ml of 50x B27, (Gibco/Invitrogen), and 20mM 
cytosine arabinofuranoside, (AraC) (Gibco/Invitrogen) 
- 70% ethanol 
- 1 x Phosphate buffered saline (PBS; Gibco/Invitrogen) 
- 1 x Hanks buffered saline solution without phenol red (HBSS; Gibco/Invitrogen) 
- lx Hanks buffered saline solution without calcium chloride, magnesium chloride, 
magnesium sulfate, and phenol red (HBSS-M; Gibco/Invitrogen) 
- DNase free Dispase dissociation media with 5mg/ml Protease (Sigma-Aldrich, 
Oakvill, ON), and 2mg/ml Collagenase type II (Gibco/Invitrogen) 
- Fetal calf serum (FCS, Gibco/Invitrogen) 
- Percol!Redigrad (Amersham Biosciences/ GE Healthcare, Baie D'Urfe, QC) 
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- 4.5mm diameter streptavidin-coated magnetic beads (Dyna beads; Dynal Biotech 
LLC, Brown Deer, WI, Product# 115.21) 
- DNase 15,000 to 20,000 units (Gibco/lnvitrogen) 
3.3.4 Chemicals and reagents for immunocytochemistry 
- Lectin binding buffer containing 0.1mM MnC12, 0.1 mM MgClz, and 0.1mM 
CaClz (Gibco/Invitrogen) 
1xPBS (Gibco/Invitrogen) 
- Fluorescein-conjugated avidin (Vector Labs, Burlington, CA; 1:50, in 1xPBS, 
stock solution 1 mg/ml) 
- Biotinylated IB4 (Sigma-Aldrich; 1:250, in 1xPBS, stock solution 1mg/ml) 
- Glycerol 50% (Fisher, Nepean, ON) in lxPBS 
- Paraformaldehyde, 4% (Fisher) in 1xPBS (Gibco/Invitrogen) 
- Triton X-100, 0.1% (Sigma-Aldrich) 
3.4 Detailed procedure 
Animal procedures were approved by the Animal Care Committee at Memorial 
University of Newfoundland. Male Sprague-Dawley rats 4-6 weeks of age were housed 
4 animals per cage in a temperature- and humidity-controlled animal care facility with a 
12-h light/dark cycle. Animals were given a constant supply of laboratory chow and tap 
water. 
3.4.1 Dyna bead coating and preparation (see Fig 3. 1) 
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Figure 3.1. Procedural summary of cellular-selection. A schematic diagram 
summarizing the steps required in preparing magnetic beads for use, capture and release 
of the desired cells, and plating of both selected and non-selected cell populations. 
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Fig 3.1 
(i) Transfer IOOml of streptavidin-coated beads (4.5mm, Product# 115.21) to a 
1.5ml eppendorf tube and place tube in the Dynal Magnetic Separator for a 
minimum of 1 min to allow adequate bead capture. 
(ii) Aspirate and discard supernatant, remove tube from the magnetic separator 
and resuspend the beads in 1ml of 1xPBS; invert several times to ensure that 
the beads are mixed completely and that no beads have settled. 
(iii) Place beads back in the Dyna] Magnetic separator for a minimum of 1 min to 
ensure that all beads are captured and that solution is free of suspended beads. 
Repeat steps (ii) and (iii) three times. 
(iv) On the third wash aspirate all remaining supernatant and resuspend coated 
beads in 500ml of 1xPBS with 40mg ofbiotinylated-IB4. Mix the bead I IB4 
suspension (on the Nutator) at room temperature for 1 hr or until ready to use; 
to ensure that the beads do not settle during this step flip the tube every 1 0-15 
mms. 
(v) Just prior to use, remove the tube with the coated beads from the Nutator, 
place in the magnetic separator and allow a minimum of 1 min to ensure that 
all beads have been captured, then aspirate and discard the supernatant. Wash 
three times as in steps (ii) and (iii); on the third wash leave the beads in 1 OOml 
of 1 xPBS. Coated beads are now ready to be added to the cell suspension. 
3.4.2 DRG dissociation, selection, and culture 
3.4.2.1 DRG Dissociation 
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(i) Sacrifice nits by live decapitation (n = 3) and remove spinal column using 
large sharp tip scissors and notch-tip forceps, cut a v-shaped opening in the 
back of the spinal column, expose and remove the spinal cord. 
(ii) Remove DRGs from all spinal levels using a stereomicroscope with 45-degree 
fine-tip jewelers forceps and 45-degree fine-tip micro-surgical scissors (all 
equipment has been sterilized with 70% ethanol). Place the DRGs in a 35mm 
Petri dish ofice-cold NB (Gibco ). Generally, 48-52 ganglia can be isolated 
from one spinal column. 
(iii) Transfer DRGs to a 15ml conical tube using a cracked Pasteur pipette that was 
previously rinsed with HBSS to prevent the DRGs from sticking (by cracking 
the tip off the Pasteur pipette an opening large enough to aspirate the DRGs is 
created). 
(iv) Wash DRGs by filling the 15ml conical tube to the IOml mark with HBSS, 
cap and invert tube 3 times. Allow the DRGs to settle, aspirate the media, and 
repeat 1 time.· 
(v) Aspirate all remaining supernatant and resuspend DRGs in lml of dispase 
dissociation media and place in a 37° C water bath for 50 min. Tap the tube 
every 5 min to dislodge the DRGs ensuring adequate exposure. 
(vi) Add lml ofFCS and 8ml ofHBSS-M and centrifuge at room temperature for 
5 min at 200xg. 
(vii) Aspirate supernatant and resuspend pellet in 2ml ofModNB. 
(viii) Triturate DRGs by using a series of polished Pasteur pipets each with a 
smaller diameter opening. Triturate for 10 times and allow large DRG 
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fragments to settle. Remove the supernatant with dissociated cells and place 
in a new 15ml tube. Suspend DRG fragments in 2ml ofModNB and continue 
trituration for another 10 cycles. Again, the media containing any DRG 
fragments is allowed to settle and the supernatant is removed and added to the 
tube containing the previously dissociated cells. This process is repeated 
using smaller diameter pipets each time until no DRG fragments remain. 
(ix) Centrifuge the tube of dissociated DRG neurons at 200xg for 5 mins at room 
temperature, remove and discard the supernatant and resuspend the cells in 
3ml of fresh ModNB (more or less media is required when not using 3 rats, 
generally 1ml per rat is sufficient). 
(x) Transfer the cell suspension with a Pasteur pipette onto a previously made 
continuous 3 0% Percol gradient ( Amersham Biosciences) in 15ml conical 
tubes. This gradient is produced by mixing 3ml of 100% Percol solution with 
7ml of 0.15% NaCl. A maximum of lml of the cell suspension is used per 
1 Oml of Percol gradient. 
(xi) Centrifuge at 500xg for 20 mins at room temperature. Use a Pasteur pipette to 
carefully aspirate the DRG enriched pellet that has migrated through the 30% 
Percol gradient. Be very cautious not to take an excessive amount of the 
surrounding Percol solution nor to expel any air that could disturb the pellet. 
(xii) Transfer the cells to a new 15ml tube filled with 12ml of Mod-NB and 
centrifuge at 200xg for 5 mins at room temp. Remove and discard supernatant 
and resuspend the cells in 1ml ofMod-NB. 
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3.4.3 Selection and culture (see Fig 3. 1) 
(i) Take previously coated and washed Dyna beads and place in the magnetic 
separator to allow adequate bead capture and remove any remaining 
' 
supernatant. Add the cell suspension to the coated Dyna beads in a 1.5ml 
eppendorf tube and gently rotate at 4 ° C for 30 mins on the Nutator; flip the 
tube every 5 min to ensure that the beads do not settle. 
(ii) Remove tube with cell/bead suspension from the Nutator, place in the Dynal 
Magnetic Separator and allow to sit for a minimum of 1 min to ensure that all 
beads have been captured. Carefully transfer the supernatant to a new tube 
marked NS and place it back in the magnetic separator until ready for plating 
(NS contains the non-selected cell population that does not have any beads 
attached). Carefully resuspend the beads in 1ml of Mod-NB and gently invert 
to wash away any remaining non-selected cells. Place bead-bound cells back 
in the Dynal Magnetic Separator and allow to sit for a minimum of 1 min, and 
then remove and discard the supernatant. 
(iii) Resuspend the beads in lml ofMod-NB with 4ml of DNase and rotate on the 
Nutator at room temperature for 10 mins. Streptavidin is bound to the beads 
via a DNA cross linker, thus DNase treatment breaks the DNA cross-linked-
Streptavidin from the beads, releasing the selected cells into the media. 
(iv) Remove tube from Nutator, gently pipet the cell/bead suspension up and down 
5 times and place tube in the Dynal Magnetic Separator, allow the suspension 
to sit for a minimum of 1 min to ensure adequate bead capture. Because 
Streptavidin has been released from the beads via the DNase treatment, the 
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captured beads now will not be bound to any cells. Transfer the supernatant 
to a new tube labeled Sand place it in the magnetic separator. This tube now 
contains the selected cell population with the beads removed. 
(v) To ensure that all selected cells have been released, add 500ml ofMod-NB to 
the original tube with beads and using a polished Pasteur pipet gently aspirate 
and expel the beads. Place them back into the magnetic separator, allow 1 
min for adequate capture and transfer the supernatant to tube S; the 
supernatant will contain any remaining cells that have been released from the 
beads. 
(vi) Plate the selected cells from tube S and non-selected from tube NS (in 
separate wells) at a concentration of 100-150 cells per well in pre-coated 16 
well chamber slides. In these experiments slides have been coated with 2x PL 
followed by 2x LN. Cultures were maintained for 24 hrs after plating for 
analysis of neurite growth. 
3.4.4 Immunocytochemistry 
(i) Wash cells plated on 16 well chamber slides two times with lxPBS for 5 mins 
and subsequently fix with 4% paraformaldehyde in lxPBS for 15 mins. 
(ii) Three 5 mins washes in 1 xPBS are subsequently followed by permeabilization 
with 0.1% Triton X-1 00 in PBS for 10 mins. 
(iii) For IB4 detection, wash 1 time for 5 mins with lxPBS and subsequently 
replace PBS with the lectin binding buffer for lhr to block non-specific 
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binding. When immunostaining for NF200, CGRP, Trk, p75, or other 
neuronal markers proceed to step (vi). 
(iv) Incubate with biotinylated IB4 ( 40mg/ml) overnight at 4 o C for detection of 
IB4 +ve ce.ll populations. 
(v) Perform three 5 min washes with 1xPBS, incubate for 1hr with Fluorescein-
conjugated avidin to localize biotinylated-IB4. If not immunostaining, 
proceed to step (ix). 
(vi) For co-immunostaining, incubate with 10% NGS in 1xPBS for lhr. 
(vii) Incubate cells with desired antibody (1 :250-1:1000, eg. pan Trk 1:250, Santa 
Cruz Biotech, Santa Cruz, CA) overnight at 4° C. 
(viii) Perform three 5 min washes with lxPBS, incubate with Cy2 or Cy5 labeled 
secondary antibodies for 1hr at room temperature to localize primary marker. 
Note - for double labeling, use of Cy2 and Cy3 is not recommended due to 
overlap in the spectra. 
(ix) Perform three· 5 min washes with 1 xPBS, and subsequently mount a coverslip 
on the slide with 50% glycerol in lxPBS and seal with clear nail polish. 
(x) Stained cells were viewed and images captured using an Olympus laser-
scanning microscope at 20x magnification equipped with the appropriate 
filters to view Fluorescein-conjugated avidin, Cy2, and Cy5. 
3.5 Results 
The protocol is summarized in Fig 3. 1. With the use of IB4-coated magnetic 
beads we were able to obtain a pure culture of IB4+ve DRG neurons. Fig 3.2A shows 
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Figure 3.2. IB4-selected and non-selected cell populations plated on LN. The 
IB4+ve cells that were selected using magnetic beads and the remaining non-selected 
IB4-ve cells were plated on 50!-1-g/ml LN. Live cell phase microscopy was performed 
immediately after selection before bead release (A) or 24 hrs after plating (B, C). A: 
IB4+ve cell during selection before bead release with Dyna beads attached to its surface. 
Scale bar - 100 !"' m. B-C: Selected IB4+ve and non-selected IB4-ve cells plated on 
laminin for 24 hrs. Scale bar- 50 !J.m. 
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Fig 3.2 
the typical IB4+ve cell that had IB4-coated beads attached to its surface. It is apparent 
that the IB4-coated beads are att'ached to the cell as they are in focus at the upper field of 
view whereas other unattached beads sitting on the surface of the plate are out of focus. 
After selection, both selected IB4+ve and non-selected IB4 negative (IB4-ve) cells were 
plated on LN. These cultures were grown at 3 7 ° C for 24 hrs and later imaged using 
phase microscopy. The IB4-selected population contained mainly small, with few large, 
diameter neurons (Fig 3.2 B) while the non-selected cells ranged in size, with some small 
but mainly medium and large diameter neurons (Fig 3.2C). These observations are in 
accordance with previous reports which suggest that the IB4+ve population is mainly 
small with a limited number of large diameter neurons (Bennett et al., 2000; Priestley et 
al., 2002a). Also the non-selected population is made up of small and medium CGRP+ve 
neurons as well as medium and large NF200+ve neurons (Averill et al., 2001; Gavazzi et 
al., 1999; Priestley et al., 2002a). To validate if cultures of selected and non-selected 
cells were made up of homogenous populations, the cells were co-labeled with IB4 and a 
pan Trk (directed against Trk A, B, & C) antibody and imaged using confocal 
microscopy (Fig 3.3). As shown in Fig 3.3, the IB4-selected cells only show positive 
labeling for IB4 and do not show Trk staining (Fig 3.3, A-C). Conversely cells in the 
non-selected condition only show Trk positive staining and do not show positive IB4 
labeling (Fig 3.3, D-F). Thus, we are confident that the selection protocol is functioning 
exactly as expected. The IB4-selected population consists of IB4+ve cells with no 
detectable contamination ofTrk+ve (Fig 3.3) nor P75+ve neurons (data not shown). The 
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Figure 3.3. IB4-selected and non-selected cell populations plated on LN. The 
IB4+ve cells that were selected using magnetic beads and the remaining non-selected 
IB4-ve cells were plated on 50 !-1-g/ml LN. A-C: Selected IB4+ve cells plated on LN, Co-
labeled with IB4 and a panTrk antibody 24 hrs after plating. A: Positive IB4 labeling. B: 
Trk immunostaining shows no co-labeled cells. C: Merged confocal image of IB4 and 
Trk labeling together. These three panels show that selected IB4+ve cells do not show 
significant Trk staining, although they are positively labeled with IB4. D-F: Non-selected 
IB4-ve cells plated on LN and co-labeled with IB4 a panTrk antibody 24 hrs after plating. 
0: IB4 labeling shows no labeled cells. E: Positive Trk immunostaining. F: Merged 
confocal images of both Trk and IB4 labeling together. These three panels show that non-
selected IB4-ve cells show significant Trk staining but display no IB4 labeling. Scale bar 
-50 !-1-ffi. 
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Fig 3.3 
non-selected population shows little or no residual IB4+ve cells. As previously reported, 
IB4+ve neurons do not generally express the Trk nor the p75NTR family of receptors 
(Averill et al., 1995; Priestley et al., 2002a). 
To show that these selected IB4+ve neurons are alive and responsive, IB4-
selected neurons were plated on LN in the presence or absence ofNGF or GDNF. With 
the absence of Trk and p75NTR these cells should not respond to NGF. However, these 
cells do express GFRa 1 and RET and are therefore responsive to GDNF (Averill et al., 
1995; Priestley et al., 2002a). As shown in Fig 3.4 IB4+ve cells plated in the absence of 
added growth factors (Fig 3.4 A) or in the presence ofNGF (Fig 3.4 B) had no significant 
neurite outgrowth. However, when GDNF was added IB4+ve cells responded with a 
robust increase in neurite outgrowth, indicating that these are viable and healthy neurons 
(Fig 3.4 C). 
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Figure 3.4. IB4-selected cell population plated on LN in the presence or absence of 
added growth factors and labeled for IB4. IB4+ve cells were plated on 50 ~-tg/ml of 
LN in the presence or absence of added growth factors (NGF or GDNF). Cells were 
fixed and labeled with IB4. IB4+ve cells do not show significant neurite outgrowth when 
plated on LN (A) in the absence of added growth factors, nor is there any stimulation of 
growth with NGF (B). However, GDNF does elicit significant growth from these IB4+ve 
cells when plated on LN (K). Scale bar- 50 ~-tm. 
CON NGF GDNF 
LN 
Fig 3.4 
3.6 Discussion 
3.6.1 Overall assessment of prdtocol 
Normal cultures ofDRG neurons are typically generated by whole ganglion dissociation 
resulting in the presence of each of the subpopulations ofDRG neurons. Our results 
illustrate that pure subpopulations of viable DRG neuron cultures can be reproducibly 
generated by the use of magnetic beads from Dynal. This technique offers new 
possibilities in the study of survival and regeneration of sensory neurons. As different 
environmental conditions, such as availability of growth factors and extracellular matrix 
molecules, elicit different responses from different DRG subpopulations it is important to 
be able to study each population separately (Averill et al., 1995; Gavazzi et al., 1999; 
Priestley et al., 2002b ). Although we have detailed methods for selection of IB4+ve 
cells, we have also used this method for selecting p75NTR+ve cells (using anti mouse-
IgG coated Dyna beads) and Trk+ve cells (using biotinylated anti rabbit antibodies and 
streptavidin coated Dyna beads). The only difference in these selections is that either 
streptavidin or anti mouse-IgG coated beads are used. 
3.6.2 Trouble-shooting 
A key factor for successful DRG selection is that the rotation and washing steps 
are done gently. If these steps are not done carefully, then the cells will be released from 
the beads resulting in a low yield of selected neurons. At the same time care must also be 
taken to do the procedure as quickly as possible, for if long periods of time are taken the 
viability of the cells drop dramatically. For this reason it is not recommended that any 
more then 4 rat dissections be carried out at once. Also care has to be taken when 
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removing the DRGs td ensure that the roots are carefully trimmed away, as contaminating 
non-neuronal cells will interfere with the selection process (i.e. they may express the 
I 
same cell surface marker as the cells you are trying to capture). It is also important to 
keep all dissection media' ice cold. When performing the enzymatic dissociation in 
section 3.2, step (V), it is important that DNase is not used or does not come in contact 
with beads or cells to be selected. DNase will release cross-linked avidin from the beads 
releasing the biotinylated IB4 and preventing cellular selection. Finally, during the 
selection process when the coated beads are being incubated with the cell suspension, it is 
important that the beads are not allowed to settle in the bottom or on the side of the tube 
(the beads are relatively heavy and tend to settle very quickly). Thus, for the 30 min 
rotation period carefully tum the tube over every 5 mins gently dislodging any beads that 
may have settled. 
3.6.3 Alternative and support protocols 
The enzymatic dissociation and purification procedure in section 3.2 (iv-xi) can be 
replaced with previously described procedures (Mearow and Kril, 1995). 
- Enzymatic dissociation using lml of dissociation medial containing collagenase 
and place in a 37° C water bath for 40 mins, wash 3 times with lxHBSS, 
resuspend in 500ml Trypsin 500ml HBSS and place in a 3r C water bath for 20 
mins, tap the tube every 5 mins in each step to ensure that DRGs receive adequate 
exposure (iv). 
- Filter the cell suspension through a 70mm nylon filter (Falcon, BD Biosciences) 
to remove debris, allowing the suspension to be used for bead selection (xi). 
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Cultures prepared in this way have less chance for cell loss because more 
vigorous enzymatic dissociation has been used and the percol step has been eliminated. 
I 
However, these cultures will contain more non-neuronal cells, which may pose a problem 
when selecting. 
3. 7 Quick procedure 
3. 7.1 Dyna bead coating and preparation 
(i) Wash lOOf-tl of streptavidin coated beads with lxPBS in a 1.5ml eppendorf 
tube by using a Dynal Magnetic Separator. 
(ii) Resuspend washed beads in 500ml of lxPBS with 40mg of biotinylated anti-
IB4. Rotate at room temperature for a minimum of 1 hr. 
(iii) Just prior to use aspirate and discard the supernatant, wash three times 
resuspend in lOOml of lxPBS. Beads are now ready to be added to the cell 
suspension of interest. 
3.7.2 DRG dissociation, selection, and culture 
(i) Remove DRGs place in a 35mm Petri dish of ice-cold neurobasal media 
supplemented with 1% penicillin/streptomycin. 
(ii) Wash DRGs with lOmllxHBSS. 
(iii) Resuspend DRGs in lml of dissociation media containing dispase and place in 
a 3 7° C water bath for 50 mins. 
(iv) Add lml FCS and 8ml of HBSS-M and centrifuge at room temperature for 5 
mins at 200xg. 
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(v) Resuspend pellet in 2ml ofModNB. 
(vi) Triturate DRGs 10 tirhes and allow remaining DRG fragments to settle, move 
supernatant to a new tube and repeat until all remaining DRG fragments are 
dissociated. 
(vii) Centrifuge and resuspend the pellet in fresh ModNB. 
(viii) Transfer the cell suspension to a 30% Percol gradient in 15ml conical tubes 
and centrifuge. Aspirate enriched DRG fraction taking extreme caution not to 
take an excessive amount of the surrounding Percol solution or to disturb the 
pellet. 
(ix) Wash pellet in fresh ModNB, centrifuge and resuspend in lml of ModNB 
with previously coated Dyna beads and gently rotate at 4° C for 30 mins. 
(x) Capture selected cells using the magnetic separator, remove and plate the non-
selected cells. Wash selected cells, add DNase, rotate at room temperature 
and remove and plate selected cells. 
Fig 3.1 is a summary diagram of bead coating, cellular selection, capture, release, and 
plating of both selected and non-selected cell populations. 
3.7.3 Immunocytochemistry 
(xi) Cells plated on glass slides are washed and fixed. 
(xii) After washing, cells are permeablized with 0.1% Triton X-1 00 and blocked 
with a lectin binding buffer for IB4 labeling, or with 10% NGS in PBS for 
immunostaining. 
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(xiii) Incubate at 4° C overnight with the biotinylated IB4 or with appropriate 
primary antibodies (i.e. Fig 3.2, pan Trk, 1:250, Santa Cruz). 
I 
(xiv) After washing localize biotinylated IB4 with fluorescein-conjugated avidin or 
primary antibodies with appropriate Cy2 or Cy5 secondary markers (1 hr at 
room temperature). 
(xv) Wash slides with lxPBS, and mount coverslips with 50% glycerol, seal with 
clear nail polish. 
(i) Visualize using a laser-scanning confocal microscope equipped with the 
appropriate filters. 
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CHAPTER4 
I 
LAMININ AND GROWTH FACTOR INDUCED NEURITE 
GROWTH IS DIFFERENTIALLY REGULATED IN 
SUBPOPULATIONS OF ADULT DRG NEURONS VIA THE 
PI 3-K/AKT AND MEK/MAPK SIGNALLING PATHWAYS 
(Accepted by the European Journal ofNeuroscience, May, 2006) 
4.1 Introduction 
The adult DRG is made up of a heterogeneous population of cells subdivided on 
the basis of neurochemistry, morphology, trophic requirements, and sensory modalities 
(Averill et al., 1995; Gavazzi et al., 1999; Petruska et al., 2000; Priestley et al., 2002a). 
Three major cell groups have been identified with potential for further subclassification. 
The first group comprises the large and medium diameter neurons, identified based on 
expression of heavy chain neurofilament (NF200+ve) and typically have myelinated 
axons. These neurons express the p75 neurotrophin receptor and TrkC, although TrkA 
and TrkB receptors are also reported (Averill et al., 1995; Priestley et al., 2002a). Thus, 
these cells are able to respond to NT-3, NGF, and BDNF. The next two major groups 
consist of mainly small diameter neurons and are considered to be either peptidergic, 
expressing calcitonin gene related peptide (CGRP+ve), or non-peptidergic, binding the 
lectin Griffonia Simplicifolia IB4 (Averill et al., 1995; Priestley et al., 2002a). These 
groups are considered to be unmyelinated or thinly myelinated nociceptive afferents. The 
CGRP+ve population expresses a high level of both p75 neurotrophin receptor and TrkA 
and preferentially respond to NGF. The IB4-binding population has neither p75 nor Trk 
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receptors, but instead expresses the receptor tyrosine kinase RET and the GFRa 1 subunit, 
making these cells responsive to GDNF and unresponsive to the neurotrophins NGF, 
NT3, and BDNF (Bennett et al., 1998; Kashiba et al., 2001; Molliver et al., 1997). 
In the current study' we demonstrate that these cellular differences are important 
when attempting to stimulate axonal regeneration from these neurons. We have 
previously shown that both NGF and laminin (a major component of the peripheral 
extracellular matrix) are strong promoters of neuronal regeneration in vitro (Jones et al., 
2003; Tucker et al., 2005a). These factors can work in conjunction with each other to 
stimulate neurite growth not achievable by either factor alone, an effect which was shown 
to be in part due to crosstalk between integrin and growth factor signalling pathways 
(Tucker et al., 2005a). However, laminin-induced integrin activation (in both the 
presence and absence of added NGF) was not sufficient to promote neurite growth from 
all DRG neurons, despite the fact that laminin-binding integrins are expressed in the 
majority of these cells regardless of subpopulation (Condie and Letourneau, 1997; 
Tomaselli et al., 1993). Thus, it was hypothesized that laminin induced neurite growth is 
population specific, and in part due to the differential requirement for specific signalling 
pathways by the different neuronal subpopulations. 
To test this hypothesis we have focused on the growth response of selected 
subpopulations of adult DRG neurons with respect to laminin and growth factor receptor 
activation, using a magnetic bead-based selection protocol (Tucker et al., 2005b ). 
Because adult DRG neurons survive in the absence of added trophic factors they make an 
ideal model for studying the effects of neurotrophins and extracellular matrix molecules 
on peripheral nervous system regeneration (Dodge et al., 2002; Tucker et al., 2005a). 
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Our results indicate that laminin-induced neurite growth initially occurs in the NF200+ve 
cell population, followed by a delayed growth response from the CGRP+ve cells; because 
both NF200+ve and CGRP+ve populations are known to be responsive to NGF to avoid 
further confusion these cells are identified as the NGF-responsive population 
(Chattopadhyay eta!., 2003). In contrast, laminin alone is insufficient in stimulating 
significant neurite growth in the IB4+ve cell population, although this substrate is still 
required to elicit a growth response from these cells in the presence of the appropriate 
growth factor. In analysing potential downstream signalling pathways we demonstrate a 
requirement of only the PI 3-K/ Akt pathway for neurite growth from the NGF -responsive 
cell population, while neurite growth in the IB4+ve cell population required both PI 3-
K/ Akt and MEK/MAPK signalling. While we have previously published data showing a 
role for laminin and the PI 3-K signalling in DRG neurite growth, for the first time (to 
our knowledge) we are now able to show very distinct responses from selected 
populations of sensory neurons, responses that are masked by the usual culture models of 
these cells. Of particular significance is the fact that the small nociceptive GDNF 
responsive cells do not appear to be able to respond with neurite growth to any of the 
extracellular matrix molecules usually found in the peripheral nerve, which is in contrast 
to the situation observed with both NGF-responsive nociceptive and proprioceptive 
neurons. It is also important to note that this is the first time that neuronal subpopulations 
within the adult DRG have been identified as having different signalling requirements for 
axonal regeneration. Therefore, these results are important for the development of 
potential therapies for nerve regeneration after injury or in peripheral neuropathies such 
as those associated with diabetes. 
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4.2 Materials and methods 
4.2.'1 Neuronal culture 
Dorsal root ganglia (DRG) from young adult ( 4-6 wk) Sprague-Dawley rats 
(Memorial University ofNewfoundland Vivarium and Charles River Canada, Montreal, 
QC) were dissected and dissociated. In accordance with University Animal Care 
guidelines, animals were live decapitated, ganglia from all spinal levels were removed, 
and the roots were trimmed. To isolate individual DRG neurons, both enzymatic and 
mechanical dissociation was used. Enzymatic dissociation was carried out first and 
performed by incubating the ganglia in 0.25% collagenase for 45 min, and 0.25% trypsin 
for 40 min (Invitrogen/ Gibco BRL, Burlington, Ont). Mechanical dissociation was 
carried out next and performed by repeated cycles of aspiration and expulsion of the 
DRG fragments through a flame narrowed pasture pipette. Upon completion, dissociated 
DRG neurons were suspended in serum-free Neurobasal medium (NB, Invitrogen) 
supplemented with 1 OOU penicillin/streptomycin, B27 supplement (Invitrogen), and 
20mM cytosine arabinoside (modified NB). This suspension was then layered on top of a 
30% Percoll solution (Amersham Bioscience, Baie d'Urfe, QC) in 15ml conical tubes and 
centrifuged at 400g for 20 min at room temperature. Pellets were then carefully extracted 
with a sterile pasture pipette, placed in a fresh 15ml tube, washed with the previous 
suspension media, and centrifuged to remove any remaining Percoll. Neurons were 
plated in either Lab-Tek 16-well chamber slides (Nunc International, Naperville, NC) for 
neurite growth assessment or 12-well plates for Western blot analysis, and incubated at 
37°C with 95% 0 2 and 5% C02 for 24 and 48 hrs. Slides and culture plates were coated 
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twice with poly-D-lysine (PL, 1 !lg/ml, BD Bioscience, Bedford, MA), laminin, (LN, 1 
!lg/ml, 10 !lg/ml, 25 !lg/ml or SO !lglml, Invitrogen), collagen (COL, 50 !lg/ml, Sigma), 
or fibronectin (FB, 50 !lg/ml, Gibco). The neurons were cultured in modified serum-free 
NB alone or supplemented with NGF (25 ng/ml, Cedarlane Labs, Hornby, ON), or 
GDNF (25 ng/ml, Cedarlane Labs). 
4.2.2 Cell Selection 
Specific cell populations were selected as discussed in chapter 3; Briefly 
streptavidin-coated beads were incubated with biotinylated Griffonia Simplicifolia IB4 
lectin (Sigma) for 2 hrs at room temp by gentle rotation. Beads were then washed 
removing any excess lectin and added to the cell suspension. This suspension of cells 
and Dynal beads was incubated at room temp for 30 min followed by bead capture with a 
Dynal magnetic separator. The supernatant was removed and plated as the non-selected 
NGF-responsive cell population, which included both NF200+ve and CGRP+ve cells. 
Next the beads and selected cells were washed and further incubated with DNase for 15 
mins to release the selected cells from the beads. These cells were then plated as a 
homogenous selected IB4+ve cell population (purity 2: 95%, with < 2% non-neuronal 
cells). 
4.2.3 Immunocytochemistry 
Neurons were fixed in 4% paraformaldehyde (pH 7-7.4) in PBS for 15 mins, 
permeablized with 0.1% Triton-X-100 and blocked with 10% normal goat serum in PBS. 
For neuronal and neuritic identification, antibodies directed against peripherin (1 :250), 
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PGP 9.5 (1:250, Chemicon, Temuclua, CA), and tubulin (1:1000, Sigma) were employed. 
To identify cellular subpopulations antibodies directed against heavy chain neurofilament 
NF200 (1 :1500, RT97, University of Iowa Developmental Biology Hybridoma Bank), 
calcitonin gene related peptide (1 :1500, CGRP, Sigma), panTrk (1 :250, Santa Cruz, Santa 
Cruz, CA) and a biotin-conjugated lectin IB4 (1 :250, Sigma) were used. Cells were 
incubated with the primary antibodies at 4°C for 16-20 hrs, followed by Cy2- or CyS-
tagged secondary antibodies (Jackson Immunoresearch Labs, West Grove, PA) or HRP-
DAB detection; in the case of IB4-detection FITC-Streptavidin was used. These slides 
were cover slipped with glycerol and imaged with light or confocal laser scanning 
microscopy. 
4.2.4 Enzyme Inhibition 
Signalling pathways were inhibited by the use of specific pharmacological 
inhibitors. Inhibitors targeting PI 3-K (LY294002, 2-(4-morpholinyl)-8-phenyl-4H-
1 benzopyran-4-one, Calbiochem), Akt (Akti, 1L-6-hydoxymethyl-chiro-inositol2-[(R)-2-
0-methyl-3-0-octadecylcarbonate, Calbiochem), and MEK (U0126, 1 ,4-diamino-2,3-
dicyano-1 ,4-bis (2-aminophenylthio) butadiene, Calbiochem) were added to the culture 
media at the time of plating, thus the cells were treated for 24 hrs. The cultures were 
fixed and labelled for the appropriate markers. 
4.2.5 Measurements ofNeurite Growth 
Neurite initiation (neuritogenesis) was first quantified by determining the 
percentage of total tubulin stained neurons with neurites twice the length of their cell 
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body diameter. Growth was assessed at 24 hrs after plating. Individual neuron tracings 
of DAB-stained neurons were carried out using the Neurolucida® (MicroBrightField, 
VT) tracing program. Only neurons for which we were able to identify unambiguously 
the associated neurites or neuritic networks were chosen for tracing analysis. Data 
analyses were carried out with the NeuroExplorer® software package; here Sholl analysis 
(intersection point and length) and total neurite length data were collected. Sholl analysis 
measures both the number of intersection points of axons crossing 20 r-tm concentric 
circles radiating from the cell body and the length of the neurites within each concentric 
circle, thus giving a measure of both elaboration and total growth of the neurites. Total 
neurite length is a measure of the cumulative length of neurites produced. Data were 
imported into a graphing and statistical analysis software program (Prism 4, GraphPad 
Corp) for further analyses. For each condition examined (control-PL +NGF or -NGF, LN 
+NGF or -NGF) 50 neurons were completely traced, with cells pooled from 
approximately 3-6 different plating experiments. A minimum of 800 cells was analyzed 
for the entirety of this study. 
4.2.6 Immunoblotting 
For Western analyses, neurons were plated in 12-well plates that had been coated 
with PL or LN (25 r-tg/ml, Invitrogen) in the presence or absence of NGF (25 ng/ml, 
Cedarlane Labs), or GDNF (25 ng/ml, Cedarlane Labs). Neurons were subsequently 
processed at 24 hrs after plating by removing the original plating media, adding 300 r-tl of 
PBS containing 0.5 mM Orthovanadate to each well, and scraping the cells off the plating 
surface using a beveled tip rubber scrapper. Collected samples were briefly centrifuged 
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to pellet the cells, supernatant was removed, and the cells were lysed by gentle rotation 
overnight using 50 Ill of lysis buffer containing TBS with 1% NP-40, 10% glycerol, 1 
I 
mM phenylmethyl sulphonyl fluoride (PMSF), 10 mg/ml aprotinin, 1 mg/ml leupeptin, 
and 0.5 mM sodium orthovimadate. Following cell lysis and centrifugation (10,000 rpm, 
5 min), the supernatants were used to determine protein concentrations using a BCA 
protein assay (Pierce Chemicals, Rockford, IL. ). Equivalent amounts of protein (50 !lg) 
were subjected to SDS-PAGE (8%-10% acrylamide). Following transfer to 
nitrocellulose, the blots were stained with Ponceau Red, photographed, assessed for the 
equivalency of protein loading, and cut to allow the top and bottom portions of the blot to 
be probed simultaneously. Ponceau Red was subsequently removed using Tris-Buffered 
Saline and the blots were blocked with 3% milk in Tris-Buffered Saline with 0.2% 
Tween-20, and subsequently incubated with the following antibodies (1: 1 ,000) overnight 
at 4°C: with (31 integrin (1:1000, Santa Cruz, Santa Cruz CA), and Actin (1:1000, 
Sigma). The next day, blots were washed, incubated in the appropriate horseradish 
peroxidase conjugated 'secondary antibody (anti-rabbit or anti-mouse lgG- HRP; 
Boehringer Mannheim, I :5,000), and visualized using chemiluminence reagents (ECL, 
NEN, Boston, MA) and exposure to X-ray film (Cronex MRF Clear base, Agfa Corp, 
Greenville, SC). Developed films were subsequently digitized and densitometrically 
analyzed using the Image J software (NIH image downloadable software). (31 integrin 
was normalized against actin, and digital images of the blots were used to make 
composite figures with Adobe Photoshop graphics software (Adobe Corp, Mountain View 
CA). 
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4.2. 7 Statistical Analysis 
All reported data analyses are based on a minimum of 3 separate experiments for 
each manipulation. Data are plotted as mean ± SEM and significance is noted only if 
p<0.05 as determined by ANOVA using Tukey testing for post hoc comparisons for 
multiple group analyses. 
4.3 Results 
4.3.1 DRG neurons plated on increasing concentrations of laminin show increased 
neurite growth and increased expression of fll integrin 
In these experiments, we were interested in the effects of both the extracellular 
matrix molecule laminin (LN) and the growth factor NGF on neurite growth. Briefly 
DRG neurons were plated on either poly-D-lysine (PL, lacking any sequence required to 
produce integrin activation) or increasing concentrations of LN (which will activate 
integrins) in the presence or absence of NGF. To allow for neuronal visualization cells 
were fixed and immunostained 24 hrs after plating for tubulin and PGP 9.5. When cells 
were plated on increasing concentrations of LN, from 0 (PL) to 50 ~-tg/ml, greater 
amounts of neurite growth were observed (Fig 4.1 A-E). Further increases in neurite 
growth were achieved by plating the DRG cells in the presence of added NGF (Fig 4.1 F-
J). Optimal growth conditions existed when cells were plated on 50 ~-tg/ml of LN in the 
presence of 25 ng/ml ofNGF (Fig 4.1 J). 
We also examined (31 integrin subunit expression, and observed a significant 
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Figure 4.1. Increasing concentrations of laminin stimulates increased neurite 
growth and ~1 integrin expression in adult DRG neurons. A-J: Neurons were plated 
on poly-0-lysine (PL, A, F), or laminin (LN) at concentrations of 1 !J.glml (B, G), I 0 
!J.glml (C, H), 25 !J.g/ml (D, I), and 50 !J.glml (E, J). They were subsequently fixed and 
immunostained for anti-peripherin as outlined in the methods. Confocal laser scanning 
microscopy was used to visualize stained neurons 24 hrs after plating. Increased neurite 
growth was seen with increasing concentrations of LN with maximal growth observed at 
25-50 !J.glml. Scale bar- 20 !J.m. K-L: Western blots of neurons plated on PL or 
previously stated LN concentrations in the absence (K) or presence (L) ofNGF. Blots 
were probed for ~I integrin and actin. Significant increases in ~ 1 expression were 
observed with increasing LN concentrations. Significance was tested using one-way 
ANOVA with Tukey post-hoc testing. * p< 0.05, ** p<O.OO l. 
PL 1ug LN 
·NGF 
+NGF 
K PL 10 25 50 
Actin - ~ ._. .......,. ..._.. 
'2 
~ 
u 
~ 
..... 
e 
0 
~ 
co 
0:: 
c::::::JPL -NGF 
c::::::J LN 1ug -NGF 
- LN 1 Oug -NGF 
- LN 25ug -NGF 
- LN 50ug -NGF 
10ug LN 
L 
'2 
~ 
u 
~ 
.... 
e 
0 
~ 
co 
0:: 
25ug LN 
PL 10 
c::::::JPL+NGF 
c::::::JLN 1ug +NGF 
-LN 10ug +NGF 
- LN 25ug +NGF 
-LN 50ug +NGF 
SOug LN 
25 50 
Fig 4.1 
increase in j31 integrin 'expression in cells in response to increasing LN concentrations in 
both the presence and absence of NGF (Fig 4.1 K-L, *p<0.05, **p<O.OOI). The first 
I 
significant increase in integrin expression was seen at 10 ~-tg/ml with a further increase at 
' 25 ~-tg/ml and 50 ~--tglml. Similar results have been reported for the effect ofLN and NGF 
on embryonic DRG neurons (Condie and Letourneau, 1997); it has also been noted that 
increasing integrin expression in adult DRG neurons can enhance neurite growth 
(Condie, 2001 ). 
4.3.2 Laminin-induced neurite growth at 24 hrs after plating is most extensive in 
NF200+ve DRG cells 
We had noticed both here and in previous studies that not all neurons plated on 
LN, or those that underwent soluble LN stimulation, responded with significant neurite 
growth. As shown in Fig 4.2, in this mixed population of cells there are some neurons 
that put out neurites on LN in the absence ofNGF (Fig 4.2C, arrows), and when NGF is 
added, there is an enhancement of growth in some neurons (Fig 4.2D arrows), although 
others fail to respond (Fig 4.2D, arrowheads). To further investigate this, we first sought 
to identify the responsive cells initially using immunocytochemistry for markers reported 
to be relatively specific for different subcategories of DRG neurons. Cells were plated on 
LN or PL in the presence or absence ofNGF, and fixed and immunostained for NF200 
(RT97) which tends to label the medium and large myelinated neurons (Priestley et al., 
2002a) and CGRP, which is selective for smaller nociceptive myelinated and 
unmyelinated neurons (Priestley et al., 2002a). As shown in Fig 4.3, at 24 hrs after 
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Figure 4.2. Not all DRG neurons respond to laminin with increased neurite growth. 
Neurons were plated on either PL (A, B), or LN, 50 !-1-glml (C, D) in the presence (B, D) 
or absence (A, C) ofNGF. They were fixed, immunostained for PGP 9.5, and confocal 
laser scanning microscopy was used to visualize neurons 24 hrs after plating. A 
subpopulation of DRG neurons responds to LN-induced integrin stimulation with 
increased neurite growth (C, arrow) while other cells remain unaffected (C, D, 
arrowheads). The growth response can be further enhanced with the addition ofNGF (D, 
arrow). Scale bar- 50 !-1-ffi. 
PL PL +NGF LN LN +NGF 
Fig 4.2 
Figure 4.3. Laminin-induced neurite growth is most extensive in the NF200+ve 
DRG neurons. Neurons were plated on PL or LN (50 1-1-g/ml) in the presence or absence 
of NGF. At 24 hrs after plating cells were fixed and immunostained for anti-CGRP 
(green) and anti-NF200 (red). A-D: NF200+ve (red) neurons plated on LN show a robust 
increase in neurite growth (B, arrowhead), which was potentiated by the addition ofNGF 
(D, red cell). CGRP+ve neurons (green) show only small amounts of neurite growth 
when plated on LN alone, however plating them in the presence of NGF did stimulate 
increased neurite growth (D, green cell and arrowheads) that was not observed when 
plated on PL plus NGF. Scale bar- 50 1-1-m. 
PL LN 
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plating NF200+ve neurons (red) exhibit extensive neurite growth on LN (Fig 4.3 B), 
which was further increased by the addition of NGF (Fig 4.3 D). In contrast, the small 
CGRP+ve cells (green) show only small amounts of neurite growth on LN alone at this 
time point (Fig 4.3 B, note arrow pointing to green cell with some small neurites; also see 
Fig 4.6 below for 48 hr growth on LN), but did show extensive neurite growth in 
response to NGF (Fig 4.3 D, note green neuron and associated neurites, arrowheads). 
They did not, however, appear to respond to NGF with neurite growth at this time point 
when plated on PL (Fig 4.3 C) (further analysis of neurite growth for these cell 
populations can be found in Fig 4.1 0). 
4.3.3 IB4+ve neurons do not respond with increased neurite growth in the absence 
ofGDNF 
Because the DRG neuronal population is heterogeneous, with cells selectively 
responding to at least LN and various trophic factors, we decided to undertake a cellular 
selection protocol in order to further examine factors contributing to growth in the 
specific populations. In order to do this we utilized Dynal magnetic beads coated with 
the ligand of interest (Tucker et al., 2005b). Briefly, streptavidin-coated magnetic beads 
were washed and coated with biotinylated lectin IB4. The beads were then incubated 
with the dissociated neuronal suspension in order to capture IB4+ve cells. Bead-bound 
cells were then isolated by being placed in a magnetic separator and the supernatant was 
removed. This allowed us to culture the selected IB4+ve population separately from the 
remaining non-selected population, which were termed the NGF-responsive cell 
population and consisted of the NF200+ve and CGRP+ve neurons. We opted for the 
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selection of the IB4+ve cells for a number of reasons, not the least of which was the lack 
of other appropriate cell surface1 markers compatible with the available Dynal beads. At 
the time we carried out these experiments, only anti-mouse IgG-coated beads (and not 
anti-rabbit IgG) were available, and although we could select p75+ve neurons using a 
monoclonal antibody, because of the lack of monoclonal antibodies against the external 
portion of the Trk receptors we were unable to select out specific Trk-expressing 
populations. 
Selected IB4+ve and non-selected NGF -responsive cells (NF200+ve and 
CGRP+ve cells remaining in supernatant after magnetic bead capture) were then plated 
on PL or LN in the presence or absence of NGF or GDNF for 24 hrs. Cells were 
subsequently fixed and labeled with IB4 and immunostained using a pan-Trk antibody. 
As shown in Fig 4.4, IB4+ve cells (green) show little or no neurite growth when plated 
on PL (Fig 4.4 A, PL-S) or LN (Fig 4.4 C, LN-S). Furthermore, as might be expected, 
the IB4+ve cells did not respond to NGF on either PL (Fig 4.4 E) or LN (Fig 4.4 H). 
Since IB4+ve neurons are reported to be GDNF -responsive (Bennett et al., 1998; 
Paveliev et al., 2004), we treated neurons on either PL (Fig 4.4 I) or LN (Fig 4.4 K) with 
GDNF and observed that GDNF elicited neurite growth only from neurons plated on LN 
(Fig 4.4 K). Because of the apparent lack of response of the IB4+ve neurons to the LN 
substrate alone, we asked whether other ECM molecules that are known to be present 
within the PNS were better able to promote neurite growth from this population of cells. 
We thus plated the selected IB4+ve population of cells on fibronectin (FB) or collagen-
IV (Col) coated slides and assessed the amount of growth in the presence or absence of 
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Figure 4.4. IB4+ve and NGF -responsive cell populations labelled for IB4 and 
immunostained with a pan Trk antibody. The IB4+ve cells that were selected using 
magnetic beads (as outlined in Methods) and the remaining non-selected NGF-responsive 
cells were plated on PL or 50 1-1-g/ml LN in the presence or absence of added growth 
factors (NGF or GDNF). Cells were fixed and labelled with biotinylated IB4 lectin 
(green) or immunostained using a pan Trk antibody (red). IB4+ve cells do not show 
significant neurite growth on PL (A) or LN (C), nor is there any stimulation of growth 
with NGF (E, G). However, GDNF does elicit significant growth from these IB4+ve 
cells when plated on LN (K). NGF-responsive cells show significant neurite growth 
when plated on LN (D), which was potentiated by the addition of NGF (H). However, 
these cells were not responsive to GDNF (L). Scale bar- 50 ~-tm. 
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fig 4.4 
added NGF or GDNF at 24 hrs after plating. IB4+ve neurons did not exhibit any 
significant amount of growth on either Col or FB alone, and the addition of NGF or 
GDNF had no further influence (data not shown). In addition to these integrin ligands, 
NCAM has been reported to be a ligand for GDNF receptor components (Liu et al., 2002; 
Paratcha et al., 2003; Thelen et al., 2002). It is possible that cell adhesion molecules like 
NCAM or Ll might be more important in promoting neurite growth from this population 
of cells, although we have not investigated this. 
Cells of the NGF-responsive Trk+ve population (red) displayed significant neurite 
growth when plated on LN alone (Fig 4.4 D, LN-NS), and the addition ofNGF further 
enhanced this growth (Fig 4.4 H). Note that the addition of GDNF (Fig 4.4 L) did not 
result in further increased growth in the Trk+ve cells on LN (compare Figs 4.4 D and 4.4 
L). These results indicate that the selected IB4+ve neurons are unresponsive to LN alone 
and require both LN and GDNF to elicit significant neurite growth. Unlike the IB4+ve 
cells, the NGF-responsive Trk+ve neurons respond with robust increases in neurite 
growth when plated on .LN which was further increased by the addition of NGF and 
unaffected by GDNF. In our cultures, the majority of the NF200+ve cells appear to be 
NGF-responsive. Prior work has also noted that large proprioceptive neurons do express 
TrkA and respond to NGF (Chattopadhyay et al., 2003), and we have previously reported 
that only a small proportion of cells in our cultures express TrkC (<10%) (Jones et al., 
2003; Kimpinski et al., 1997). 
Fig 4.5 provides quantitation of the results noted above. The number of cells with 
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Figure 4.5. Quantitative analysis of neurite growth from IB4+ve and NGF-
responsive cell populations in the presence or absence of NGF and GDNF. A, D: 
Percentage of IB4+ve (A) and NGF-responsive (D) cells with neurites when plated on PL 
or LN +/-added growth factors (NGF, GDNF). B, E: Total neurite length of IB4+ve (B) 
and NGF-responsive (E) cells plated on PL or LN +/- added growth factors (NGF, 
GDNF). C, F: Number of intersections of IB4+ve (C) and NGF-responsive (F) cells 
plated on PL or LN +/-added growth factors (NGF, GDNF). Panels, A-C. clearly show 
that IB4+ve cells plated on LN or PL show little growth in the absence of GDNF. The 
addition of GDNF to LN-plated cells results in a significant increase in all parameters. 
NGF had no significant effect on this population of cells. In contrast, panels 0-F show 
that a significant increase in the percentage of cells with neurites, total neurite length, and 
neuritic elaboration was observed when NGF -responsive cells were plated on LN, with 
all parameters further enhanced by the addition of NGF. NGF also stimulated a 
significant increase in the percentage of cells with neurites and total neurite length of 
NGF-responsive cells when plated on PL. However, the presence of GDNF had no 
significant effect on this cell population. Significance was tested using one-way 
ANOVA with Tukey post-hoc testing. * p<0.05 ** p<O.OOl. 
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neurites, neuritic length and degree of neuritic elaboration for the IB4+ve and NGF-
responsive cell populations wend calculated. In order to quantitate the amount and pattern 
of growth (here and in subsequent experiments), neurons were traced and analyzed for 
total neurite length and complexity or patterns of neurite growth (Sholl analysis) using 
the image analysis software Neurolucida® and NeuroExplorer® as per the Methods 
section and as previously reported (Jones et al., 2003; Tucker et al., 2005a). As shown in 
Fig 4.5 A, the IB4+ve population did not show a significant number of neurite bearing 
cells when plated on PL or LN in the absence of added GDNF; similarly, no significant 
increase in total neurite length (B) or complexity of neurite growth (C) were observed. 
However, a striking increase in the percentage of neurons with neurites was observed 
when plated on LN in the presence of GDNF, with greater than 80% of the cells showing 
growth. Likewise a significant increase in total neurite growth (total neurite 
length/neuron) (B) and neurite complexity (C) was observed with the addition of GDNF. 
The addition of NGF has a small, although non-significant, effect on increasing neurite 
growth; this is likely related to the small percentage of neurons that have been reported to 
be both IB4+ve and express TrkA receptors (Averill et al., 1995; Kashiba et al., 2003). 
Unlike the IB4+ve cell population, LN alone stimulates a significant increase in 
neurite growth in the NGF-responsive cell population. Approximately 50% of these 
neurons exhibit neurite growth in response to LN alone, and this percentage is increased 
to almost 80% when NGF is present. This percent increase correlates with observed 
significant increases in total neurite length (Fig 4.5 E) and neurite complexity (Fig 4.5 F), 
wherein growth (total neurite length/neuron) was increased from approximately 300 !J.m 
on PL to approximately 2000 !liD on LN. A further significant increase in total neurite 
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growth (Fig 4.5 E) and neurite complexity (Fig 4.5 F) was observed with the addition of 
NGF, with mean total neurite growth reaching 3800 ~m/neuron. As noted above, the 
addition of GDNF does not influence neurite growth from this population of cells. Note 
' 
that NGF treatment of cells plated on PL also results in about 20% of the cells expressing 
small neurites (Fig 4.5 D) with a small but significant increase in total neurite length (Fig 
4.5 E). 
These results again show that the NGF-responsive population is responsive to LN 
in the absence of added growth factors and that this response is potentiated by the 
addition of NGF but unaffected by GDNF. Conversely, the IB4+ve cell population 
seems to be unresponsive to LN alone but exhibits a robust response when GDNF is 
present. 
4.3.4 The lack of LN induced neurite growth of the IB4+ve neurons is not due to a 
delayed growth response 
To test whether 'or not the lack of neurite growth observed in the IB4+ve cell 
population was due to a delay in neurite growth, IB4+ve and NGF-responsive cells were 
plated on LN for 48 hrs and subsequently fixed and labelled with IB4, or immunostained 
for CGRP and NF200. At 48 hrs after plating selected IB4+ve cells still did not express 
any significant amount of neurite growth in the absence of added GDNF, with less then 
10% of the cells having neurites (Fig 4.6 A, D). However, the NGF-responsive cell 
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Figure 4.6. Neurite growth from IB4+ve and NGF-responsive cell populations 
plated on Laminin (LN) in the absence of added growth factors for 48 hrs. A: 
Selected IB4+ve cells were plated on LN in the absence of added growth factors and 
labeled for IB4 (LN-S). B-C: NGF-responsive cells were plated on LN in the absence of 
added growth factors and immunostained for CGRP (LN-NS-CGRP) and NF200 (LN-
NS-CGRP). 0: Percent of IB4+ve and NGF-responsive cells with neurites plated on LN 
in the absence of added growth factors. Confocal laser scanning microscopy was used to 
visualize stained neurons 48 hrs after plating. IB4+ve cells do not show any significant 
amount of neurite growth at this time point when plated on LN in the absence of added 
growth factors (A, 0). Similar to the situation at 24 hrs, a significant number ofNGF-
responsive cells extended neurites (B, C, D) when plated on LN in the absence of added 
growth factors. However, neurite growth from the CGRP+ve cell population was much 
more extensive at this time point than that observed at 24 hrs after plating (B). 
Significance was tested using one-way ANOVA with Tukey post-hoc testing. ** p< 
0.001. 
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population again showed a significant amount of neurite growth, with approximately 80% 
of the cells extending neurites (Fig 4.6 B, C, D). Most notably, extensive neurite growth 
(which was much smaller at the earlier time point) was observed in the CGRP+ve cell 
population (Fig 4.6 B). This suggests that the CGRP+ve cells are indeed responsive to 
LN in the absence of added growth factors, but require an extended period of time to 
elicit a similar response to that seen in the NF200+ve cell population. These results 
suggest that lack of LN induced neurite growth of the IB4+ve neurons is not due to a 
delayed growth response and that integrin activation alone is insufficient in eliciting 
neurite growth from this population of cells. 
4.3.5 Signalling pathways important in neurite growth for the IB4+ve cell 
population 
To elucidate the signalling pathways employed by neurons that responded to LN 
and GDNF together (i.e., the selected IB4+ve cells), a series of experiments using 
pharmacological inhibitors of phosphoinositide 3-kinase (PI3-K, L Y290034), protein 
kinaseB/Akt (Akti) and MAP kinase kinase (MEK, U0126) were carried out. IB4+ve 
cells were plated on LN in the presence or absence of GDNF for 24 hrs, subsequently 
fixed, immunostained with peripherin, and processed for HRP-DAB histochemistry 
followed by light microscopy (Fig 4. 7). As noted above, cells plated on LN in the 
absence of added growth factors have little or no neurite growth (Fig 4. 7 E), while 
neurons plated on LN in the presence of GDNF display extensive neurite growth (Fig 4. 7 
A). To elucidate the signalling components important in the LN+GDNF-induced neurite 
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Figure 4.7. Inhibition of PI-3K, Akt and MAPK attenuates growth of IB4+ve cells 
plated on LN. A-H: Cells were plated on LN +/- GONF and immunostained for 
peripherin, followed by DAB secondary labeling. Light microscopy was used to 
visualize stained neurons 24 hrs after plating. IB4+ve cells plated on LN in the presence 
of GONF show an increase in neurite growth (A). Increased neurite growth observed 
when cells were plated on LN in the presence of GDNF was attenuated with the addition 
of L Y294002 (B), Akti (C). and U0126 (0). No increase in neurite growth was observed 
when IB4+ve cells were plated on LN in the absence of GDNF (E), therefore, no effect 
on neurite growth was observed with the addition of L Y294002 (F), Akti (G), or UO 126 
(H). Scale bar- 25 f-tm. 
U0126 
e ... 
• 
-GDNF 
. ' 
•••• ',,,., .•, :: .. 'I .
Fig 4.7 
growth, pharmacological inhibitors ofPI3-K (LY, 10 mM), Akt (Akti, 10 mM) and MEK 
(U0126, 10 mM) were added to the culture medium. Each inhibitor blocked neurite 
I 
growth on LN in the presence of GDNF (Fig 4.7 B -L Y, Fig 4.7 C-Akti, Fig 4.7 D-
U0126); because then:; was little or no growth in the absence ofGDNF, the inhibitors had 
no apparent effect (Fig 4.7 F-LY, Fig 4.7 G-Akti, Fig 4.7 H-U0126). 
Quantitative analyses of the number of cells with neurites and neuritic length and 
elaboration are presented in Fig 4.8. First, the total number of neurons plated was 
counted and then the number exhibiting neurites greater than 2 soma diameters was 
recorded. Second, each neuron that exhibited neurite growth was traced providing data 
for complex and total neurite length. The data are presented in Fig 4.8 with cells plated 
in the absence (Fig 4.8 A, C, and E) or presence (Fig 4.8 B, D, and F) ofGDNF. 
As shown in Fig 4.8, less than 10% of the IB4+ve cells extend neurites when plated on 
LN alone (Fig 4.8 A, first column), while the addition of GDNF increases this to about 
80% (Fig 4.8 B, first column). However, the addition of L Y (Fig 4.8 B, second column), 
Akti (Fig 4.8 B, third column) or U0126 (Fig 4.8 B, fourth column) significantly inhibits 
the number of cells with neurites. In order to further quantitate the amount and pattern of 
growth, neurons were traced and analyzed for total neurite length and complexity or 
patterns of neurite growth (Sholl analysis) using the image analysis software 
Neurolucida® and NeuroExplorer® as per the Methods section and as previously 
reported (Jones et al., 2003; Tucker et al., 2005a). Results of these analyses are presented 
in Fig 4.8 C-F, where panels C and D present total neurite growth of IB4+ve neurons 
plated on LN in either the absence (Fig 4.8C) or presence (Fig 4.8D) of GDNF; and 
panels E and F present the data from the Sholl analyses as the number of intersection 
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Figure 4.8. Quantitative analysis of the effect of L Y294002, Akti, or U0126 on 
neurite growth from IB4+ve cells 24 hrs after plating. A: Percent of cells with 
neurites on LN minus GDNF. B: Percent of cells with neurites on LN plus GDNF. C: 
Total neurite length on LN minus GDNF. D: Total neurite length on LN plus GDNF. E: 
Number of intersections on LN minus GDNF. F: Number of intersections on LN plus 
GDNF. The percent of cells with neurites was decreased with the addition ofL Y294002, 
Akti, or UO 126 in the presence of GDNF (B), as was total neurite length (0). The 
amount of neuritic elaboration (indicated by the number of intersections that neurites 
make with concentric 20 1-tm rings) was attenuated with the addition of L Y294002, Akti 
or UO 126 in the presence of GDNF (F). Significance was tested using one-way ANOV A 
with Tukey post-hoc testing. ** p<O.OO 1. 
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points for the IB4+ve neurons plated on LN in either the absence (Fig 4.8E) or presence 
(Fig 4.8F) of GDNF. 
The data in Fig 4.8 D show more clearly the effect of inhibiting either the PI 3-K, 
Akt, or MAPK pathways on total neurite growth of IB4+ve cells plated plus GDNF. 
Growth was attenuated by approximately 75%, with total neurite length dropping from 
800 ~-tm to less then 200 ~-tm with the addition of inhibitors (Fig 4.8 D-L Y column 2, Fig 
4.8 D-Akti column 3, Fig 4.8 D-U0126 column 4). Because total neurite growth for 
IB4+ve cells plated in the absence of GDNF was negligible, the inhibitors had no 
significant effect. 
The Sholl analyses provide an estimation of the complexity of growth or the 
amount of branching, by quantifying neurite intersection points as described in the 
Methods section. As with the amount of neurite growth, neurite complexity (equated by 
the number of intersections across 20 ~-tm concentric rings) of IB4+ve neurons plated in 
the presence ofGDNF was significantly inhibited by the addition ofLY, Akti, or U0126 
(Fig 4.8 F). 
Results from these experiments indicate that both the PI3-K/Akt and 
MEK/MAPK pathways are important in stimulating neurite growth in adult IB4+ve DRG 
neurons since inhibition of either of these pathways clearly resulted in a significant 
decrease in growth compared to the control situation. 
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4.3.6 Signalling pathways important in neurite growth for the NGF -responsive cell 
population 
Because we were also interested in the signalling pathways employed by neurons 
that responded to LN .and NGF (i.e., the NF200+ve and CGRP+ve cell populations), we 
carried out a series of experiments with the NGF-responsive population using the same 
pharmacological inhibitors noted above. 
NGF-responsive cells were plated on PL or LN in the presence or absence ofNGF 
for 24 hrs, subsequently fixed and immunostained for tubulin followed by confocal 
analysis (Fig 4.9). As noted above, cells plated on PL have little or no growth (Fig 4.9 A-
B), while neurons plated on LN display extensive neurite growth (Fig 4.9 C), which is 
further enhanced by NGF (Fig 4.9 D). To elucidate the signalling components important 
in the LN-induced neurite growth, pharmacological inhibitors of PB-K (L Y, 10 mM), 
Akt (Akti, 10 mM) and MEK (U0126, 10 mM) were added to the culture medium. Both 
L Y and Akti blocked neurite growth on LN in the absence ofNGF (Fig 4.9 G-LY, Fig 
4.9 K-Akti), although there was still some remaining growth in the LN+NGF condition 
(Fig 4.9 H, L; see below). As expected there was no effect on the cells plated on PL in 
the presence (Fig 4.9 F) or absence (Fig 4.9 E) ofNGF; the PL conditions were included 
as controls. In contrast to the effects of L Y and Akti, inhibition of MEK, and thus 
MAPK, did not inhibit growth on LN alone (Fig 4.9 0) nor in the presence (Fig 4.9 P) of 
NGF. In fact, the addition ofU0126 appeared to have increased neurite growth (Fig 4.9 
P). Again little effect was observed for cells plated on PL in the presence ofU0126 (Fig 
4.9 M, N). 
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Figure 4.9. Inhibition of PI-3K or Akt, but not MAPK, blocks neurite growth of 
NGF -responsive cells plated on LN. A-P: Cells were plated on PL, or LN, +/- NGF 
and immunostained for peripherin. Confocal laser scanning microscopy was used to 
visualize stained neurons 24 hrs after plating. NGF-responsive cells plated on LN show 
substantial neurite growth (C), and the addition of NGF stimulates an increase in neurite 
growth on both PL (B) and LN (D). Increases in neurite growth observed on PL+NGF, 
LN-NGF, and LN+NGF were attenuated with the addition of L Y294002 (F, G, and H 
respectively) and Akti (J. K, and L respectively). Neurite growth was unaffected or 
potentially enhanced by the addition of UO 126 (N, 0, and P respectively). Scale bar- 50 
~m. 
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In subsequent experiments, cells were plated on LN and treated with NGF or the 
inhibitors as noted above, but' were immunostained and processed for HRP-DAB 
histochemistry, to facilitate quantitative analyses of the number of cells with neurites, 
neuritic length and degree of neuritic elaboration. Total numbers of neurons plated were 
counted and the number of neurons exhibiting neurites greater than 2 soma diameters was 
analyzed. The data are presented in Fig 4.10 for the cells plated on LN minus NGF (Fig 
4.10 A, C, E) or plus NGF (Fig 4.10 B, D, F). 
As shown in Fig 4.1 0, approximately 50% of the cells extend neurites when 
plated on LN alone (Fig 4.10 A, first column), while NGF increases this to about 75% 
(Fig 4.10 B, first column). L Y inhibits the percentage of neurons with neurite growth by 
approximately 20% in the absence of NGF (Fig 4.10 A, second column) and by about 
35% in the presence of NGF (Fig 4.10 B, second column). Akti further inhibits the 
number of neurons with growth by about 30-35% in the absence of NGF (Fig 4.10 A, 
third column) and by about 40% in presence of NGF (Fig 4.10 B, third column). 
However, unlikeLY or Akti, U0126 had no significant effect on the percentage of cells 
with neurites (Fig 4.10 A, B - last column). 
In order to further quantitate the amount and pattern of growth, neurons were 
analyzed by tracing neurites, as noted in Section 4.3.5. Results of these analyses are also 
presented in Fig 4.10, where panels C-D present total neurite growth for cells plated on 
LN alone (Fig 4.10 C) or plus NGF (Fig 4.10 D). Panels E-F present the data from the 
Scholl analyses as the number of intersection points for the same set of cells again in the 
absence (Fig 4.10 E) or presence (Fig 4.10 F) ofNGF. The data in Fig 4.10 C-D show 
more clearly the effect of inhibiting the PI 3-K/Akt and MEK/MAPK pathways on total 
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Figure 4.10. Quantitative analysis of the effect of LY294002, Akti, or U0126 on 
neurite growth from NG F -responsive cells at 24 hrs after plating. A: Percent of cells 
with neurites on LN minus NGF. B: Percent of cells with neurites on LN plus NGF. C: 
Total neurite length on LN minus NGF. D: Total neurite length on LN plus NGF. E: 
Number of intersections on LN minus NGF. F: Number of intersections on LN plus 
NGF. The percent of cells with neurites was attenuated with the addition of L Y294002 
and Akti in both the presence (B) and absence (A) of NGF. However the addition of 
UO 126 had no significant effect on the percent of cells with neurites (A, B). Total neurite 
length was also attenuated with the addition of L Y294002 and Akti in both the presence 
(D) and absence (C) ofNGF. Although the addition ofUOl26 had no significant effect 
on total neurite length when plated in the absence (C) of NGF, a significant increase in 
total neurite length was observed in the presence (D) of NGF. The amount of neuritic 
elaboration was attenuated with the addition of L Y294002 and Akti in both the presence 
(F) and absence (E) ofNGF. However the addition ofU0126 had no significant effect on 
neuritic elaboration in either the presence (F) or absence (E) of NGF. Signiticance was 
tested using one-way ANOV A with Tukey post-hoc testing. ** p<O.OO 1. 
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neurite growth ofNGF'-responsive cells. In the absence ofNGF (Fig 4.10 C), growth was 
attenuated by approximately 75% with the addition of L Y (Fig 4.10 C, second column, 
decr~ased from about 1800 ~-tm to < 400 ~-tm), and by 80% with the addition of Akti (Fig 
4.10 C, third column, total' neurite length decreased from 1800 ~-tm to < 200 ~-tm). A 
slight, but non-significant, increase in neurite growth was seen with the addition of 
U0126 in the absence ofNGF (Fig 4.10 C, column 4). In the presence ofNGF (Fig 4.10 
D) growth was decreased by about 80% with the addition of L Y (Fig 4.10 D, second 
column, 3800 ~-tm to < 800 ~-tm), and by about 90% with the addition of Akti (Fig 4.10 D, 
third column, 3800 ~-tm to< 300 ~-tm). In contrast, a significant increase in neurite growth 
of about 20% was observed with the addition ofU0126 in the presence ofNGF (Fig 4.10 
D, column 4, total neurite length increased from 3800 ~-tm to 5700 ~-tm). 
As with the amount of neurite growth, neurite complexity of the NGF-responsive 
neurons in the absence (Fig 4.10 E) or presence (Fig 4.10 F) of NGF was also 
significantly inhibited by the addition of both L Y, and Akti, but was unaffected by 
U0126. 
Results from these sets of experiments indicate that the PI 3-K/Akt pathway is 
important in stimulating LN-induced neurite growth in NGF-responsive DRG neurons, 
since inhibition of this pathway clearly results in a significant decrease in growth 
compared to the control situation. These results also illustrate that, although selected 
IB4+ve cells extend neurites on LN in the presence of GDNF, this growth is much less 
extensive than that observed from the NGF-responsive cells. For instance, in selected 
IB4+ve cells with LN plus GDNF, total neurite growth reached a maximum of 800 ~-tm 
(Fig 4.8 D, column one), while the corresponding amount for the NGF-responsive 
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neurons is approximately 3500 fAll (Fig 4.10 D, column one). The Sholl analyses in 
these studies also illustrate th~t the NGF-responsive neurons clearly display more 
complex patterns of branching; compare a maximum of 3 intersection points at 100 ~m 
away from the cell body for IB4+ve cells (Fig 4.8 F), with 12 intersections (minus NGF, 
Fig 4.10 E) increasing to 25 intersections with NGF present (Fig 4.10 F). 
4.4 Discussion 
In the present study we have investigated the role of growth factor and 
extracellular matrix molecule (ECM) stimulation on neurite growth and regeneration of 
selected sub-populations of DRG neurons. We have utilized a magnetic bead selection 
technique to study growth responses of two major DRG neuron subpopulations in 
isolation. Our results demonstrate that the NGF-responsive neurons show neurite growth 
when plated on LN, even in the absence of added neurotrophins, and this can be further 
enhanced by the provision ofNGF, while neither BDNF nor NT3 were able to duplicate 
the effects ofNGF (data not shown). These effects appeared to be selective to LN, as 
these cells did not respond with neurite growth when plated on FB or Col (data not 
shown). In contrast, the IB4+ve neurons did not exhibit any detectable neurite growth 
when plated on LN or any of the other ECM molecules tested (FB, Col) in the absence of 
GDNF. However, these cells did respond with a robust increase in neurite growth when 
plated on LN and treated with GDNF (GDNF did not elicit neurite growth in these cells 
when plated on FB or Col). 
The potential signalling mechanisms were studied for each of the different 
subpopulations ofDRG neurons. We investigated the dependence of the NGF-responsive 
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neurons on the PI3-K/Akt and MEK/MAPK signalling pathways. These pathways have 
been shown to play a role in axonal growth from DRG explants and dissociated neurons 
I 
(Edstrom and Ekstrom, 2003; Jones et al., 2003; Jones et al., 2003; Kimpinski and 
' Mearow, 2001; Liu and Snider, 2001; Markus et al., 2002b; Tucker et al., 2005a; 
Wiklund et al., 1996; Zhou et al., 2004). We have also noted that integrin-dependent 
activation of components of these pathways are important for neurite growth in these 
cells (Tucker et al., 2005a). Inhibition of the PI3-K/Akt pathway blocked neurite growth 
in all situations, while there was no obvious requirement for the MEK/MAPK pathway, 
as inhibition with U0126 had no negative effect. In fact inhibition of MEK/MAPK 
tended to have a positive effect on growth, which may be due to increased activity of Akt 
(Jones et al., 2003; Ladet al., 2003). 
Dependence on these same signalling pathways was also examined in the IB4+ve 
cell population. Inhibition of the PI3-K/Akt pathway blocked neurite growth from 
IB4+ve cells, while, unlike the NGF-responsive cell population, inhibition of the 
MEK/MAPK pathway also attenuated neurite growth in these cells. GDNF can activate 
several intracellular signalling pathways to promote cell survival and neurite growth in a 
variety of cell types (Airaksinen and Saarma, 2002). However, there have been relatively 
few studies examining the contribution of GDNF -activated signalling to neurite growth in 
DRG neurons (Leclere et al., 1998; Paveliev et al., 2004). A recent study notes the 
importance of Src family kinases (SFKs), and suggests that, while the signalling 
pathways mediating the effects of SFKs on DRG neurite growth are unknown, PI 3-K 
could play a role (Paveliev et al., 2004). The link between SFK and GDNF-induced 
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growth in that study also supports our data indicating a requirement for integrin-mediated 
component to the GDNF-induced growth in DRG neurons. 
The influence ofECM, particularly laminin, on axonal growth and regeneration 
is well established (Grimpe and Silver, 2002; Luckenbill-Edds, 1997; McKerracher et al., 
1996). Studies dealing specifically with DRG explants and neurons have also reported 
the positive effects of ECM and neurotrophic factors (Edstrom et al., 1996; Hari et al., 
2004; Liu et al., 2002; Tonge et al., 1997) but few, if any, have noted any differences in 
the responsiveness of particular classes of neurons to ECM substrates or have considered 
the importance of the extracellular matrix as a requirement for many of these processes. 
Our results indicate clear distinctions in the response of neuronal subpopulations to 
integrin activation by one ECM molecule, LN, as well as the requirement for specific 
signalling pathways. 
4.4.1 What is the reason for the different responses? Are there intrinsic differences 
in ECM receptors expressed by the different neuron populations? 
Our data show that IB4+ve cells differ from the NGF-responsive neurons in their 
ability to regenerate processes after dissociation. The obvious question is whether/how 
these cells differ in either their intrinsic growth capacity or their ability to respond to 
ECM molecules such as LN, FB or Col. 
In terms of intrinsic growth ability, GAP-43 is associated with axonal growth and 
regeneration (Bomze et al., 2001; Skene, 1989). While GAP-43 is reported to be 
primarily expressed by small-medium sized DRG neurons in vivo, there are no reported 
differences in the expression or upregulation of GAP-43 in these different neuronal 
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subpopulations after injury or culturing that would account for our observations here 
(Mearow et al., 1994; Verge et al., 1990; Woolf et al., 1990). Another possibility relates 
I 
to observations that the initial arborizing growth displayed by some DRG neurons is 
transcription-independent ~nd does not appear to require neurotrophins (Smith and 
Skene, 1997); the larger neurons may express higher levels of proteins required to initiate 
neurite growth in the absence of added neurotrophic factors compared to the smaller 
cells, which could explain why the CGRP+ve cell populations exhibit a delayed growth 
response. However, the lack of growth on LN in the absence of GDNF in the IB4+ve 
cells cannot be explained simply by a lag in growth. We have followed cultures for up to 
72 hrs and the IB4+ve cells still do not respond in the absence of GDNF, although when 
stimulated with GDNF they are able to put out processes (data not shown). 
Are there differences in their ability to respond to ECM molecules? Ability to 
respond to ECM essentially depends upon the expression of the appropriate ligands for 
these molecules, eg., the integrins. The majority of DRG neurons express [31 integrin and 
a combination of the various a subunits, (Condie and Letourneau, 1997; Guan et al., 
2003; Tomaselli et al., 1993; Wallquist et al., 2004). The integrins alf31, a3f31, a6f:\J, 
and a7f31 are able to act as laminin receptors (Malinda and Kleinman, 1996). Although 
LN alone was not sufficient to elicit a significant growth response from the IB4+ve cell 
population, these cells express LN binding integrins (Guan et al., 2003; Wallquist et al., 
2004) and this substrate was still required in order to achieve GDNF-induced neurite 
growth. During embryonic development the different subpopulations of chick DRG 
neurons have been reported to express different a chains, with presumptive 
proprioceptive afferents having higher expression of a3 f31, a4f31 and a5 f31 and 
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extending neurites on both LN and FB; cutaneous afferents had a stronger preference for 
LN and higher expression of a7~1 (Guan et al., 2003). Recent data have suggested that 
a 7 may play a role in the regeneration of the large proprioceptive sensory axons and 
motor axons in mice (Ekstrom et al., 2003; Gardiner et al., 2005; Werner et al., 2000). 
These studies reported that a7 is expressed by only the large cells, although it was noted 
that a7 was upregulated in both small and large neurons after injury (Gardiner et al., 
2005; Werner et al., 2000). In contrast, Wallquist and colleagues reported that almost all 
DRG neurons expressed a7 and that all cells upregulated it after injury (Wallquist et al., 
2004). Our preliminary data (Mearow, Tucker and Rahimtula, in preparation) also 
suggest that there is no apparent difference in the expression of a 7, or in a V or a6 
expression between the selected and non-selected neurons. We have previously reported 
expression of both a3 and al in cultured DRG neurons (Tucker et al., 2005a), although 
we have not yet completed our studies of potential difference among the subpopulations. 
Thus, there do not appear to be any obvious differences amongst the 
subpopulations in terms of the integrins expressed. Since they do appear to express a 
similar repertoire of LN receptors, another possibility is that the relative numbers of 
receptors, and thus the effectiveness of activating signalling cascades, may differ. The 
NGF-responsive cells might have more receptors and thus be able to respond more 
efficiently to limiting amounts of the ECM in the absence of growth factors such as NGF. 
The IB4+ve neurons might have fewer receptors and require contribution from both 
integrin-activated and growth factor activated components to reach a threshold of 
signalling that could result in growth. We are currently examining this possibility, which 
would seem to be supported by the work of Condie and colleagues (Condie, 2001; 
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Condie and Letourneau, 1997; Lemons et al., 2005). Overexpression/upregulation of 
expression of integrin subunits in adult DRG neurons enhances their regenerative ability 
I 
(Condie, 2001 ), and upregulation of select a 1, a3 and a6 subunits in embryonic neurons 
' provides them with the. ability to overcome the inhibitory effects ofCSPGs (Condie et al., 
1999; Lemons et al., 2005). 
4.4.2 Relevance to repair of peripheral neuropathies. 
In peripheral neuropathy, such as that associated with diabetes, the most 
susceptible axons tend to be the small diameter nociceptive nerve fiber populations, while 
the larger diameter fibers tend to be less vulnerable and affected later in the disease 
(Polydefkis et al., 2003; Yasuda et al., 2003; Zochodne, 1999; Zochodne et al., 2001 ). 
Much of the research associated with sensory polyneuropathies has focused on 
prevention through treatment, although there is more emphasis now being placed on 
attempts to stimulate regeneration. As we have noted in this study, in order to achieve an 
effective regenerative response, the cell requires support from both trophic factors and 
components of the ECM. In experimental models of diabetes, trophic support is altered 
(Leinninger et al., 2004; Tomlinson et al., 1997), attachment of DRG neurons to the ECM 
is impaired (Sango et al., 1995), the axonal cytoskeleton and transport is compromised 
(Fernyhough and Schmidt, 2002; McLean, 1997; Scott et al., 1999), and the regeneration 
of peripheral nerves is impaired (Kennedy and Zochodne, 2005). Our study points to 
potential specific environmental requirements and signalling events that could provide 
therapeutic targets for the treatment and repair of neuropathies such as those associated 
with diabetes. However, future studies are required to further characterize the points of 
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collaboration between integrin and growth factor activated pathways important in 
optimizing regeneration. 
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CHAPTERS 
IDENTIFICATION OF SRC AS THE KEY INTERMEDIATE 
BETWEEN INTEGRIN AND TRK ACTIVATED SIGNALLING 
PATHWAYS IN THE STIMULATION OF NEURITE GROWTH IN 
NGF-RESPONSIVE DRG NEURONS 
(Manuscript in preparation) 
5.1 Introduction 
It has long been known that axonal regeneration is much more extensive in the PNS 
than in the CNS. The poor regenerative ability of the CNS is in part due to the presence 
of inhibitory extracellular matrix substrates such as MAG, Nogo, and OMgp, and the 
paucity of essential neurotrophins such as NGF, and BDNF (Cai et al., 1999; Hunt et al., 
2002; Jacobs and Fehlings, 2003). Inhibitory conditions such as these are not present in 
the PNS; however, like the CNS, the extracellular environment in which growth occurs is 
still critically important. We have recently characterized signalling pathways activated 
by NGF and IGF-1, which promote neuronal survival and neurite growth from adult DRG 
sensory neurons in vitro (Kimpinski, 2001; Dodge, 2002; Jones, 2003; Tucker, 2005; 
Tucker et al, 2006 in press). Our results illustrate that the provision of such growth 
factors supports an increase in extensive neurite growth, which is dependent upon the 
availability of a permissive culture substrate (i.e. laminin). 
Unlike the inhibitory substrates found in the CNS, components of the ECM found in 
the PNS, such as laminin, entactin, and fibronectin, are essential for axonal regeneration. 
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These permissive molecules have an effect by signalling via integrin receptors, which 
consist of heterodimers of a and ~ subunits, the cytoplasmic tails of which are short and 
have no intrinsic enzymatic activity. Upon activation, integrin receptors cluster, form 
focal adhesions, and stimulate the recruitment of specific adapter proteins, which activate 
a series of downstream signalling molecules (Giancotti and Ruoslahti, 1999; Guo and 
Giancotti, 2004; Howe et al., 1998). Different combinations of these receptors bind to 
different substrate molecules; for instance, integrins al~l, a3~l,and a 7 ~ 1 act as 
laminin receptors and have been shown to mediate the binding of DRG neurons and 
neuronal cell lines to laminin (Condie, 2001; Condie and Letourneau, 1997; Gardiner et 
al., 2005; Guo and Giancotti, 2004; Lefcort et al., 1992; Tomaselli et al., 1993; Tucker et 
al., 2005a). 
We have previously shown that both NGF and laminin are strong promoters of adult 
DRG neurite growth (Jones et al., 2003; Tucker et al., 2005a). These factors are able to 
work in conjunction with each other to stimulate increased neurite growth not achievable 
by either factor alone, which is in part due to crosstalk between integrin and growth 
factor signalling pathways (Tucker et al., 2005a). 
The adult DRG is made up of a heterogeneous population of cells subdivided on the 
basis of neurochemistry, morphology, trophic requirements, and sensory modalities 
(Averill et al., 1995; Gavazzi et al., 1999; Petruska et al., 2000; Priestley et al., 2002a). 
At least three major cell groups have been identified with the potential for further 
subclassification. The first is comprised of large and medium diameter neurons, 
identified based on their expression of heavy chain neurofilament (NF200), and typically 
have myelinated axons. These neurons express the p75 neurotrophin receptor as well as 
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TrkA, TrkB, and TrkC, making them responsive to NGF, BDNF, NT3, and NT4/5 
(Averill et al., 1995; Priestley et al., 2002a). The next two groups consist mainly of small 
diameter neurons, have unmyelinated or thinly myelinated nociceptive afferents, and are 
either peptidergic, expressing calcitonin gene related peptide (CORP), or non-peptidegic, 
binding the lectin Griffonia Simplicifolia IB4 (Averill et al., 1995; Priestley et al., 2002a). 
The CGRP+ve population expresses a high level of both p75 neurotrophin receptor and 
TrkA, and responds to NGF. However, the IB4-binding population has neither p75 nor 
Trk receptors, but instead expresses the receptor tyrosine kinase RET and the GFRa 1 
subunit, making these cells responsive to GDNF and unresponsive to NGF (Bennett et al., 
1998; Kashiba et al., 200 I; Molliver et al., 1997). 
We have previously shown that the NGF-responsive cell population (NF200+ve and 
CGRP+ve) responds to laminin with increased neurite growth in the absence of added 
trophic factors, and that neurite growth is potentiated by the addition of NGF (Tucker et 
al, 2006, in press). This growth response has been shown to be critically dependent on 
the PI 3-K/Akt pathway; however, the upstream point of collaboration between LN and 
NGF stimulation remains to be elucidated. The signalling intermediates, Src, Fyn, ILK, 
and Fak, are common components to various cell adhesion and growth factor receptors. 
For instance, Src has been shown to be activated by integrins, the netrin receptor DCC, 
Eph receptors, IGF receptors, Trk receptors, and the GDNF receptor Ret in various cell 
types (Altun-Gultekin and Wagner, 1996; Encinas et al., 2001; Helmke et al., 1998; 
Iwasaki et al., 1998; Li et al., 2004; Sato et al., 1998; Tucker et al., 2005a). Therefore, 
the possibility exists that one of these common components could provide the essential 
link between NGF and laminin induced axonal regeneration in adult DRG neurons. 
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Our previous findings have identified Src as a possible collaborative component 
upstream of PI 3-K/Akt signal1ing, activated by both NGF and LN, which leads to 
stimulation of optimal levels of neurite growth from adult NGF-responsive DRG neurons. 
These studies examined NGF and LN induced neurite growth 24 hr after plating; 
however, in the course of these experiments it became evident that extensive neurite 
growth was occurring at much earlier time points. Thus, to determine the critical points 
of collaboration between NGF and LN induced signalling, a time course of early 
signalling intermediate activation was conducted. If Src is the critical point of 
collaboration between NGF and integrin activated signalling in these cells, inhibition of 
this component should lead to the interruption of neurite growth via alteration of 
downstream targets. To test this hypothesis, pharmacological inhibition of specific 
signalling components was performed, and early neurite growth and signalling analysis 
was carried out. Adult NGF-responsive DRG neurons were treated with NGF, laminin 
(LN), and laminin plus NGF (LN+N) for 10 min, 1 hr, or 6 hrs and subsequently 
analysed. Adult DRG neurons make an ideal model for studying the effects of 
neurotrophins and extracellular matrix molecules on peripheral nervous system 
regeneration because they survive in the absence of added trophic factors, as well as in 
the presence of the added inhibitors (Dodge et al., 2002; Tucker et al., 2005a). 
Short-term stimulation with NGF, LN, or LN+N for 6 hrs induces increased 
neurite growth, which can be blocked by inhibition of PI 3-K, and subsequent decreased 
activation of Akt. Inhibition of Src at the tested time points also inhibits neurite growth 
following NGF, LN, or LN+N stimulation, due to the subsequent inhibition of 
downstream signalling intermediates Fak and Akt. Src inhibition also results in 
-172-
decreased activation 'of MAPK, indicating that Src is upstream of this signalling 
component. Inhibition of PI 3-K via the pharmacological inhibitor L Y294002 does not 
I 
affect MAPK activation, indicating that this intermediate is not upstream of MAPK, and 
is subsequently locate~ downstream ofSrc. However, inhibition ofPI 3-K does affect the 
activity of Src and Fak, potentially due to the presence of a negative feedback system, 
giving this pathway ultimate control over neurite growth. To our knowledge, this is the 
first time that Src has been shown to be the key point of collaboration between NGF and 
laminin induced signalling, and subsequent neurite growth from adult NGF-responsive 
DRG neurons. These findings have identified a key target in the attempt to stimulate 
optimal levels of neuronal regeneration in both PNS and CNS neurons. 
5.2 Materials and Methods 
5.2.1 Neuronal cultures 
Dorsal root ganglia (DRG) from young adult (4-6 wk) Sprague-Dawley rats 
(Memorial University of Newfoundland Vivarium and Charles River Canada, Montreal, 
QC) were dissected and dissociated. In accordance with University Animal Care 
guidelines, animals were live decapitated, ganglia from all spinal levels were removed, 
and the roots were trimmed. To isolate individual DRG neurons, both enzymatic and 
mechanical dissociation was used. Enzymatic dissociation was carried out first and 
performed by incubating the ganglia in 0.25% collagenase for 45 min, and 0.25% trypsin 
for 40 min (Invitrogen/ Gibco BRL, Burlington, Ont). Mechanical dissociation was 
carried out next and performed by repeated cycles of aspiration and expulsion of the 
DRG fragments through a flame narrowed pasture pipette. Upon completion, dissociated 
DRG neurons were suspended in serum-free Neurobasal medium (NB, Invitrogen) 
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supplemented with 1 OOU penicillin/streptomycin, B27 supplement (Invitrogen), and 
20mM cytosine arabinoside (motlified NB). This suspension was then layered on top of a 
30% Percoll solution (Amersham Bioscience, Baie d'Urfe, QC) in 15ml conical tubes and 
centrifuged at 400g for 20 min at room temperature. Pellets were then carefully extracted 
with a sterile pasture pipette, placed in a fresh 15ml tube, washed with the previous 
suspension media, and centrifuged to remove any remaining Percoll. Neurons were 
plated in either Lab-Tek 16-well chamber slides (Nunc International, Naperville, NC) for 
neurite growth assessment or 12-well plates for Western blot analysis, (plates and slides 
were coated twice with Poly-D-lysine, PL, 1 ~-tg/ml, BD Bioscience, Bedford, MA) and 
incubated at 37°C with 95% 0 2 and 5% C02 for 2 hrs in the presence or absence of the 
pharmacological inhibitors L Y294002, UO 126 or PP2. After the initial 2 hr incubation 
with inhibitors, NGF (25 ng/ml, Cedarlane Labs, Hornby, ON), laminin (LN, 25 ~-tg/m1, 
Invitrogen) or laminin +NGF (LNN, 25 ng/ml ofNGF Cedarlane Labs, and 25 f-tg/ml of 
LN Invitrogen) were added to the cells where appropriate and cultures were then 
incubated for a further 1 0 min, 1 hr, or 6 hrs. For the Western blot analysis, 4 animals 
were used to provide enough neurons for one 12-well culture plate. Each 12-well plate 
provided a single time point for the control (no treatment), NGF, LN, and LN+N 
treatment conditions. Therefore, three, 12-well plates were required to complete a single 
experiment for each ofthe 10 min, 1 hr, and 6 hr time points studied. This procedure was 
performed for both the control (no inhibitor condition), and pathway specific inhibitor 
conditions, and was repeated a minimum of three times. Thus, to complete the entire 
experiment, thirty-six 12-well plates, and a minimum of 144 animals were required. 
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5.2.2 Cell Selection 
Specific cell populations were selected as discussed in chapter 3; briefly 
I 
streptavidin-coated beads were incubated with biotinylated Griffonia Simplicifolia IB4 
lectin (Sigma) for 2 hrs at room temp by gentle rotation. Beads were then washed 
removing any excess lectin and added to the cell suspension. This suspension of cells 
and Dynal beads was incubated at room temp for 30 min followed by bead capture with a 
Dynal magnetic separator. The supernatant was removed and plated as the non-selected 
NGF-responsive cell population, which included both NF200+ve and CGRP+ve cells. In 
this series of experiments we were primarily interested in the interaction between LN and 
NGF in the NGF-responsive cell population, thus, the beads and selected IB4+ve cells 
were discarded. 
5.2.3 Immunocytochemistry 
Neurons were fixed in 4% paraformaldehyde (pH 7-7.4) in PBS for 15 mins, 
permeablized with 0.1% :friton-X-1 00 and blocked with 10% normal goat serum in PBS. 
For neuronal and neurite identification, antibodies directed against total tubulin ( 1:1000, 
Sigma) were employed. Cells were incubated with the primary antibodies at 4°C for 16-
20 hrs, followed by Cy2-tagged secondary antibody (Jackson Immunoresearch Labs, 
West Grove, PA) detection. These slides were cover slipped with glycerol and imaged 
with confocal laser scanning microscopy. 
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5.2.4 Enzyme Inhibition 
Signalling pathways were inhibited by the use of specific pharmacological 
inhibitors. Inhibitors targeting PI 3-K (LY294002, 2-(4-morpholinyl)-8-phenyl-4H-
l benzopyran-4-one, Calbiochem), MEK (UO 126, 1 ,4-diamino-2,3-dicyano-1 ,4-bis (2-
aminophenylthio) butadiene, Calbiochem), and the Src Family Kinases (SFKs) (PP2, 4-
Amino-5-( 4-chloropheny I)-7 -( t-buty I )pyrazolo [3 ,4-d ]pyrimidine, Calbiochem) were 
added to the culture media at the time of plating (2 hrs prior to NGF and/or LN 
treatment). Cultures were either fixed and labelled for the appropriate markers, or 
collected for Western blot analysis, at 10 min, 1 hr, or 6 hrs after treatment. 
5.2.5 Neurite Growth Analysis 
Neurite growth was quantified by determining the percentage of total tubulin 
stained neurons that extended processes. Growth was assessed at 10 min, 1 hr, and 6 hrs 
after stimulation. For each condition examined (control, NGF, LN, or LN+N), a 
minimum of 200 neurons was counted, and each experiment was repeated 3 times. Thus, 
a minimum of 600 cells per condition was analyzed, giving a total of 2400 cells for the 
entire experiment. 
5.2.6 lrnrnunoblotting 
For Western analyses, neurons were cultured in 12-well plates containing 
modified serum-free NB, with or without L Y294002, U0126 or PP2 for 2 h, and 
subsequently treated with either normal media, or media containing NGF (25 ng/ml, 
Cedarlane Labs), LN (25 !lglml, Invitrogen) or LN+N (25 ng/ml ofNGF Cedarlane Labs, 
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and 25 !lg/ml of LN Invitrogen). Neurons were subsequently processed at 10 min, 1 hr, 
or 6 hrs after stimulation by removing the original plating media, adding 300 111 of PBS 
I 
containing 0.5 mM Orthovanadate to each well, and scraping the cells off the plating 
surface using a beveled tip' rubber scrapper. Collected samples were briefly centrifuged 
to pellet the cells, supernatant was removed, and the cells were lysed by gentle rotation 
overnight using 50 111 of lysis buffer containing TBS with 1% NP-40, 10% glycerol, 1 
mM phenylmethyl sulphonyl fluoride (PMSF), 10 mg/ml aprotinin, 1 mg/ml leupeptin, 
and 0.5 mM sodium orthovanadate. Following cell lysis and centrifugation (10,000 rpm, 
5 min), the supernatants were used to determine protein concentrations using a BCA 
protein assay (Pierce Chemicals, Rockford, IL.). Equivalent amounts of protein (50 !lg) 
were subjected to SDS-PAGE (8%-10% acrylamide). Following transfer to 
nitrocellulose, the blots were stained with Ponceau Red, photographed, assessed for the 
equivalency of protein loading, and cut to allow the top and bottom portions of the blot to 
be probed simultaneously. Ponceau Red was subsequently removed using Tris-Buffered 
Saline and the blots were blocked with 3% milk in Tris-Buffered Saline with 0.2% 
Tween-20, and subsequently incubated with the following antibodies (1: 1 ,000) overnight 
at 4°C: phospho-Src, MAPK (1:1000, Santa Cruz, Santa Cruz CA), phospho-Akt, Akt, 
phospho-p44/42 MAPK (1: 1000, NEB/Cell Signaling, Beverley, MA), phospho-Fak v397, 
and Fak (1 :1000, Biosource Inc, Camerillo, CA). The next day, blots were washed, 
incubated in the appropriate horseradish peroxidase conjugated secondary antibody (anti-
rabbit or anti-mouse IgG- HRP; Boehringer Mannheim, 1 :5,000), and visualized using 
chemiluminence reagents (ECL, NEN, Boston, MA) and exposure to X-ray film (Cronex 
MRF Clear base, Agfa Corp, Greenville, SC). Developed films were subsequently 
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digitized and densitometrically analyzed using the Image 1 software (NIH image 
downloadable software). Phosphorylated substrates were normalized against their non-
phosphorylated forms, however, as we did not have a functioning Src antibody, phospho-
Src was normalized against MAPK. Digital images of the blots were used to make 
composite figures with Adobe Photoshop graphics software (Adobe Corp, Mountain View 
CA). 
5.2. 7 Statistical Analysis 
All reported data analyses are based on a minimum of 3 separate experiments for 
each manipulation. Data are plotted as mean ± SEM and significance is noted only if 
p<0.05 as determined by ANOVA using Tukey testing for post hoc comparisons for 
multiple group analyses. 
5.3 Results 
5.3.1 Inhibition of Src or PI 3-K blocks NGF- and LN-induced axon growth 
In our previous studies, we examined the requirement for both the PI 3-K/Akt and 
MEK/MAPK signalling pathways on LN- and NGF-induced neurite growth at 24 hrs. 
However, because neurite growth is detectable as early as 1-2 hrs after plating, we know 
that the intracellular signalling events required for neuritogenesis must be initiated almost 
immediately after ligand binding (Williams et al., 2005). Thus, by looking at the 24 hr 
time point previously, we were not able to identify the potential signalling intermediate 
relationships and temporal signalling events required for neurite growth. 
-178-
Thus, in order 'to establish the relationship between the signalling intermediates 
required for neurite growth and the potential temporal differences in their activation we 
I 
opted to perform a series of early time point experiments. We first analysed the effects of 
the inhibitors on the morph'ology of early neurite growth and then assessed the time and 
degree of intermediate activation by Western blot analysis. 
To assess the requirement for PI 3-K, MEK, and Src on neurite growth, adult 
NGF-responsive DRG neurons were plated on PL for 2 hrs in the presence (Fig 5.1, L Y, 
D-F; UO, G-I; PP2, J-L) or absence (Fig 5.1, Con, A-C) of enzyme specific 
pharmacological inhibitors prior to NGF, LN, or LN+N treatment. After addition of 
NGF, LN or LN+N, neurons were further incubated for 10 min, 1 hr, or 6 hrs at 37°C, 
and subsequently fixed and immunostained with antibodies directed against total tubulin 
to allow for neuritic identification. As shown in Fig 5.1, 6 hr treatment with NGF (A), 
LN (B), or LN+N (C) results in neurite outgrowth in the absence of added inhibitors 
(since 6 hr treatment elicited the most robust growth response, data for these time point 
are shown). Although growth was minimal with the addition ofNGF alone (Fig 5.1 A), 
extensive growth was observed when the neurons were treated with LN (Fig 5.1 B), 
which was further increased with LN+N treatment (Fig 5.1 C). 
When cultured in the presence of the PI 3-K inhibitor, L Y294002, growth induced 
by NGF (Fig 5.1 D), LN (Fig 5.1 E), and LN+N (Fig 5.1 F) was inhibited. Similar results 
were observed with the addition of the Src family kinase inhibitor, PP2 (Fig 5.1 J-L). 
However, the addition of the MEK inhibitor, U0126, did not appear to have any affect on 
neurite growth at the tested time points (Fig 5.1 G-1). 
These data suggest that NGF, LN, and LN+N-induced neurite growth from adult 
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Figure 5.1. Inhibition of either PI-3K, or Src, but not MAPK, blocks neuritogenesis 
of NGF -responsive cells 6 hrs after stimulation. A-L: Cells were plated on PL and 
immunostained for total tubulin. Confocal laser scanning microscopy was used to 
visualize stained neurons 6 hrs after plating. NGF-responsive cells plated on PL show 
increased neurite growth when treated with NGF (A), LN (B), or LN+N (C). Observed 
increases in neurite growth after NGF, LN, or LN+N stimulation were attenuated with the 
addition of L Y294002 (D, E, and F respectively), or PP2 (J, K, and L respectively). 
Neurite growth was unaffected by the addition of UO 126 (G, H, and I respectively). 
Scale bar- 50 f.tm. 
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Fig 5.1 
NGF-responsive DRG neurons can be detected by 6 hrs after treatment and is dependent 
on Src and PI 3-K signalling, but is not dependent on MEK/MAPK signalling. This 
confirms that neurite growth is initiated at very early stages after treatment, and that 
signalling initiated for this growth must occur almost immediately after ligand binding. 
Quantitation for conditions represented in Fig 5.1 is presented in Fig 5.2 as the 
percent of cells with neurites. Varying amounts and patterns of neurite growth were 
detected by 6 hrs after treatment with NGF, LN, and LN+N as noted in Fig 5.1. In order 
to quantify these results, we categorized cells with elaborate neurite growth as having 
+++ growth. Cells with 1-2 neurites that were at least 2 cell body diameters in length, but 
with little branching were categorized as ++, and cells that had little growth, but 
possessed large lamellopodia were categorized by + (see Fig 5.2A for representative 
examples). Quantification of these results are presented in Fig 5.2 B-E. 
The most neurite growth was observed after 6 hr LN+N treatment (Fig 5.2B), in 
this condition 30-35% of the cells had elaborate neurite growth, 10% of the cells had 
smaller, less branched neurites, and 10-15% of the cells displayed large lamellopodia. 
Approximately 20% of the cells extended elaborate neurite growth after LN treatment, 
while 8-1 0% of the cells had smaller, less branched neurites, and roughly 5% of the cells 
displayed large lamellopodia. Although 6 hr treatment with NGF induced significantly 
more neurite growth than the un-treated control condition, there were no cells with 
elaborate neurite growth, and only 10-12% with smaller neurites, and 5% with large 
lamellopodia. These data show that the co-treatment with LN+N appears to accelerate 
the growth that is observed with either LN or NGF alone at this early time point. 
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Figure 5.2. Analysis of the effect of L Y294002, U0126, and PP2 on neurite growth 
from NG F -responsive cells 6 hrs after stimulation. A: Legend indicating growth 
patterns for subsequent analysis (+: little neurite growth with large lamellopodia; ++: 
few neurites extending at least two cell body diameters with little branching; +++: 
extensive neurite growth with extensive branching). B-E; Percent of cells with neurites 
on PL in the absence of added inhibitors or in the presence of L Y294002, UO 126, and 
PP2. before and after NGF (A, C), LN (A, D), or LN+N (A, E) stimulation. The percent 
of cells with neurites was attenuated with the addition ofL Y294002, and PP2, after NGF 
(C), LN (D), and LN+N (E) stimulation, however U0126 had no significant effect on the 
percent of cells with neurites. The control condition in C, D, and E, correspond to the 
circled area in B of the same color. Significance was tested using one-way ANOV A with 
Tukey post-hoc testing. * p<O.OOS, ** p<O.OOl. 
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Fig 5.2 
To analyse the contribution of PI 3-K, MEK, and Src to neurite growth, the 
neurons were plated in the presehce of the pharmacological inhibitors L Y294002 (PI 3-K 
inhibitor), U0126 (MEK inhibitor), and PP2 (Src family kinase inhibitor). As indicated 
in Fig 5.2 C, inhibition of either PI 3-K or Src, significantly inhibited NGF-induced 
neurite initiation and growth. Inhibition of PI 3-K with L Y294002, and Src with PP2, 
blocked NGF (Fig 5.2 C), LN (Fig 5.2 D), and LN+N-induced (Fig 5.2 E) neurite growth; 
however, MEK inhibition had no effect. Interestingly while neuritogenesis was inhibited, 
neither L Y294002 nor PP2 appeared to influence the number of cells with lamellopodia, 
suggesting perhaps that the effects of these pathway specific inhibitors are at the stage of 
neuritogenesis (Williams et al., 2005). 
5.3.2 Timeline of activation of the signalling intermediates Src, Fak, Akt, and 
MAPK after short-term stimulation with NGF, LN, and LN+N. 
We have previously shown that 24 hrs after treatment, LN+N stimulates a level of 
neurite growth from adult NGF-responsive DRG neurons that is not achievable with 
either LN or NGF treatment alone. We have also noted that this neurite growth is 
critically dependent on the activation of the PI 3-K/Akt pathway. However, it remains to 
be determined how the early activation of these signalling intermediates is responsible for 
the increased neurite growth induced by LN+N. Therefore, in order to investigate the 
early events activated by NGF, LN, or LN+N experiments similar to those noted above 
were carried out. Again neurons were plated on PL, and incubated for 2 hrs with or 
without pathway specific inhibitors prior to treatment with NGF, LN, or LN+N for 
lOmin, 1 hr, or 6 hrs. We hypothesized that NGF or LN activates its signalling cascades 
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with different temponil characteristics. The combination of the two might then act to 
either result in stronger or more sustained signalling that results in enhanced neurite 
I 
growth. 
In Fig 5.3, represent~tive Western blots and corresponding densitometric analyses 
plotted as a function of treatment time are shown. Each graph is designed such that it 
represents a single signalling intermediate, and each line on the graph represents the 
timeline of activation for the corresponding intermediate after a specific treatment. The 
PL line is the control (no treatment) condition; since no detectable phosphorylation was 
observed for any of the studied intermediates except MAPK, this lane was not included 
on the representative Western blot. However, it is important to note that there is a basal 
level of constitutive MAPK phosphorylation in these cells, and thus, the treatment effect 
appears to be much smaller than that observed for the other signalling intermediates. It is 
also important to note that for each time point and condition studied triplicate platings 
were analysed and data represents the mean ± SEM; thus, even though some of the error 
bars are masked by the symbols in Fig 5.3- Fig 5.7 they are present. To simplify the 
results, the effects of each treatment (NGF, LN, or LN+N) on the activation of Src, Fak, 
Akt and MAPK respectively, are grouped together and described separately below. 
Effect ofNGF treatment on the activity ofSrc, Fak, Akt, and MAPK 
As shown in Fig 5.3 A, NGF treatment stimulated a significant increase in the 
phosphorylation of Src at the earliest point analyzed, 10 min relative to control, this 
increase was sustained over the tested time course, with maximal levels noted at 6 hrs. In 
contrast, NGF resulted in early and transient Fak phosphorylation; maximal levels were 
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Figure 5.3. Western blot analysis indicating the timeline of Src, Fak, Akt, and 
MAPK activation, essential for neurite growth after short-term stimulation with 
NGF, LN, and LN+N. Adult ORO neurons were plated on PL coated dishes, and 
incubated for 2 hat 37°C. Neurons were subsequently treated with NGF, LN, or LN+N 
for 1Om in, 1 hr, or 6 hrs, after which time Western blotting of cell lysates was carried out. 
A-D: Western blot and corresponding timeline of activation of early signalling 
intermediates: Src (A), Fak (B), Akt (C), and MAPK (D), in response to short term 
( l Omin, 1 hr, and 6 hrs) NGF and LN stimulation. n = 3-4 separate experiments. 
Significance was tested using one-way ANOVA with Tukey post-hoc testing. * p< 0.05, 
**p<O.OOI. 
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Fig 5.3 
observed at 10 min, but levels dropped back to baseline by 1 hr (Fig 5.3 B). NGF also 
induced a significant level of phosphorylated Akt at 10 min relative to control, which 
further increased, peaking at 1 hr, before declining to baseline by the 6 hr time point (Fig 
5.3 C). Finally, NGF treatment induced a significant increase in MAPK phosphorylation 
at 10 min relative to control, and the increase was sustained across all time points (Fig 5.3 
D). 
Effect of LN treatment on the activity of Src, Fak, Akt, and MAPK 
As shown in Fig 5.3 A, LN treatment resulted in a significant increase in the 
phosphorylation of Src at 10 min relative to control, but levels declined significantly by 1 
hr where it remained up to 6 hrs. An examination of the effects of LN treatment on Fak, 
Akt, and MAPK phosphorylation revealed a delayed activation with a significant increase 
in phosphorylated Fak, Akt, and MAPK being detected by 1 hr after LN treatment, and 
subsequently declining to baseline by 6 hrs (Fig 5.3 B, C, D). 
Effect of LN+N treatment on the activity of Src, Fak, Akt, and MAPK 
As shown in Fig 5.3 A, LN+N treatment resulted in a significant increase in the 
phosphorylation of Src at 10 min relative to control. This was less than that observed 
with LN alone and greater than that with NGF alone. The phosphorylation increased to a 
peak at 1 hr which was similar to that observed with NGF alone. Fak phosphorylation 
was increased by 10 min relative to control, and unlike NGF alone, was sustained for 1 
hr, before declining to baseline by 6 hrs (Fig 5.3 B). LN+N also induced a significant 
level of phosphorylated Akt at 10 min relative to control, but pAkt levels were sustained 
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across all time points (Fig 5.3 C). Finally, LN+N treatment induced a significant increase 
in MAPK phosphorylation at 10 min relative to control; the phosphorylation 
subsequently declined to baseline levels over the tested time course (Fig 5.3 D). 
Summary of the timeline of activation data 
In summary, the time at which each of the tested signalling intermediates is 
activated is highly dependent on the treatment performed. Notably the pattern and time 
at which each of the intermediates is activated varies greatly. 
LN+N appears to sustain Src phosphorylation over the course of the experiment, 
keeping phosphorylated Src levels up in contrast to the relative transient effect of LN 
treatment alone: the LN+N this treatment also induces a level of Src phosphorylation by 
10 min that is higher than that seen with NGF alone. Similarly LN+N gives a higher 
level of Src phosphorylation at 1 hr than either NGF or LN alone. 
LN+N treatment results in early Fak phosphorylation (similar to that with NGF 
alone) which is sustained for 1 hr (to give levels similar with LN alone). In contrast, 
phosphorylation ofFak by NGF drops to base line by 1 hr, while phosphorylation ofFak 
by LN does not occur until 1 hr. Thus, it appears that LN+N takes the early 
phosphorylation ofFak that NGF induces and couples it with the later phosphorylation of 
Fak that LN induces. 
LN+N acts to maintain the activation of Akt over the course of the experiment, 
such that an early increase in Akt phosphorylation by 10 min is similar to that after NGF 
treatment alone, and the level of Akt phosphorylation by 1 hr is similar to that after LN 
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treatment alone. In contrast, LN+N keeps the phosphorylated levels of Akt up by 6 hrs, 
which is lost by either LN or NGF treatment alone. 
These results indicate that the enhanced growth induced by LN+N treatment is not 
merely due to an additive response in signalling intermediate phosphorylation. For 
example, it was possible that increased neurite growth induced by LN+N was simply due 
to a level of signalling intermediate phosphorylation across all time points that was equal 
to that induced by LN and NGF added together. Thus, it is important to note that this was 
not the case. For example, as suggested above unlike treatment with LN or NGF alone, 
LN+N induces a sustained activation of Akt across all time points, which potentially 
explains why LN+N rather then either treatment alone gives enhanced neurite growth. 
5.3.3 Addition of PP2, L Y294002, and U0126 identify Src as a key signalling 
intermediate located upstream of both PI 3-K/Akt and MEK/MAPK signalling 
pathways. 
Although we have identified the time at which each of the different signalling 
intermediates is activated after NGF, LN, and LN+N treatment, we also wished to 
identifY the hierarchical location of each of these signalling intermediates. Thus, to try 
and determine where each of the studied intermediates are located with relation to each 
other, the neurons were treated with the PI 3-K inhibitor L Y294002 (Fig 5.4), the MEK 
inhibitor U0126 (Fig 5.5), or the Src family kinase inhibitor PP2 (Fig 5.6), and incubated 
for 2 hrs prior to treatment with NGF, LN, or LN+N for 10 min, 1 hr, or 6 hrs. Cells 
were lysed and Western analysis was carried out as outlined in Section 5.2.6. 
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As in the previous experiment, representative Western blots and corresponding 
densitometric analysis plotted as a function of treatment time are shown. Again each 
graph is designed such that it represents a single signalling intermediate, and each line on 
the graph represents the tirrieline of activation for the corresponding intermediate after a 
specific treatment. The only difference is that specific pharmacological inhibitors are 
added to the culture media at the time of plating. Again the PL line is the control (no 
treatment) condition, and as no identifiable phosphorylation was seen for any of the 
studied intermediates except MAPK, this lane was again excluded from the representative 
Western blots. It is important to note that in all conditions, including the PL (no 
treatment) group, the pharmacological inhibitors were present before and during 
treatment. 
Effect of L Y294002 treatment on the activity of Src, Fak, Akt, and MAPK 
NGF induced phosphorylation of Src, Fak, and Akt are significantly attenuated 
across all time points in,the presence ofthe PI 3-K inhibitor, LY294002 (Fig 5.4 A, B, 
C), relative to control (Fig 5.3 A, B, C, respectively). In contrast, the pattern of MAPK 
phosphorylation in response to NGF treatment was unaffected by the inhibition of PI 3-K 
(Fig 5.4 D). Phosphorylation of Src, Fak, and Akt by LN and LN+N treatment was also 
inhibited by L Y294002 (Fig 5.4 A, B, C), relative to control (Fig 5.3 A, B, C), while 
MAPK phosphorylation was unaffected (Fig 5.4 D). These results indicate that PI 3-K 
may influence the activity of Src, Fak, and Akt, but is not upstream of MAPK. 
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Figure 5.4. Inhibition of PI 3-K results in attenuation of NGF, LN and LN+N 
signalling. Adult DRG neurons were plated on PL coated dishes, and incubated for 2 h 
at 3 7°C. Neurons were subsequently treated with NGF, LN. or LN+N for 1 Omin, 1 hr, or 
6 hrs, after which time Western blotting of celllysates was carried out. A-D: Western 
blot and corresponding timeline of activation of early signalling intermediates: Src (A), 
Fak (B), Akt (C), and MAPK (D), in response to short term (1 Omin, 1 hr, and 6 hrs) NGF 
and LN stimulation. n = 3-4 separate experiments. Significance was tested using one-
way AN OVA with Tukey post-hoc testing. * p< 0.05, ** p<O.OO 1. 
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Effect of U0126 on the activity of Src, Fak, Akt, and MAPK 
NGF induced phosphorylation of Src, Fak, and Akt were not significantly affected 
at any of the tested time points in the presence of the MEK inhibitor, U0126 (Fig 5.5 A, 
B, C), relative to control (Fig 5.3 A, B, C respectively). In contrast, the pattern ofMAPK 
phosphorylation in response to NGF treatment was significantly attenuated by the 
inhibition of MEK (Fig 5.5 D). Cellular responses to LN and LN+N treatment yielded a 
similar attenuation MAPK phosphorylation (Fig 5.5 D), relative to control (Fig 5.3 D), 
while Src, Fak, and Akt phosphorylation were unaffected (Fig 5.5 A, B, C). These results 
indicate that MEK is located upstream of MAPK and does not exert any apparent 
influence over the activity of Akt, Src, or Fak. 
Effect of PP2 on the activity of Src, Fak, Akt, and MAPK 
PP2 inhibits the activation of Src, Fak, Akt, and MAPK by all the treatments (Fig 
5.6 A, B, C, D), relative to control (Fig 5.3 A, B, C, D respectively). These results 
indicate that Src is likely located upstream of Fak, PI 3-K, Akt, and MAPK, and acts as 
the major point of collaboration between NGF and LN induced signalling pathways and 
subsequent neurite growth. 
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Figure 5.5. MEK inhibition does not negatively influence the activation of Src, Fak, 
or Akt by NGF, LN, or LN+N. Adult DRG neurons were plated on PL coated dishes, 
and incubated for 2 h at 37°C. Neurons were subsequently treated with NGF, LN, or 
LN+N for lOmin, I hr, or 6 hrs, after which time Western blotting of cell lysates was 
carried out. A-0: Western blot and corresponding timeline of activation of early 
signalling intermediates: Src (A), Fak (B), Akt (C), and MAPK (D), in response to short 
term ( l 0 min, 1 hr, and 6 hrs) NGF and LN stimulation. n = 3-4 separate experiments. 
Significance was tested using one-way ANOV A with Tukey post-hoc testing. * p< 0.05, 
** p<O.OOl. 
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Figure 5.6. Inhibition of Src attenuates NGF, LN and LN+N signalling. 
Adult DRG neurons were plated on PL coated dishes, and incubated for 2 hrs at 
37°C. Neurons were subsequently treated with NGF, LN, or LN+N for 10 min, 1 hr, or 6 
hrs, after which time Western blotting of celllysates was carried out. A-D: Western blot 
and corresponding timeline of activation of early signalling intermediates: Src (A), Fak 
(B), Akt (C), and MAPK (0), in response to short term (10 min, 1 hr, and 6 hr) NGF and 
LN stimulation. n = 3-4 separate experiments. Significance was tested using one-way 
ANOVA with Tukey post-hoc testing. * p< 0.05, ** p<O.OOl. 
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5.4 Discussion 
The ability of the PI 3-K/Akt pathway to promote neurite growth has been well 
documented in a variety of different cell types (Higuchi et al., 2003; Jones et al., 2003; 
Kaplan and Miller, 2000; Mills et al., 2003; Tucker et al., 2005a). Activation of this 
pathway, and subsequent neurite growth, can be achieved by signalling through both 
integrin receptors, via laminin binding (Sarner et al., 2000; Tucker et al., 2005a), and 
growth factor receptors, via NGF binding (Jones et al., 2003; Kaplan and Miller, 2000). 
However, the process by which cross talk occurs between integrin and growth factor 
receptor activation, leading to the stimulation of PI 3-K/Akt and optimal neurite growth is 
poorly understood. Although we have previously identified Src as a possible 
collaborative component upstream of PI 3-K/Akt signalling, these studies were carried 
out at 24 hrs after plating, and following further investigation, we found that extensive 
neurite growth was occurring between 1-6 hrs after treatment. Thus one would expect to 
see activation of the relevant signalling intermediates within this early time frame. It is 
clear that initial ligand binding can activate signalling cascades over relatively short 
periods oftime, so in order to determine the patterns of activation induced by NGF, LN, 
and LN+N, we undertook a temporal analysis of signalling intermediate activation 
between 1 0 min and 6 hrs. 
LN stimulation resulted in the early activation of Akt and MAPK, not just Src and 
Fak, indicating that the appropriate time points for LN and NGF induced activation is 
very early and may act to prime neurite growth. Our results suggest that the optimal 
neurite growth that occurs with LN+N treatment is due to crosstalk between LN and NGF 
induced signalling intermediates located upstream of PI 3-K. It is important to note that 
the addition of both NGF and LN together did not result in an additive level of Src 
phosphorylation. For instance, rather than LN+N resulting in maximal Src activation at 
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all time points, it actually acted to stabilize the level of active Src, resulting in a level that 
was midway between either LN or NGF treatment alone. Shortly after the 10 min LN 
stimulation, Src reached is highest level of phosphorylation; however it quickly dropped 
and stabilized by 1 hr. NGF stimulation on the other hand, started out with the lowest 
level of Src activation but continued to climb, resulting in maximum Src activation by 6 
hrs. LN+N stimulation induced the highest levels of Src activation, which was between 
NGF and LN at both 10 min and 6 hrs. As with Src phosphorylation, LN+N treatment 
induced a sustained level of Akt phosphorylation that was maintained across all time 
points. This response occurred despite the fact that phosphorylated Akt had returned to 
baseline by 6 hrs with either NGF or LN treatment alone. 
An important determinant of our conclusion that Src is a potential upstream point 
of convergence between LN and NGF induced signalling pathways is that inhibition of 
Src, via PP2, resulted in inhibition of Akt, Fak, and MAPK. This finding, paired with the 
fact that Akt and MAPK are known intermediates in both NGF-induced Trk signalling 
(Delcroix et al., 2003; Higuchi et al., 2003; Jones et al., 2003; Markus et al., 2002b; Mills 
et al., 2003; Tucker et al., 2005a; Zhou et al., 2004) and LN induced integrin signalling 
(Dey et al., 2005; Gary and Mattson, 2001; Koul et al., 2005; Mills et al., 2003; Tucker et 
al., 2005a), suggests that these intermediates are located downstream of Src. It is also 
important to note that inhibition of MEK in our experiments had no detectable effect on 
early Akt activation, and inhibition of PI 3-K has no effect on the activation of MAPK. 
This suggests that these intermediates are not in the same signalling pathway and do not 
influence one another's activity. Thus, Src activation is playing a dual role in the 
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influence of two distiNct signalling pathways, again suggesting that it acts as an upstream 
collaborative intermediate. 
Although we are confident that Src is a key point of collaboration between 
integrin and neurotrophin signalling in the studied population of cells, we are well aware 
that this is not the only possible point of integrin and growth factor cross talk. For 
instance, in a series of elegant experiments performed by Mills and colleagues (2003), 
integrin-linked kinase (ILK) was identified as being a necessary component of NGF 
induced neurite outgrowth in embryonic chick DRG neurons. In these experiments, they 
showed that Akt is directly phosphorylated by ILK, and the presence of a dominant 
negative ILK construct attenuated Akt induced neurite growth. Their study also pointed 
out that inhibition of ILK, although directly affecting Akt phosphorylation, does not 
affect the activation of the MEK/MAPK signalling pathway, suggesting that ILK in an 
important component of the PI 3-K/Akt signalling pathway, and potentially located 
downstream of Src. Thus, inhibition of Src may also lead to inhibition of ILK. However, 
because antibodies towl;lrds activated ILK were not commercially available, we were 
unable to explore this possibility further. 
As indicated previously, phosphorylation ofFak may be induced by both integrin 
and growth factor receptor activation; for instance, signalling induced by EGFR and 
integrin activation in PC12 and SH-SY5Y cells both stimulate the phosphorylation ofFak 
(Ivankovic-Dikic et al., 2000; Tucker et al., 2005a). Fak is known to bind components of 
the Src family kinases, specifically c-Src, following which this complex is translocated to 
sites of focal adhesion (Dikic et al., 1996; Schlaepfer and Hunter, 1998). These events 
then activate a series of downstream signalling molecules such as PI 3-K and MAPK, 
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which stimulate cell survival, migration, and gene expression (Clark and Brugge, 1995; 
Dikic et al., 1996; Schlaepfer add Hunter, 1998). Our results show that inhibition of Src, 
via PP2, inhibits Fak activation by NGF, LN, and LN+N treatment in DRG neurons. 
This, coupled with the fact that activation of Src occurs prior to Fak activation, indicates 
that Fak is probably not the key upstream point of collaboration between NGF and LN 
signalling in our system. However, due to a lack of available pharmacological Fak 
inhibitors, and poor transfection efficiency of dominant negative eDNA constructs into 
DRG neurons, the function of this intermediate could not be directly examined in these 
studies. The possibility still exists that activation of Src may stimulate recruitment and 
binding of Fak, leading to the activation of the PI 3-K/Akt and MEK/MAPK signalling 
pathways. As indicated by Ivankovic-Dikic and colleagues (2000), expression of 
Fak Y397F, which is unable to bind Src in SH-SY5Y cells, leads to an inhibition of neurite 
growth, although similar results were not found in PC 12 cells. It is important to note that 
even though we find that PI 3-K is located downstream of Src, this molecule still has the 
ability to influence both Src and Fak signalling, potentially by the presence of a negative 
feedback system. For instance, inhibition of Src, via PP2, could inhibit PI 3-K activation, 
and inhibition of PI 3-K, viaL Y294002, could attenuate Src activity. 
We have summarized our data in a model that illustrates the hierarchy of 
signalling intermediates required for LN+N induced optimal neurite growth in NGF-
responsive adult DRG neurons (Fig 5.7). To our knowledge, this is the first 
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Figure 5. 7. Schematic illustration of the hierarchy of intermediates essential to our 
model of Neurotrophin and Integrin mediated signalling cascades for the 
stimulation of neurite growth. L Y294002, PI 3-K inhibitor; PP2, Src family kinase 
inhibitor; UO 126, MEK inhibitor. 
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study identifying Src as a key point of collaboration between NGF and laminin induced 
signalling in adult NGF-responsive DRG neurons. As we have indicated, enhanced 
neurite growth elicited by LN+N stimulation appears to be due to the sustained activation 
of Src, which results in, the sustained activation of the downstream signalling 
intermediate Akt. We have also shown that Src is required for NGF and LN induced 
activation of the MEK/MAPK signalling pathway; however, this pathway is not required 
for neurite extension in the tested NGF-·responsive cell population. These findings are 
important as they provide new insights into the process by which NGF and LN induced 
signalling pathways collaborate to stimulate optimal levels of neurite growth. We have 
also identified that Src is a key signalling molecule that can be targeted to potentially 
stimulate maximal axonal regeneration after injury to either PNS or CNS neurons. 
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6.1 Research outcomes 
CHAPTER6 
DISCUSSION AND SUMMARY 
The fundamental goal of my research was to identify the key environmental 
conditions and subsequent cellular signalling components required to. stimulate optimal 
levels of neurite growth from adult sensory neurons. As previously suggested, this work 
stemmed from work in our lab, which looked at the effects ofNGF and IGF-1 on neurite 
growth in adult rat DRG neurons. At the time, we were concerned with the signalling 
mechanisms related to trophic factor stimulation, specifically interactions between NGF 
and IGF-1, in relation to neurite growth. We had noticed that neurons plated on laminin 
were extending processes in the absence of added growth factors. From these 
observations it was hypothesized that the ECM, laminin (which we happened to be using 
at the time), was sufficient to stimulate significant amounts of neurite growth in the 
absence of added growth factors. Although the neurotrophin field was well advanced by 
the time these experiments began, there was little information available with respect to 
the interaction between the extracellular matrix and neurotrophins. At the time, most in 
vitro neurotrophin experiments, ours included, were performed with neurons plated on 
laminin, and thus, the importance of this ECM was overlooked. This led us to formulate 
the second part of the hypothesis, which suggested that laminin-induced neurite growth 
could be potentiated by neurotrophins, especially NGF, and that this potentiation was due 
to crosstalk between extracellular matrix and neurotrophin induced signalling 
intermediates. 
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As obvious from previous chapters, a variety of different experiments were 
performed in order to test these hypotheses. To summarize my results, I have placed my 
findings in three separate categories: (1) neuronal response to laminin; (2) the effect of 
added trophic factors; (3) signalling required for neurite growth. 
6.1.1 Neuronal response to laminin 
DRG neurons plated on the ECM laminin in the absence of added growth factors 
elaborate significantly more neurite growth than cells plated on poly-D-lysine plus or 
minus NGF. Unlike laminin, poly-D-lysine is a synthetic molecule used to charge plating 
surfaces. Although this aids in cellular attachment, it does not have the ability to activate 
integrin receptors, which suggests that binding and activation of integrins are key for 
stimulating growth in DRG neurons. However, it was possible that the major difference 
in neurite growth was simply due to a difference in cell/substrate adherence. These 
concerns were satisfied by the fact that adherence was essentially identical for neurons 
plated on either surface .. To determine whether increased neurite growth was integrin 
dependent we used two different integrin inhibitors, the RGD peptide and the anti-131 
integrin antibody. From these experiments, we were able to show that integrin inhibition 
resulted in an attenuation of neurite growth. 
Although these results suggested that integrin activation alone was sufficient to 
stimulate significant neurite growth in the absence of added growth factors, we observed 
that not all neurons were responding in this way. As noted above, the DRG is made up of 
a heterogeneous population of cells that can be classified crudely based on cell body 
diameter, and more specifically, upon their ability to bind the lectin IB4 (predominantly 
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small diameter neurons), express the peptide CGRP (small and medium diameter 
neurons) or express the heavy chain neurofilament NF200 (predominantly medium and 
large diameter neurons) (Averill et al., 1995; Priestley et al., 2002a). Initial observations 
indicated that the small diameter DRG neurons were unresponsive to laminin, and only 
medium and large diameter neurons were extending neurites. However, by culturing 
cells for 48 hrs we found that this was not entirely the case; in fact, some of the small 
diameter neurons responded with extensive neurite growth while some large diameter 
neurons remained unresponsive. By using a magnetic bead-based cell selection 
technique, further analyses indicated that, unlike the CGRP and NF200+ve cell 
populations, the IB4+ve cell population was not responsive to laminin in the absence of 
added growth factors. These findings corresponded nicely with our initial observations; 
this population consisted of predominantly small diameter neurons and just a few large 
diameter neurons, which is exactly the ratio of unresponsive cells that we had observed. 
6.1.2 Effect of added trophic factors 
In initial experiments, we found that laminin-induced neurite growth was 
potentiated by the addition of NGF. However, as with the previously mentioned 
findings, NGF exerts its effects on specific cell populations. As indicated previously, the 
IB4+ve cell population does not express the NGF receptors Trk or p75, and thus these 
cells are not NGF-responsive. However, this population of cells does express the GDNF 
receptor components GFRa and Ret. When these cells were plated on laminin in the 
presence of GDNF, they responded with increased neurite growth; this result was not 
seen when these cells were plated on poly-D-lysine. These findings suggest that the 
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IB4+ve cell populatio'n is responsive to laminin; but, they require GDNF in order to 
extend neurites. On the other hand, NGF could potentiate laminin induced neurite 
I 
growth in both CGRP and NF200+ve cell populations. As our interests lay in the 
interaction between NGF and laminin induced signalling in the stimulation of neurite 
growth, these two cell populations (later collectively termed the NGF-responsive cells) 
became our main focus, in chapter 5. 
6.1.3 Signalling required for neurite growth 
Although we were mainly concerned with the signalling events required to elicit 
neurite growth in the NGF-responsive cell population, the signalling pathways utilized by 
the IB4+ve cell population were also identified (chapter 4 ). Initially through 
pharmacological inhibition, we found that laminin induced neurite growth in sensory 
DRG neurons was critically dependent on signalling through the PI-3k/Akt pathway. 
However, when we examined the GDNF- and NGF- responsive populations separately 
we identified population specific signalling. The NGF-responsive cell population 
required signalling through the PI 3-K/Akt pathway for neurite growth but did not require 
MEK/MAPK signalling. In contrast, the IB4+ve cell population required both the PI 3-
Kl Akt and MEK/MAPK signalling pathways. 
As I was interested in the population of neurons that responded to both laminin 
and NGF, my studies in chapter 5 focused on the NGF-responsive cells only. As 
indicated above, in order for these cells to extend neurites, signalling through the PI 3-
K1 Akt pathway is required. The next step then was to identify potential upstream points 
of convergence between laminin and NGF induced receptor activation, leading to the 
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stimulation of key downstream signalling components. By performing a series of timed 
stimulation experiments in the presence or absence of enzyme specific pharmacological 
inhibitors, we have identified Src as a potential upstream signalling component 
responsible for activation of the PI 3-K/Akt pathway by LN and/or NGF stimulation. 
Inhibition of Src attenuated the activation of all downstream signalling components, 
including those located in the MEK/MAPK signalling pathway. However, neither the PI 
3-K/Akt nor the MEK/MAPK pathways were able to exert any influence over the other; 
inhibition of PI 3-K did not effect the activation ofMAPK and inhibition ofMEK did not 
affect the activation of Akt. 
In these experiments, we also found that LN, NGF, or LN plus NGF could exert 
differences in the time and duration of signalling intermediate activation. Most 
interesting was the fact that laminin plus NGF stimulation induced a sustained activation 
of both Src and Akt that was not seen by the addition of either laminin or NGF alone. 
This finding could potentially explain how laminin plus NGF stimulates optimal levels of 
neurite growth. 
Figure 6.1 presents a summary of signalling events thought to be involved in 
integrin and/or growth factor activated signalling that could be attributed to neurite 
growth. Although we have identified the importance of the intermediates highlighted in 
yellow, many of the other intermediates have been suggested in the literature to be 
potential effectors in a variety of different cell types. 
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Figure 6.1. Proposed model for the hierarchy of signalling intermediates that could 
be involved in regulating neurotrophin and integrin induced neurite growth. This is 
a summary diagram from the literature that points to potential signalling intermediates 
that could possibly act as downstream effectors for the intermediates that we have 
identified. Our findings are summarized in the yellow highlighted section. Akti: AKT 
inhibitor; Echistatin, anti-b 1, ROD: integrin inhibitors; K252a: TrkA inhibitor; 
L Y294002: PI 3-K inhibitor; PP2: Src family kinase inhibitor; Rex: p75 inhibitor; 
Y27632: ROCK inhibitor. LIMK: Lin-II, Islet I and Mec 3 kinase. SSH l: slingshot. 
TESK 1: Testicular protein kinase 1. 
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6.2 Relevance to the field of axonal regeneration 
These studies are among the first to identify the importance of an interaction 
I 
between ECM and trophic factors in stimulating neurite growth from adult rat sensory 
DRG neurons. At th~ time I began these studies very little was known with respect to 
integrin mediated signalling responsible for growth in neurons, similarly even less was 
known about how these pathways synergise with growth factor pathways in stimulating 
neurite growth. Importantly, we have identified both the key environmental conditions 
and signalling components required for neurite growth in vitro and potentially for nerve 
regeneration in vivo. In tum, these results can provide potential therapeutic targets for the 
treatment and repair of both peripheral and central nerves following injury. To briefly 
discuss the global significance of these findings, I will begin by focusing on the two types 
of peripheral nerve insult mentioned in the introduction, physical nerve injury and 
diabetes. This discussion will be followed by a brief mention of the relevance of these 
findings to CNS repair. 
6.2.1 Physical nerve injury 
To alleviate the loss of function and disability associated with physical injury to 
the PNS, axonal regeneration is required. However, as suggested in the Introduction, 
although PNS regeneration is possible, it is often poor and full functional recovery rarely 
occurs (Abrams and Widenfalk, 2005; Fu and Gordon, 1995a; Fu and Gordon, 1995b). 
Many different factors contribute to insufficient functional recovery after PNS damage, 
including prolonged time for or inability to reestablish synaptic connections. When the 
time between nerve injury and reinnervation is prolonged, target tissue often degenerates, 
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making functional recovery impossible (Fu and Gordon, 1995a; Fu and Gordon, 1995b ). 
A major component of delayed target reinnervation is the formation of peripheral nerve 
gaps. Nerve gaps are formed when a segment of the peripheral nerve is lost and the 
proximal and distal nerve segments cannot simply be reconnected (Abrams and 
Widenfalk, 2005). When nerve gaps occur, surgical intervention is often necessary, and 
in many cases, one or more grafting procedures are performed (Newton and Nunamaker, 
1985). A major problem associated with nerve grafting is that it is difficult to recreate 
the healthy peripheral nerve environment. However, a variety of grafting procedures 
have been used with limited success. Grafts range from biological materials such as 
nerve, vein, and muscle, which can be isolated from either the same (autografts) or 
different (heterografts) species, to synthetic nonbiological materials such as silicone and 
polyester (Meek and Coert, 2002; Muller and Stoll, 1998; Newton and Nunamaker, 
1985). For the most part, use of these types of materials has been plagued with problems 
such as conduit collapse, enhanced scar production, and immunological rejection. The 
most commonly used grafting material still appears to be the autologous nerve; however, 
this graft is still quite poor in stimulating nerve regeneration, and in many cases, 
secondary problems as severe as the initial nerve injury maybe created (Meek and Coert, 
2002; Weber and Mackinnon, 2005). More recently, bio-absorbable conduits have 
become the focus for stimulating and guiding regenerating peripheral axons. For 
instance, polyglycolic acid, L-lactide and epsilon-caprolactone have all recently been 
used and have met with some success when attempting to stimulate peripheral nerve 
regeneration (Giardino et al., 1999; Giardino et al., 1995; Koshimune et al., 2003; 
Nakamura et al., 2004; Navissano et al., 2005; Weber et al., 2000). These conduits have 
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many promising characteristics in that they are non-toxic, non-immunogenic, resistant to 
collapse, and absorbable. Thus, scar formation using these materials is kept to a minimal 
and 'secondary surgeries are not required for their removal (Bini et al., 2004; Weber and 
Mackinnon, 2005). One of the main advantages of using this type of conduit to bridge 
peripheral nerve gaps is that they can be filled with permissive growth materials to aid in 
axonal regeneration. My current findings provide strong support for the use of the 
extracellular matrix molecule laminin in conjunction with NGF and GDNF in these 
bioabsorbable conduits in order to stimulate optimal levels of axon growth from all 
populations of regenerating sensory neurons. As I have shown, the provision of these 
factors together would stimulate a level of growth from sensory neurons that is not 
achievable by the provision of either factor alone. Treatments that only focus on one 
permissive molecule may be inadequate in helping axons to cross the injury site and get 
back to their original targets before their ability to stimulate functional recovery is lost. 
Another major problem associated with peripheral nerve damage, especially when 
nerve gaps are formed, is the creation of pain causing neuromas (Lewin-Kowalik et al., 
2006; Sakai et al., 2005; Vernadakis et al., 2003). These neuromas are formed when 
growing axons, especially sensory C fibers become tangled and form an aggregate of 
axon fibers at the beginning of the injury site. It has been suggested that the provision of 
NGF alone at sites of injury many actually act to induce neuroma formation, potentially 
because the regenerating fibers are getting cues to grow but have nowhere to travel 
because there is no remaining ECM outside of the proximal nerve stump (Lewin-Kowalik 
et a/., 2006). Filling conduits with laminin, NGF, and GDNF could possibly provide 
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regenerating sensory axons with the support they need to traverse the nerve gap, thus 
preventing neuroma formation ().nd neuropathic pain. 
6.2.2 Diabetes 
Metabolic diseases such as diabetes inflict damage on the peripheral sensory 
nervous system, characterized by demyelination, dying-back of axons, and subsequent 
failure of axonal regeneration (Kennedy and Zochodne, 2005). These neuropathies occur 
due to reduced neurotrophic support, decreased axonal flow and disruption of the ECM 
(Fernyhough and Schmidt, 2002; McLean, 1997; Scott et al., 1999), and often lead to a 
loss of sensations including pain, pressure, temperature, and vibration. Eventually 
reflexes mediated by sensory and motor fibers are also lost (McHugh and McHugh, 
2004 ). Sensory neurons of the DRG are among the most vulnerable to this type of 
metabolic injury (McHugh and McHugh, 2004; Zochodne, 1996). This increased 
vulnerability is in part due to the fact that DRG neurons and their peripheral axons lay 
outside of the blood nerve barrier, as well as the fact that the neurons have a unique 
morphological property in that 99.8% of their cytoplasm is axonal (Devor, 1999; 
McHugh and McHugh, 2004). Of the different sub-classifications of DRG neurons, the 
most susceptible and first affected neurons in diabetic environments tend to be the small 
diameter nociceptive nerve fibers of the IB4 and CGRP populations (Le Quesne and 
Fowler, 1986; Polydefkis et al., 2003; Yasuda et al., 2003; Zochodne, 1999; Zochodne et 
al., 2001). The medium and large diameter NF200 positive neurons tend to be less 
susceptible and are affected later in the disease (Lacomis, 2002; Leinninger et al., 2004; 
Sumner et al., 2003). Disruption of these neurons ultimately leads to the loss of sensation 
-217-
for painful or noxious· stimuli, as well as tactile and vibratory sensation, putting tissue at 
increased risk for neuropathic damage (Ali et al., 1989; Dell on, 2002; Leinninger et al., 
200~). The most common and debilitating damage occurs on the plantar surface of the 
foot; because the loss. of sehsation often goes undetected and untreated, this can result in 
non-healing foot ulcers, severe infection, and gangrene, the leading causes of amputation 
and morbidity in diabetic patients (Leinninger et al., 2004). 
To date, much of the research associated with sensory polyneuropathies produced 
by metabolic diseases have focused on prevention through treatments such as glucose 
regulation (McHugh and McHugh, 2004). However, due to the unique structure and 
location of the DRG, even slight undetected alterations in the extracellular environment 
can produce detrimental disruptions in sensory nerves, resulting in problems such as the 
diabetic foot (Ali et al., 1989; Le Quesne and Fowler, 1986; McHugh and McHugh, 
2004; Sumner et al., 2003; Zochodne, 1996). Thus, the focus on treatment of sensory 
polyneuropathies has shifted toward attempts to stimulate regeneration. As we have 
noted in this study, in prder to achieve an effective regenerative response, the cell 
requires support from both trophic factors and components of the extracellular matrix, 
specifically laminin, which are both disrupted in diabetes. In identifying the 
environmental requirements, as well as specific signalling events associated with unique 
laminin-induced growth responses for each of the sub-populations of DRG neurons, we 
have identified potential therapeutic targets for the treatment and repair of peripheral 
sensory nerve damage. This illustrates the inability of any one treatment alone to repair 
the damage inflicted by diseases such as diabetes on the different subpopulations of DRG 
neurons. For instance, NGF treatments would do little in the way of stimulating 
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regeneration of IB4+ve neurons, which require both LN and GDNF for neurite 
outgrowth. Similarly, if, as suggested, the extracellular matrix is disrupted and LN is not 
present, then NGF treatment will be ineffective in stimulating regeneration of CGRP+ve 
neurons. As with NGF treatment, GDNF treatment would be ineffective in stimulating 
regeneration in CGRP and NF200+ve neurons. 
6.2.3 Overcoming influences from inhibitory CNS molecules 
It has long been suggested that axonal regeneration in the CNS is poor. A variety 
of reasons for the poor regenerative capacity of CNS neurons have been suggested, two 
of which are the presence of inhibitory ECM molecules and the lack of an adequate 
neurotrophin supply (Hunt et al., 2002). The inhibitory molecules of the CNS come 
from two main sources, the myelin sheath and the glial scar (Sandvig et al., 2004). As 
suggested in the Introduction, the major inhibitory molecules found in the myelin sheath, 
including Nogo, MAG, and OMgp, are left behind after brain and spinal cord injury, 
while the inhibitory molecules of the glial scar are deposited by infiltration of reactive 
astrocytes (Hunt et al., 2002; Sandvig et al., 2004). Until recently, much of the CNS 
regeneration research had focused on how to remove these inhibitory molecules. 
However, more recently the focus has shifted to the provision of permissive molecules 
especially those found in the PNS that are known to be lacking in the CNS. For instance, 
laminin purified from the PNS has been shown to have the ability to override the 
inhibitory actions of myelin and glial scar proteins on CNS neurons (Condie et al., 1999; 
David et al., 1995; Laforest et al., 2005; Snow et al., 1996). Similarly, priming ofCNS 
neurons with NGF allows them to overcome myelin induced growth inhibition (Cai et al., 
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1999; Gao eta/., 2003). Thus, one can see how the balance could be potentially shifted 
toward promoting regeneration of CNS neurons by providing enough positive cues to 
overwhelm the inhibitory ones. Therefore, by providing both laminin and the appropriate 
neurotrophin to cells of the CNS, one may be able to overcome the influence of inhibitory 
CNS molecules. The ability of LN to overcome environmental inhibition in the CNS has 
been suggested to occur through binding of integrin receptors and subsequent activation 
of integrin dependent signalling components, such as Rae (Laforest et al., 2005). 
Similarly NGF has also been shown to activate the Rae pathway in CNS neurons (Gao et 
al., 2003). As I have suggested, in our system the presence oflaminin and NGF together 
may work by altering the kinetics of specific signalling intermediates that are important 
for neurite growth. Thus, the addition of both NGF and laminin in the CNS may act to 
change the kinetics of Rae signalling, thereby stimulating enhanced axonal regeneration 
after CNS injury. For example, as I have indicated in Fig 6.1 it is possible that LN and 
NGF together activate both PI 3-K, which could inturn activate Rae, and Src which may 
activate Ras which in turn could activate Rae. In either situation these signalling events 
may work to enhance neurite growth. 
Another important finding that could potentially relate to CNS regeneration is the 
fact that we have identified Src as a critical signalling intermediate for the regeneration of 
peripheral sensory axons. It is quite possible that the laminin- and NGF-induced 
increases in Src seen in the PNS could be directly paralleled in the CNS. Therefore, these 
findings identify another signalling target with potential therapeutic significance for CNS 
neurons. For instance, much of the research in CNS repair has focused on inhibition of 
the Rho pathway by the use of inhibitors such as the C3 enzyme to inhibit RhoA or the 
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pharmacological inhibitor Y-27632 to inhibit Rho kinase (Dergham et a/., 2002; 
Yamashita et a!., 2002). In cdnjunction with these inhibitors, it may be beneficial to 
activate the intermediates such as Src, which could potentially shift the balance even 
further toward the positive end of the spectrum (see Fig 6.1 ). 
6.3 Future directions 
Although I have identified many key environmental factors and intracellular 
signalling intermediates that are involved in neuritogenesis of adult sensory DRG 
neurons, many questions with regards to axonal regeneration remain. I will briefly 
discuss four lines of work that I see as being important to further advance the knowledge 
base in this field. 
1) We have identified the upstream and intermediate signalling components required to 
stimulate neurite growth in adult DRG neurons. However, the requirement or 
contributions of downstream effectors have not yet been identified. It has been 
previously shown that both the Rho family of small GTPases (Rho, Rae, Cdc42, P AK1) 
and the actin binding proteins (Cofillin, LIMK, TESK1) are key regulators of growth 
cone motility and axonal advancement (Gallo and Letourneau, 2004; Korey and Van 
Vactor, 2000; Meyer and Feldman, 2002) (see Fig 6.1). Therefore, the role of these 
proteins in laminin and NGF induced neurite growth need to be identified. From the 
lower highlighted portion of Fig 6.2, it becomes evident that the required signalling 
intermediates that we have identified could possibly interact with potential downstream 
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Figure 6.2. Proposed schematic illustration of how the Rho family of small GTPases 
(highlighted in blue) could be regulated by the known signalling intermediates 
(highlighted in yellow) that have been identified as being required for neurite 
growth from adult sensory DRG neurons. The area highlighted in yellow represents 
the signalling intermediates that we have identified as being important for LN and NGF 
induced neurite growth. The area highlighted in blue represents the Rho family of small 
GTPases that have been identified in the literature that could possibly play a role in 
axonal regeneration. Akti: AKT inhibitor; Echistatin, anti-b 1, RGD: integrin inhibitors; 
K252a: TrkA inhibitor; L Y294002: PI 3-K inhibitor; PP2: Src family kinase inhibitor; 
Rex: p75 inhibitor; Y27632: ROCK inhibitor. LIMK: Lin-II, Islet I and Mec 3 kinase. 
SSH l: slingshot. TESK 1: Testicular protein kinase 1. 
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Fig 6.2 
effectors that have been shown to be essential for growth cone remodelling and axonal 
extension. For example, it is possible that PI-3K may activate Rae, which could then 
activate Pak inhibiting LIMK and myosin light chain kinase (MLCK). Both of these 
intermediates have been shown to be important for retrograde flow of actin and growth 
cone retraction (Dent and Gertler, 2003; Huber et al., 2003). It has also been suggested 
that Fak, which we have shown to be activated by both NGF and LN, may inhibit 
activation of Rho and its downstream effector Rock, thereby stimulating growth cone 
extension and neurite growth (Dent and Gertler, 2003; Huber et al., 2003; Ren et al., 
2000). Although these possibilities exist, further work is necessary to confirm these 
interactions. 
2) As suggested in Section 6.2.3, our findings may be useful when attempting to 
overcome the inhibitory effects of components found in both myelin and the glial scar. 
Thus, it is important to determine how these inhibitory substrates signal to inhibit neurite 
growth and whether or not they can be influenced by the signalling events induced by 
laminin and NGF. It is well known that these inhibitory molecules exert their effects by 
signalling via RhoA and its downstream effector ROCK, however, the influence that 
activation of the Src/PI 3-K/Akt pathway may play in these signalling events are 
unknown. Similarly, it is also unclear how molecules of the glial scar actually activate 
these inhibitory signalling intermediates; for instance, the cell surface receptor for the 
chondroitin sulfate proteoglycans has not yet been identified (Schweigreiter eta!., 2004). 
The possibility exists that they exert their effects by interrupting cellular adhesion to 
positive extracellular matrix molecules such as laminin. 
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3) We have yet to identify the mechanisms that underlie the differential laminin-
induced growth response between the IB4+ve and NGF -responsive populations of DRG 
neurons. Although I have studied the interaction between laminin and NGF in the NGF-
responsive cell population only, the finding that the IB4+ve neurons do not respond to 
laminin in the absence of added GDNF is still of interest. Specifically, I would like to 
know if the observed difference between these cells is due to different integrin receptor 
expression. My initial immunocytochemistry experiments suggest that the integrin 
receptor subunits, a 1 and f31, are expressed by all populations of DRG neurons. 
However, the degree of receptor subunit expression across the different populations has 
not been identified. For example, it is possible that the IB4+ve cells, which don't 
respond to laminin in the absence of GDNF, may express fewer of these receptors. 
Similarly, as indicated in the introduction, laminin has the ability to bind to more than 
one integrin receptor, and thus it may be that there is a different pattern of integrin 
expression seen between the two cell populations. To study these possibilities, I have 
performed some preliminary work using oligo microarray analysis (oligo arrays used in 
these experiments are provided by SuperArray Bioscience Corporation, Frederick, MD, 
USA, and are called Oligo GEArrays). To carry out these types of experiments, total 
RNA from each population was used to synthesize biotin tagged cRNA. The tagged 
cRNA was bound to microarrays that have oligo sequences for the different integrin 
receptors attached to their surfaces. These arrays were visualized using xray film and 
analyzed using the provided software. Fig 6.3 is a representation of the different genes 
that have been observed on these arrays and what they actually look like when 
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Figure 6.3. ECM array gene expression and representative clustergram from NGF-
responsive and IB4+ve cell populations. Representative microarray gene 
expression and analysis for NGF-responsive and IB4+ve adult ORO neurons before (T-0) 
and after being plated on LN coated dishes for 24 hrs. A, A2: Clustergram and 
microarray of NGF-responsive cells plated on LN for 24hrs. B, B2: Clustergram and 
m1croarray of IB4+ve cells plated on LN for 24hrs. C, C2: Clustergram and 
m1croarray of NGF-responsive cells before plating. 0, 02: Clustergram and 
microarray of IB4+ve cells before plating. I: Map of gene probes and array location. 
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performing the analysis. Although these results are preliminary, differences in integrin 
expression have been identified; specifically, both al and j)l, subunits that we have 
I 
identified by ICC, seem to be differentially expressed between the two cell populations 
(Fig 6.4). As noted, these results are preliminary and subsequent replication has not been 
performed, however this technique does look promising. 
4) It has been suggested that the results obtained from flat 2D surfaces could be quite 
different from what would occur in a more physiologically relevant space. With this in 
mind, I have begun using synthetic 3D matrices to further study axon growth and 
behavior. Specifically, I began by plating neurons on 3D nanofibril cover slips that were 
either uncoated (NANs), poly-amine coated (SANs), or laminin coated, and cultures were 
stained and imaged using confocal microscopy to determine ifthe 3D structure alone aids 
in significant neurite outgrowth (The Ultra-Web Synthetic Nanofibrillar surfaces, used in 
these experiments were provided by Donaldson Company Inc., Minneapolis, MN, USA). 
Preliminary results suggest that adult DRG neurons still require laminin and/or NGF to 
elicit a growth response (Fig 6.5 A, C). However, laminin- and/or NGF-induced neurite 
growth seems to be enhanced by the 3D structure of these matrices (Fig 6.5 B, D, E, F). 
As these results are preliminary, neurite growth analysis needs to be performed to 
confirm these observations. However, if this is the case, it may provide us with more 
insight into the environmental conditions required for neurite growth in vivo. As these 
3D structures provide a model that more closely resembles the in vivo environment, they 
will also be used in experiments in which we will try to overcome the previously 
mentioned inhibitory substrates. For instance, they can be coated with inhibitory myelin 
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Figure 6.4. Analysis of ECM arrays from NGF -responsive and IB4+ve cell 
populations. RNA from NGF -responsive and IB4+ve adult DRG neurons was collected 
either immediately after isolation (T -0) or after being plated on LN coated dishes for 24 
hrs and analyzed via microarray analysis (the array location of each component for this 
experiment have been circled in Fig 6.3 ). a 1 integrin (A) and ICAM (H) RNA 
expression was significantly higher in NGF-responsive cells than in IB4+ve cells after 
being plated on laminin for 24 hrs (p<O .001 ). However, LN plating stimulated a 
significant increase in a 1 integrin and ICAM expression in both cell groups (p<O.OO 1 ). 
~ 1 (F) and av integrin (E) Rl"'l"A expression was significantly higher in NGF-responsive 
cells than in IB4+ve cells before LN plating (p<O.OO 1 ), however, no significant 
difference was seen after being plated on LN for 24 hrs (p>0.05). Laminin (G) RNA 
expression was significantly higher in NGF -responsive cells than in IB4+ve cells both 
before and after laminin plating (p<O.OO I). No significant difference was seen in aJ (B), 
aS (C), or a7 (D) integrin RNA expression. To control for between experiment variation 
( exposure/CRN A loading, etc.) densitometric analysis for each probe was corrected 
against internal housekeeping genes located on each microarray. Significance was tested 
using one-way ANOVA with Tukey post-hoc testing. * p< 0.05, ** p<O.OOI. 
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Figure 6.5. Adult DRG neurons plated on various Ultra-Web synthetic nanofibrillar 
cell growth surfaces and immunostained with tH integrin and total tubulin. Cells 
were plated on untreated (NANS), polyamine treated (SANS) or LN coated (SANS+LN) 
nanofibers plus or minus NGF for 24hrs prior to fixation and immunostained using 
antibodies against ~ l integrin (red) and total tubulin (green). Cells were imaged at 40x 
using laser scanning confocal microscopy. No significant amount of neurite growth was 
observed for cells plated on the NANS (A) or SANS (C) for 24 hrs minus NGF. 
However, significant neurite growth was observed when cells were plated on NANS (B) 
or SANS (C) plus NGF. A significant amount of neurite growth was observed for cells 
plated on LN coated SANS minus NGF (E), which was potentiated when plated plus 
NGF (F). Note the local accumulation of~ 1 integrin in the growth cones of cells plated 
on both NANS plus NGF (B) and SANS plus NGF (D) (arrows), characteristic of cells 
plated on LN (E, F), but not normally seen on similar 2D surfaces. However, the 3D 
surface alone is not sufficient to stimulate neurite growth in the absence of added NGF. 
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and glial scar proteins, and the effects of laminin and NGF can be assessed. We are also 
interested to see if the signalling pathways activated within neurons plated on these 3D 
' 
structures are the same as those identified on 2D surfaces. To show the structure of these 
3D matrices and how neurites grow when plated on them, I have included a composite 
confocal micrograph with accompanying light microscopy (Fig 6.6). As shown, neurons 
plated on these nanofibrillar surfaces extend neurites that climb over and penetrate into 
the 3D matrix. 
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Figure 6.6. Jmm Z-stack of adult DRG neurons plated on LN coated Ultra-Web 
synthetic nanofibrillar cell growth surfaces and immunostained with ~1 integrin and 
total tubuJin. Cells were plated on LN coated (SANS+LN) nanotibers minus NGF for 
24hrs prior to fixation and immunostaining using antibodies against~ l integrin (red, C, 
F, I) and total tubulin (green, B, E, H). Sequential l!J.m slices were imaged at l OOx using 
laser scanning confocal microscopy, and transmitted light (to show nanofiber structure) 
and arranged from apical (A) to basal surfaces (G). The 30 nature of the nanofiber 
surface can be identified in panels A, 0, and G as well as in subsequent enlargements J, 
K, and L (J, K. L are enlargements of the area of A, 0, and G respectively as indicated by 
the red circle). The neurite indicated by the arrow is growing over a nanofiber however 
as the scans become more basal a gap in the neurite begins to appear indicating that the 
neurite has climbed over the tiber and fallen to continue on the other side. Neurite growth 
on this LN coated 3 0 surface is more extensive then that seen on similar 20 plating 
conditions. Cell body is indicated by an asterisk. Scale bar for- 50 !J.m. 
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6.4 Conclusion 
To highlight my results I1will conclude by summarizing my major findings. · 
1) The extracellular matrix molecule laminin is sufficient to promote significant 
amounts of neurite growth from NGF-responsive adult DRG neurons in the 
absence of added growth factors. 
2) Laminin induced neurite growth in the NGF-responsive populations of DRG 
neurons is potentiated by the addition ofNGF and unaffected by the addition 
ofGDNF. 
3) The extracellular matrix molecule laminin is not sufficient to promote 
significant amounts of neurite growth from IB4+ve adult DRG neurons 
plated in the absence of added growth factors, although it appears to be 
required for GDNF-induced neurite growth. 
4) Both NGF-responsive and IB4+ve cell populations are dependent on the PI 
3-K/Akt signalling pathway for neurite growth, but only the IB4+ve cell 
population also requires the MEK/MAPK signalling pathway. 
5) Enhanced neurite growth in the NGF-responsive cell population induced by 
laminin and NGF results from crosstalk between integrin and Trk activated 
signalling pathways. 
6) Src acts as a key upstream point of collaboration between integrin and Trk 
induced activation of the PI 3-K/Akt signalling pathway in the NGF-
responsive cell population. 
-236-
7) Enhanced' neurite growth stimulated by laminin and NGF in the NGF-
responsive cell population is potentially due to a sustained activation of the 
downstream signalling intermediate Akt. 
-237-
Bibliography 
Abrams, M. and Widenfalk, J. (2005). Emerging strategies to promote 
improved functional outcome after peripheral nerve injury. Restor Neural Neurosci 23, 
367-82. 
Acheson, A., Barker, P. A., Alderson, R. F., Miller, F. D. and Murphy, R. A. 
(1991). Detection of brain-derived neurotrophic factor-like activity in fibroblasts and 
Schwann cells: inhibition by antibodies to NGF. Neuron 7, 265-75. 
Aguayo, A. J., David, S. and Bray, G. M. (1981). Influences ofthe glial 
environment on the elongation of axons after injury: transplantation studies in adult 
rodents. J Exp Bio/95, 231-40. 
Aguayo, A. J., Rasminsky, M., Bray, G. M., Carbonetto, S., McKerracher, L., 
Villegas-Perez, M.P., Vidai-Sanz, M. and Carter, D. A. (1991). Degenerative and 
regenerative responses of injured neurons in the central nervous system of adult 
mammals. Philos Trans R Soc Lond B Bioi Sci 331, 337-43. 
Airaksinen, M. S. and Saarma, M. (2002). The GDNF family: signalling, 
biological functions and therapeutic value. Nat Rev Neurosci 3, 383-94. 
Ali, Z., Carroll, M., Robertson, K. P. and Fowler, C. J. (1989). The extent of 
small fibre sensory neuropathy in diabetics with plantar foot ulceration. J Neural 
Neurosurg Psychiatry 52, 94-8. 
Allen, S. J. and Dawbarn, D. (2006). Clinical relevance of the neurotrophins and 
their receptors. Clin Sci (Lond) 110, 175-91. 
Aloe, L. (2004). Rita Levi-Montalcini: the discovery of nerve growth factor and 
modem neurobiology. Trends Cell Bio/14, 395-9. 
Aiton-Gultekin, Z. F. and Wagner, J. A. (1996). Src, ras, and rae mediate the 
migratory response elicited by NGF and PMA in PC12 cells. J Neurosci Res 44, 308-27. 
Aplin, A. E., Howe, A., Alahari, S. K. and Juliano, R. L. (1998). Signal 
transduction and signal modulation by cell adhesion receptors: the role of integrins, 
cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacal Rev 50, 
197-263. 
-238-
Aplin, A. E., Howe, A. K. and Juliano, R. L. (1999). Cell adhesion molecules, 
signal transduction and cell growth. Curr Opin Cell Biolll, 737-44. 
I 
Archelos, J. J., Previtali, S.C. and Hartung, H. P. (1999). The role ofintegrins 
in immune-mediated diseases of the nervous system. Trends Neurosci 22, 30-8. 
Arenas, E., Trupp, M., Akerud, P. and Ibanez, C. F. (1995). GDNF prevents 
degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 
15, 1465-73. 
Arvidson, B. ( 1979). A study of the perineurial diffusion barrier of a peripheral 
ganglion. Acta Neuropathol (Berl) 46, 139-44. 
Attwell, S., Mills, J., Troussard, A., Wu, C. and Dedhar, S. (2003). Integration 
of cell attachment, cytoskeletallocalization, and signaling by integrin-linked kinase 
(ILK), CH-ILKBP, and the tumor suppressor PTEN. Mol Bioi Cel/14, 4813-25. 
Atwal, J. K., Massie, B., Miller, F. D. and Kaplan, D. R. (2000). The TrkB-Shc 
site signals neuronal survival and local axon growth via MEK and P13-kinase. Neuron 
27,265-77. 
Averill, S., Delcroix, J.D., Michael, G. J., Tomlinson, D. R., Fernyhough, P. 
and Priestley, J. V. (2001). Nerve growth factor modulates the activation status and fast 
axonal transport ofERK 1/2 in adult nociceptive neurones. Mol Cell Neurosci 18, 183-
96. 
Averill, S., McMahon, S. B., Clary, D. 0., Reichardt, L. F. and Priestley, J. V. 
( 1995). Immunocytochemical localization of trkA receptors in chemically identified 
subgroups of adult rat sensory neurons. Eur J Neurosci 7, 1484-94. 
Azanchi, R., Bernal, G., Gupta, R. and Keirstead, H. S. (2004). Combined 
demyelination plus Schwann cell transplantation therapy increases spread of cells and 
axonal regeneration following contusion injury. J Neurotrauma 21, 775-88. 
Bandtlow, C. and Dechant, G. (2004). From cell death to neuronal regeneration, 
effects of the p75 neurotrophin receptor depend on interactions with partner subunits. Sci 
STKE, 24. 
-239-
Bandtlow, C. E. (2003). Regeneration in the central nervous system. Exp 
Gerontol 38, 79-86. 
Bandtlow, C. E., Heumann, R., Schwab, M. E. and Thoenen, H. (1987). 
Cellular localization of nerve growth factor synthesis by in situ hybridization. Embo J 6, 
891-9. 
Belkin, A. M. and Stepp, M. A. (2000). Integrins as receptors for laminins. 
Microsc Res Tech 51, 280-301. 
Bennett, D. L., Boucher, T. J., Armanini, M.P., Poulsen, K. T., Michael, G. 
J., Priestley, J. V., Phillips, H. S., McMahon, S. B. and Shelton, D. L. (2000). The 
glial cell line-derived neurotrophic factor family receptor components are differentially 
regulated within sensory neurons after nerve injury. J Neurosci 20, 427-37. 
Bennett, D. L., Michael, G. J., Ramachandran, N., Munson, J. B., Averill, S., 
Yan, Q., McMahon, S. B. and Priestley, J. V. (1998). A distinct subgroup of small 
DRG cells express GDNF receptor components and GDNF is protective for these neurons 
after nerve injury. J Neurosci 18, 3059-72. 
Bini, T. B., Gao, S., Xu, X., Wang, S., Ramakrishna, S. and Leong, K. W. 
(2004). Peripheral nerve regeneration by microbraided poly(L-lactide-co-glycolide) 
biodegradable polymer fibers. J Biomed Mater Res A 68, 286-95. 
Blochl, A., Blumenstein, L. and Ahmadian, M. R. (2004). Inactivation and 
activation ofRas by the neurotrophin receptor p75. Eur J Neurosci 20, 2321-35. 
Bomze, H. M., Bulsara, K. R., Iskandar, B. J., Caroni, P. and Skene, J. H. 
(200 1 ). Spinal axon regeneration evoked by replacing two growth cone proteins in adult 
neurons. Nat Neurosci 4, 38-43. 
Borrello, M.G., Alberti, L., Arighi, E., Bongarzone, 1., Battistini, C., 
Bardelli, A., Pasini, B., Piutti, C., Rizzetti, M. G., Mondellini, P. et al. (1996). The full 
oncogenic activity ofRet/ptc2 depends on tyrosine 539, a docking site for phospholipase 
Cgamma. Mol Cell Bio/16, 2151-63. 
Bradbury, E. J., Moon, L. D., Popat, R. J., King, V. R., Bennett, G. S., Patel, 
P. N., Fawcett, J. W. and McMahon, S. B. (2002). Chondroitinase ABC promotes 
functional recovery after spinal cord injury. Nature 416, 636-40. 
-240-
Brewster, W. J., Fernyhough, P., Diemel, L. T., Mohiuddin, L. and 
Tomlinson, D. R. (1994). Diabetic neuropathy, nerve growth factor and other 
neurotrophic factors. Trends Ne~rosci 17,321-5. 
Brunton, V. G., MacPherson, I. R. and Frame, M. C. (2004). Cell adhesion 
receptors, tyrosine kinases and actin modulators: a complex three-way circuitry. Biochim 
Biophys Acta 1692, 121-44. 
Bunge, M. B. (1994a). Transplantation ofpurified populations of Schwarm cells 
into lesioned adult rat spinal cord. J Neuro/242, 836-9. 
Bunge, M. B. and Bunge, R. P. (1986). Linkage between Schwann cell 
extracellular matrix production and ensheathment function. Ann N Y A cad Sci 486, 241-7. 
Bunge, R. P. (1987). Tissue culture observations relevant to the study of axon-
Schwann cell interactions during peripheral nerve development and repair. J Exp Bioi 
132, 21-34. 
Bunge, R. P. (1993). Expanding roles for the Schwann cell: ensheathment, 
myelination, trophism and regeneration. Curr Opin Neurobio/3, 805-9. 
Bunge, R. P. (1994b). The role of the Schwann cell in trophic support and 
regeneration. J Neuro/242, S 19-21. 
Bunge, R. P. and Wood, P.M. (1987). Tissue culture studies of interactions 
between axons and myelinating cells of the central and peripheral nervous system. Prog 
Brain Res 71, 143-52. 
Burmeister, D. W. and Goldberg, D. J. (1988). Micropruning: the mechanism 
oftuming of Aplysia growth cones at substrate borders in vitro. J Neurosci 8, 3151-9. 
Cai, D., Qiu, J., Cao, Z., McAtee, M., Bregman, B.S. and Filbin, M. T. 
(2001). Neuronal cyclic AMP controls the developmental loss in ability ofaxons to 
regenerate. J Neurosci 21,4731-9. 
Cai, D., Shen, Y., De Bellard, M., Tang, S. and Filbin, M. T. (1999). Prior 
exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin 
via a cAMP-dependent mechanism. Neuron 22, 89-101. 
-241-
Caswell, P. T. ~nd Norman, J. C. (2006). Integrin trafficking and the control of 
cell migration. Traffic 7, 14-21. 
Ceni, C. and Barker, P. A. (2005). Getting RIP'd Stunts Your Growth. Neuron 
46, 839-40. 
Chao, M. V., Rajagopal, R. and Lee, F. S. (2006). Neurotrophin signalling in 
health and disease. Clin Sci (Land) 110, 167-73. 
Chattopadhyay, M., Goss, J., Lacomis, D., Goins, W. C., Glorioso, J. C., 
Mata, M. and Fink, D. J. (2003). Protective effect ofHSV-mediated gene transfer of 
nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA 
receptors in large sensory neurons of adult animals. Eur J Neurosci 17, 732-40. 
Chen, H. C., Appeddu, P. A., Isoda, H. and Guan, J. L. (1996). 
Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding 
phosphatidylinositol 3-kinase. J Bioi Chem 27i, 26329-34. 
Chen, M.S., Huber, A. B., van der Haar, M. E., Frank, M., Schnell, L., 
Spillmann, A. A., Christ, F. and Schwab, M. E. (2000). Nogo-A is a myelin-associated 
neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403, 
434-9. 
Chen, Z. (2002). Progress of peripheral nerve repair. Chin J.Traumato/5, 323-5. 
Chen, Z. L. and Strickland, S. (2003). Laminin gammal is critical for Schwann 
cell differentiation, axon myelination, and regeneration in the peripheral nerve. J Cell 
Bio/163, 889-99. 
Cheng, C. and Zochodne, D. W. (2002). In vivo proliferation, migration and 
phenotypic changes of Schwann cells in the presence of myelinated fibers. Neuroscience 
115, 321-9. 
Chernousov, M.A., Scherer, S. S., Stahl, R. C. and Carey, D. J. (1999). p200, 
a collagen secreted by Schwann cells, is expressed in developing nerves and in adult 
nerves following axotomy. J Neurosci Res 56, 284-94. 
Clark, E. A. and Brugge, J. S. (1995). Integrins and signal transduction 
pathways: the road taken. Science 268, 233-9. 
-242-
Clark, E. A. and Hynes, R. 0. (1997). 1997 keystone symposium on signal 
transduction by cell adhesion receptors. Biochim Biophys Acta 1333, R9-16. 
I 
Colognato, H., ffrench-Constant, C. and Feltri, M. L. (2005). Human diseases 
reveal novel roles for neurallaminins. Trends Neurosci 28, 480-6. 
Condie, M. L. (200 1 ). Adult neuronal regeneration induced by transgenic integrin 
expression. J Neurosci 21, 4782-8. 
Condie, M. L. and Letourneau, P. C. (1997). Ligand-induced changes in 
integrin expression regulate neuronal adhesion and neurite outgrowth. Nature 389, 852-6. 
Condie, M. L., Snow, D. M. and Letourneau, P. C. (1999). Embryonic neurons 
adapt to the inhibitory proteoglycan aggrecan by increasing integrin expression. J 
Neurosci 19, 10036-43. 
Coulpier, M. and Ibanez, C. F. (2004). Retrograde propagation of GDNF-
mediated signals in sympathetic neurons. Mol Cell Neurosci 27, 132-9. 
Cowan, W. M. (2001). Viktor Hamburger and Rita Levi-Montalcini: the path to 
the discovery of nerve growth factor. Annu Rev Neurosci 24, 551-600. 
Creedon, D. J., Tansey, M. G., Baloh, R. H., Osborne, P. A., Lampe, P. A., 
Fahrner, T. J., Heuckeroth, R. 0., Milbrandt, J. and Johnson, E. M., Jr. (1997). 
Neurturin shares receptors and signal transduction pathways with glial cell line-derived 
neurotrophic factor in sympathetic neurons. Proc Nat/ Acad Sci US A 94, 7018-23. 
Cunningham, M. E. and Greene, L. A. (1998). A function-structure model for 
NGF-activated TRK. Embo J 17, 7282-93. 
David, S. and Aguayo, A. J. (1981). Axonal elongation into peripheral nervous 
system "bridges" after central nervous system injury in adult rats. Science 214, 931-3. 
David, S., Braun, P. E., Jackson, D. L., Kottis, V. and McKerracher, L. 
(1995). Laminin overrides the inhibitory effects of peripheral nervous system and central 
nervous system myelin-derived inhibitors of neurite growth. J Neurosci Res 42, 594-602. 
-243-
de Curtis, I. and Malanchini, B. (1997). Integrin-mediated tyrosine 
phosphorylation and redistribution ofpaxillin during neuronal adhesion. Exp Cell Res 
230, 233-43. 
Delcroix, J.D., Valletta, J. S., Wu, C., Hunt, S. J., Kowal, A. S. and Mobley, 
W. C. (2003). NGF signaling in sensory neurons: evidence that early endosomes carry 
NGF retrograde signals. Neuron 39, 69-84. 
Dellon, A. L. (2002). Preventing foot ulceration and amputation by 
decompressing peripheral nerves in patients with diabetic neuropathy. Ostomy Wound 
Manage 48, 36-45. 
Dent, E. W. and Gertler, F. B. (2003). Cytoskeletal dynamics and transport in 
growth cone motility and axon guidance. Neuron 40, 209-27. 
Dergham, P., Ellezam, B., Essagian, C., Avedissian, H., Lubell, W. D. and 
McKerracher, L. (2002). Rho signaling pathway targeted to promote spinal cord repair. 
J Neurosci 22,6570-7. 
Devor, M. (1999). Unexplained peculiarities ofthe dorsal root ganglion. Pain 
Suppl6, 827-35. 
Dey, N., Howell, B. W., De, P. K. and Durden, D. L. (2005). CSK negatively 
regulates nerve growth factor induced neural differentiation and augments AKT kinase 
activity. Exp Cell Res 307, 1-14. 
Dezawa, M. (2002). Central and peripheral nerve regeneration by transplantation 
of Schwann cells and transdifferentiated bone marrow stromal cells. Anat Sci Int 77, 12-
25. 
Diamond, J., Holmes, M. and Coughlin, M. (1992). Endogenous NGF and 
nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult 
rat. J Neurosci 12, 1454-66. 
Dikic, 1., Tokiwa, G., Lev, S., Courtneidge, S. A. and Schlessinger, J. (1996). 
A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase 
activation. Nature 383, 547-50. 
-244-
Dodge, M. E., Rahimtula, M. and Mearow, K. M. (2002). Factors contributing 
to neurotrophin-independent survival of adult sensory neurons. Brain Res 953, 144-56. 
I 
Dodge, M. E., Wang, J., Guy, C., Rankin, S., Rahimtula, M. and Mearow, K. 
M. (2006). Stress-induced heat shock protein 27 expression and its role in dorsal root 
ganglion neuronal survival. Brain Res 1068, 34-48. 
Domeniconi, M., Cao, Z., Spencer, T., Sivasankaran, R., Wang, K., Nikulina, 
E., Kimura, N., Cai, H., Deng, K., Gao, Y. et al. (2002). Myelin-associated 
glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35, 
283-90. 
Domeniconi, M., Zampieri, N., Spencer, T., Hilaire, M., Mellado, W., Chao, 
M. V. and Filbin, M. T. (2005). MAG induces regulated intramembrane proteolysis of 
the p75 neurotrophin receptor to inhibit neurite outgrowth. Neuron 46, 849-55. 
Durbec, P., Marcos-Gutierrez, C. V., Kilkenny, C., Grigoriou, M., 
Wartiowaara, K., Suvanto, P., Smith, D., Ponder, B., Costantini, F., Saarma, M. et 
al. (1996). GDNF signalling through the Ret receptor tyrosine kinase. Nature 381, 789-
93. 
Eble, J. A. and Haier, J. (2006). Integrins in cancer treatment. Curr Cancer 
Drug Targets 6, 89-105. 
Edstrom, A. and Ekstrom, P. A. (2003). Role ofphosphatidylinositol3-kinase 
in neuronal survival and axonal outgrowth of adult mouse dorsal root ganglia explants. J 
Neurosci Res 74, 726-35. 
Edstrom, A., Ekstrom, P. A. and Tonge, D. (1996). Axonal outgrowth and 
neuronal apoptosis in cultured adult mouse dorsal root ganglion preparations: effects of 
neurotrophins, of inhibition ofneurotrophin actions and ofprior axotomy. 75, 1165-
1174. 
Ekstrom, P. A., Mayer, U., Panjwani, A., Pountney, D., Pizzey, J. and Tonge, 
D. A. (2003). Involvement of alpha7betal integrin in the conditioning-lesion effect on 
sensory axon regeneration. Mol Cell Neurosci 22, 383-95. 
Ellezam, B., Dubreuil, C., Winton, M., Loy, L., Dergham, P., Selles-Navarro, 
I. and McKerracher, L. (2002). Inactivation of intracellular Rho to stimulate axon 
growth and regeneration. Prog Brain Res 137, 371-80. 
--245-
Encinas, M., Tansey, M.G., Tsui-Pierchala, B. A., Comella, J. X., Milbrandt, 
J. and Johnson, E. M., Jr. (2001). c-Src is required for glial cell line-derived 
neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a 
pho~phatidylinositol-3 kinase (PI-3K)-dependent pathway. J Neurosci 21, 1464-72. 
Fairless, R. and Barnett, S. C. (2005). Olfactory ensheathing cells: their role in 
central nervous system repair. Int J Biochem Cell Bio/37, 693-9. 
Feldman, E. L., Russell, J. W., Sullivan, K. A. and Golovoy, D. (1999). New 
insights into the pathogenesis of diabetic neuropathy. Curr Opin Neuro/12, 553-63. 
Feldman, E. L., Stevens, M. J. and Greene, D. A. (1997). Pathogenesis of 
diabetic neuropathy. Clin Neurosci 4, 365-70. 
Fenrich, K. and Gordon, T. (2004). Canadian Association of Neuroscience 
review: axonal regeneration in the peripheral and central nervous systems--current issues 
and advances. Can J Neural Sci 31, 142-56. 
Fernyhough, P. and Schmidt, R. E. (2002). Neurofilaments in diabetic 
neuropathy. Int Rev Neurobio/50, 115-44. 
ffrench-Constant, C. and Colognato, H. (2004). Integrins: versatile integrators 
of extracellular signals. Trends Cell Bio/14, 678-86. 
Filbin, M. T. (2000). Axon regeneration: Vaccinating against spinal cord injury. 
Curr Bio/10, RI00-3. 
Filbin, M. T. (2003). Myelin-associated inhibitors of axonal regeneration in the 
adult mammalian CNS. Nat Rev Neurosci 4, 703-13. 
Forscher, P. and Smith, S. J. (1988). Actions of cytochalasins on the 
organization of actin filaments and microtubules in a neuronal growth cone. J Cell Bioi 
107, 1505-16. 
Fouad, K., Schnell, L., Bunge, M. B., Schwab, M. E., Liebscher, T. and 
Pearse, D. D. (2005). Combining Schwarm cell bridges and olfactory-ensheathing glia 
grafts with chondroitinase promotes locomotor recovery after complete transection of the 
spinal cord. J Neurosci 25, 1169-78. 
-246-
Fournier, A. E., GrandPre, T. and Strittmatter, S.M. (2001). Identification of 
a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409, 341-6. 
I 
Fu, S. Y. and Gordon, T. (1995a). Contributing factors to poor functional 
recovery after delayed nerve repair: prolonged axotomy. J Neurosci 15, 3876-85. 
Fu, S. Y. and Gordon, T. (1995b). Contributing factors to poor functional 
recovery after delayed nerve repair: prolonged denervation. J Neurosci 15, 3886-95. 
Fu, S. Y. and Gordon, T. (1997). The cellular and molecular basis of peripheral 
nerve regeneration. Mol Neurobiol14, 67-116. 
Fugleholm, K., Schmalbruch, H. and Krarup, C. (1994). Early peripheral 
nerve regeneration after crushing, sectioning, and freeze studied by implanted electrodes 
in the cat. J Neurosci 14, 2659-73. 
Gallo, G. and Letourneau, P. C. (2004). Regulation of growth cone actin 
filaments by guidance cues. J Neurobiol58, 92-102. 
Gao, Y., Nikulina, E., Mellado, W. and Filbin, M. T. (2003). Neurotrophins 
elevate cAMP to reach a threshold required to overcome inhibition by MAG through 
extracellular signal-regulated kinase-dependent inhibition of phosphodiesterase. J 
Neurosci 23, 11770-7. 
Gardiner, N.J., Fernyhough, P., Tomlinson, D. R., Mayer, U., von der Mark, 
H. and Streuli, C. H. (2005). Alpha7 integrin mediates neurite outgrowth of distinct 
populations of adult sensory neurons. Mol Cell Neurosci 28, 229-40. 
Gary, D. S. and Mattson, M.P. (2001). Integrin signaling via the PI3-kinase-
Akt pathway increases neuronal resistance to glutamate-induced apoptosis. J Neurochem 
76, 1485-96. 
Gatti, A. (2003). Sustained and transient downregulation ofSrc kinases in 
response to nerve growth factor and epidermal growth factor, respectively. Cell Signal 
15, 1031-7. 
Gavazzi, I., Kumar, R. D., McMahon, S. B. and Cohen, J. (1999). Growth 
responses of different subpopulations of adult sensory neurons to neurotrophic factors in 
vitro. Eur J Neurosci 11, 3405-14. 
-247-
George, R. and Griffin, J. W. (1994). Delayed macrophage responses and 
myelin clearance during Wallerian degeneration in the central nervous system: the dorsal 
radiculotomy model. Exp Neuro/129, 225-36. 
Giancotti, F. G. (2003). A structural view of integrin activation and signaling. 
Dev Cell4, 149-51. ' 
Giancotti, F. G. and Ruoslahti, E. (1999). Integrin signaling. Science 285, 1028-
32. 
Giancotti, F. G. and Tarone, G. (2003). Positional control of cell fate through 
joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Bio/19, 173-206. 
Giardino, R., Fini, M., Nicoli Aldini, N., Giavaresi, G. and Rocca, M. (1999). 
Polylactide bioabsorbable polymers for guided tissue regeneration. J Trauma 47, 303-8. 
Giardino, R., Nicoli Aldini, N., Perego, G., Cella, G., Maltarello, M. C., Fini, 
M., Rocca, M. and Giavaresi, G. (1995). Biological and synthetic conduits in peripheral 
nerve repair: a comparative experimental study. Int J ArtifOrgans 18, 225-30. 
Ginsberg, M. H., Partridge, A. and Shattil, S. J. (2005). Integrin regulation. 
Curr Opin Cell Bio/17, 509-16. 
Goldberg, D. J. and Burmeister, D. W. (1986). Stages in axon formation: 
observations of growth of Aplysia axons in culture using video-enhanced contrast-
differential interference contrast microscopy. J Cell Bio/103, 1921-31. 
Goldberg, D. J. and Burmeister, D. W. (1988). Growth cone movement. Trends 
Neurosci 11, 257-8. 
Goldberg, D. J. and Burmeister, D. W. (1989). Looking into growth cones. 
Trends Neurosci 12, 503-6. 
GrandPre, T., Nakamura, F., Vartanian, T. and Strittmatter, S.M. (2000). 
Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 
403, 439-44. 
-248-
Gray, H., Williams, P. L. and Bannister, L. H. (1995). Gray's anatomy: the 
anatomical basis of medicine and surgery. New York: Churchill Livingstone. 
I 
Grimpe, B. and Silver, J. (2002). The extracellular matrix in axon regeneration. 
137, 333-349. 
Guan, W., Puthenvecdu, M.A. and Condie, M. L. (2003). Sensory neuron 
subtypes have unique substratum preference and receptor expression before target 
innervation. J Neurosci 23, 1781-91. 
Gundersen, R. W. (1988). Interference reflection microscopic study of dorsal 
root growth cones on different substrates: assessment of growth cone-substrate contacts. J 
Neurosci Res 21, 298-306. 
Guo, W. and Giancotti, F. G. (2004). Integrin signalling during tumour 
progression. Nat Rev Mol Cell Bioi 5, 816-26. 
Hall, S. (1997). Axonal regeneration through acellular muscle grafts. J Anat 190 
(Pt 1), 57-71. 
Hall, S.M. and Kent, A. P. (1996). An immuno-electronmicroscopical study of 
the distribution of laminin within autografts of denatured muscle. J Neurocyto/25, 209-
17. 
Hamburger, V. (1993). The history ofthe discovery ofthe nerve growth factor. J 
Neurobio/24, 893-7. 
Hanke, J. H., Gardner, J.P., Dow, R. L., Changelian, P. S., Brissette, W. H., 
Weringer, E. J., Pollok, B. A. and Connelly, P. A. (1996). Discovery of a novel, potent, 
and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT -dependent T 
cell activation. J Bioi Chem 271, 695-701. 
Hannigan, G. E., Leung-Hagesteijn, C., Fitz-Gibbon, L., Coppolino, M. G., 
Radeva, G., Film us, J., Bell, J. C. and Dedhar, S. (1996). Regulation of cell adhesion 
and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 
379, 91-6. 
-249-
Hari, A., Djoh'ar, B., Skutella, T. and Montazeri, S. (2004). Neurotrophins and 
extracellular matrix molecules modulate sensory axon outgrowth. Int J Dev Neurosci 22, 
113-7. 
Hellweg, R. and Hartung, H. D. (1990). Endogenous levels of nerve growth 
factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the 
pathogenesis of diabetic neuropathy. J Neurosci Res 26, 258-67. 
Helmke, S., Lohse, K., Mikule, K., Wood, M. R. and Pfenninger, K. H. 
(1998). SRC binding to the cytoskeleton, triggered by growth cone attachment to laminin, 
is protein tyrosine phosphatase-dependent. J Cell Sci 111 (Pt 16), 2465-75. 
Hempstead, B. L., Martin-Zanca, D., Kaplan, D. R., Parada, L. F. and Chao, 
M. V. (1991). High-affinity NGF binding requires coexpression of the trk proto-
oncogene and the low-affinity NGF receptor. Nature 350, 678-83. 
Henderson, C. E., Phillips, H. S., Pollock, R. A., Davies, A. M., Lemeulle, C., 
Armanini, M., Simmons, L., Moffet, B., Vandlen, R. A., Simpson, L. C. et al. (1994). 
GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. 
Science 266, 1062-4. 
Higuchi, M., Onishi, K., Masuyama, N. and Gotoh, Y. (2003). The 
phosphatidylinositol-3 kinase (PI3K)-Akt pathway suppresses neurite branch formation 
in NGF-treated PC12 cells. Genes Cells 8, 657-69. 
Howe, A., Aplin, A. E., Alahari, S. K. and Juliano, R. L. (1998). Integrin 
signaling and cell growth control. Curr Opin Cell Bio/10, 220-31. 
Huber, A. B., Kolodkin, A. L., Ginty, D. D. and Cloutier, J. F. (2003). 
Signaling at the growth cone: ligand-receptor complexes and the control of axon growth 
and guidance. Annu Rev Neurosci 26, 509-63. 
Hunt, D., Coffin, R. S. and Anderson, P. N. (2002). The Nogo receptor, its 
ligands and axonal regeneration in the spinal cord; a review. J Neurocyto/31, 93-120. 
Hynes, R. 0. (1992). Integrins: versatility, modulation, and signaling in cell 
adhesion. Cel/69, 11-25. 
-250-
Hynes, R. 0. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 
110, 673-87. 
Ishikawa, T., Miyagi, M., Ohtori, S., Aoki, Y., Ozawa, T., Doya, H., Saito, T., 
Moriya, H. and Takahashi, K. (2005). Characteristics of sensory DRG neurons 
innervating the lumbar facet joints in rats. Eur Spine J 14, 559-64. 
Ivankovic-Dikic, I., Gronroos, E., Blaukat, A., Barth, B. U. and Dikic, I. 
(2000). Pyk2 and F AK regulate neurite outgrowth induced by growth factors and 
integrins. Nat Cell Bio/2, 574-81. 
Iwasaki, Y., Gay, B., Wada, K. and Koizumi, S. (1998). Association ofthe Src 
family tyrosine kinase Fyn with TrkB. J Neurochern 71, 106-11. 
Jacobs, W. B. and Fehlings, M.G. (2003). The molecular basis of neural 
regeneration. Neurosurgery 53, 943-48; discussion 948-50. 
Jakobsen, J., Brimijoin, S., Skau, K., Sidenius, P. and Wells, D. (1981). 
Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve 
growth factor in streptozotocin-diabetic rats. Diabetes 30, 797-803. 
Jessen, K. R., Mirsky, R. and Morgan, L. (1987). Myelinated, but not 
unmyelinated axons, reversibly down-regulate N-CAM in Schwann cells. J Neurocytol 
16, 681-8. 
Jiang, Y. and Jakobsen, J. (2004). The role of the p75 neurotrophin receptor in 
the morphology of dorsal root ganglion cells in streptozotocin diabetic mice: effects of 
sciatic nerve crush. Diabetologia. 
Jones, D. M., Tucker, B. A., Rahimtula, M. and Mearow, K. M. (2003). The 
synergistic effects ofNGF and IGF-1 on neurite growth in adult sensory neurons: 
convergence on the PI 3-kinase signaling pathway. J Neurochern 86, 1116-28. 
Jones, R. J., Brunton, V. G. and Frame, M. C. (2000). Adhesion-linked kinases 
in cancer; emphasis on src, focal adhesion kinase and PI 3-kinase. Eur J Cancer 36, 
1595-606. 
Kaplan, D. R. and Miller, F. D. (1997). Signal transduction by the neurotrophin 
receptors. Curr Opin Cell Bio/9, 213-21. 
-251-
Kaplan, D. R. and Miller, F. D. (2000). Neurotrophin signal transduction in the 
nervous system. Curr Opin Neurobiol10, 381-91. 
Kashiba, H., Uchida, Y. and Senba, E. (2001). Difference in binding by 
isolectin B4 to trkA and c-ret mRNA-expressing neurons in rat sensory ganglia. Brain 
Res Mol Brain Res 95, 18-2o. 
Kashiba, H., Uchida, Y. and Senba, E. (2003). Distribution and colocalization 
ofNGF and GDNF family ligand receptor mRNAs in dorsal root and nodose ganglion 
neurons of adult rats. Brain Res Mol Brain Res 110, 52-62. 
Kennedy, J. M. and Zochodne, D. W. (2000). The regenerative deficit of 
peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. 
Brain 123 (Pt 10), 2118-29. 
Kennedy, J. M. and Zochodne, D. W. (2005). Impaired peripheral nerve 
regeneration in diabetes mellitus. J Peripher Nerv Syst 10, 144-57. 
Kim, B., van Golen, C. M. and Feldman, E. L. (2004). Insulin-like growth 
factor-! signaling in human neuroblastoma cells. Oncogene 23, 130-41. 
Kimpinski, K., Campenot, R. B. and Mearow, K. (1997). Effects ofthe 
neurotrophins nerve growth factor, neurotrophin-3, and brain-derived neurotrophic factor 
(BDNF) on neurite gro~h from adult sensory neurons in compartmented cultures. J 
Neurobiol33, 395-410. 
Kimpinski, K. and Mearow, K. (2001). Neurite growth promotion by nerve 
growth factor and insulin-like growth factor-1 in cultured adult sensory neurons: role of 
phosphoinositide 3-kinase and mitogen activated protein kinase. J Neurosci Res 63, 486-
99. 
Klapka, N., Hermanns, S., Straten, G., Masanneck, C., Duis, S., Hamers, F. 
P., Muller, D., Zuschratter, W. and Muller, H. W. (2005). Suppression of fibrous 
scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal 
tract axons, rescue of primary motoneurons in somatosensory cortex and significant 
functional recovery. Eur J Neurosci 22, 3047-58. 
Klapka, N. and Muller, H. W. (2006). Collagen matrix in spinal cord injury. J 
Neurotrauma 23, 422-36. 
-252-
Klesse, L. J., Meyers, K. A., Marshall, C. J. and Parada, L. F. (1999). Nerve 
growth factor induces survival and differentiation through two distinct signaling cascades 
in PC12 cells. Oncogene 18, 2055-68. 
Korey, C. A. and Van Vactor, D. (2000). From the growth cone surface to the 
cytoskeleton: one journey, many paths. J Neurobio/44, 184-93. 
Kornberg, L., Earp, H. S., Parsons, J. T., Schaller, M. and Juliano, R. L. 
(1992). Cell adhesion or integrin clustering increases phosphorylation of a focal 
adhesion-associated tyrosine kinase. J Bioi Chern 267, 23439-42. 
Koshimune, M., Takamatsu, K., Nakatsuka, H., Inui, K., Yamano, Y. and 
Ikada, Y. (2003). Creating bioabsorbable Schwann cell coated conduits through tissue 
engineering. Biomed Mater Eng 13,223-9. 
Kottis, V., Thibault, P., Mikol, D., Xiao, Z. C., Zhang, R., Dergham, P. and 
Braun, P. E. (2002). Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of 
neurite outgrowth. J Neurochem 82, 1566-9. 
Koul, D., Shen, R., Bergh, S., Lu, Y., de Groot, J. F., Liu, T. J., Mills, G. B. 
and Yung, W. K. (2005). Targeting integrin-linked kinase inhibits Akt signaling 
pathways and decreases tumor progression of human glioblastoma. Mol Cancer Ther 4, 
1681-8. 
Krause, M., Dent, E. W., Bear, J. E., Loureiro, J. J. and Gertler, F. B. (2003). 
Ena!V ASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev 
Cell Dev Bio/19, 541-64. 
Kuecherer-Ehret, A., Graeber, M. B., Edgar, D., Thoenen, H. and 
Kreutzberg, G. W. (1990). Immunoelectron microscopic localization oflaminin in 
normal and regenerating mouse sciatic nerve. J Neurocyto/19, 101-9. 
Koffler, D. (2000). Can regeneration be promoted within the spinal cord? P R 
Health Sci J 19, 241-52. 
Lacomis, D. (2002). Small-fiber neuropathy. Muscle Nerve 26, 173-88. 
-253-
Lad, S. P., Peterson, D. A., Bradshaw, R. A. and Neet, K. E. (2003). Individual 
and combined effects ofTrkA and p75NTR nerve growth factor receptors. A role for the 
high affinity receptor site. J Bioll Chem 278, 24808-17. 
Laforest, S., Milanini, J., Parat, F., Thimonier, J. and Lehmann, M. (2005). 
Evidences that beta1 integrin and Rac1 are involved in the overriding effect of laminin on 
myelin-associated glycoprotein inhibitory activity on neuronal cells. Mol Cell Neurosci 
30,418-28. 
Le Quesne, P.M. and Fowler, C. J. (1986). A study ofpain threshold in 
diabetics with neuropathic foot lesions. J Neural Neurosurg Psychiatry 49, 1191-4. 
Lebrand, C., Dent, E. W., Strasser, G. A., Lanier, L. M., Krause, M., 
Svitkina, T. M., Borisy, G. G. and Gertler, F. B. (2004). Critical role ofEna/V ASP 
proteins for filopodia formation in neurons and in function downstream of netrin-1. 
Neuron 42, 37-49. 
Leclere, P., Ekstrom, P., Edstrom, A., Priestley, J., Averill, S. and Tonge, D. 
A. (1998). Effects of glial cell line-derived neurotrophic factor on axonal growth and 
apoptosis in adult mammalian sensory neurons in vitro. 82, 545-558. 
Lee, F. S., Rajagopal, R., Kim, A. H., Chang, P. C. and Chao, M. V. (2002). 
Activation ofTrk neurotrophin receptor signaling by pituitary adenylate cyclase-
activating polypeptides. J Bioi Chem 277,9096-102. 
Lee, K. F., Davies, A.M. and Jaenisch, R. (1994). p75-deficient embryonic 
dorsal root sensory and neonatal sympathetic neurons display a decreased sensitivity to 
NGF. Development 120, 1027-33. 
Lefcort, F., Venstrom, K., McDonald, J. A. and Reichardt, L. F. (1992). 
Regulation of expression of fibronectin and its receptor, alpha 5 beta 1, during 
development and regeneration of peripheral nerve. Development 116, 767-82. 
Lehmann, M., Fournier, A., Selles-Navarro, I., Dergham, P., Sebok, A., 
Leclerc, N., Tigyi, G. and McKerracher, L. (1999). Inactivation of Rho signaling 
pathway promotes CNS axon regeneration. J Neurosci 19, 7537-47. 
Leinninger, G. M., Vincent, A.M. and Feldman, E. L. (2004). The role of 
growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst 9, 26-53. 
-254-
Lemons, M. L~, Barua, S., Abanto, M. L., Halfter, W. and Condie, M. L. 
(2005). Adaptation of sensory neurons to hyalectin and decorin proteoglycans. J Neurosci 
25, 4964-73. 
Lenz, H. J. (2005). Antiangiogenic agents in cancer therapy. Oncology (Williston 
Park) 19, 17-25. 
Letourneau, P. C., Shattuck, T. A. and Ressler, A. H. (1986). Branching of 
sensory and sympathetic neurites in vitro is inhibited by treatment with taxol. J Neurosci 
6, 1912-7. 
Letourneau, P. C., Shattuck, T. A. and Ressler, A. H. (1987). "Pull" and 
"push" in neurite elongation: observations on the effects of different concentrations of 
cytochalasin B and taxol. Cell Motif Cytoskeleton 8, 193-209. 
Levi-Montalcini, R., Dal Toso, R., della Valle, F., Skaper, S.D. and Leon, A. 
(1995). Update of the NGF saga. J Neurol Sci 130, 119-27. 
Levy, D., Kubes, P. and Zochodne, D. W. (2001). Delayed peripheral nerve 
degeneration, regeneration, and pain in mice lacking inducible nitric oxide synthase. J 
Neuropathol Exp Neurol60, 411-21. 
Lewin-Kowalik, J., Marcol, W., Kotulska, K., Mandera, M. and Klimczak, A. 
(2006). Prevention and management of painful neuroma. Neurol Med Chir (Tokyo) 46, 
62-7; discussion 67-8. · 
Li, W., Lee, J., Vikis, H. G., Lee, S. H., Liu, G., Aurandt, J., Shen, T. L., 
Fearon, E. R., Guan, J. L., Han, M. et al. (2004). Activation ofFAK and Src are 
receptor-proximal events required for netrin signaling. Nat Neurosci 7, 1213-21. 
Lin, L. F., Doherty, D. H., Lile, J. D., Bektesh, S. and Collins, F. (1993). 
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. 
Science 260, 1130-2. 
Liu, R. Y., Schmid, R. S., Snider, W. D. and Maness, P. F. (2002). NGF 
enhances sensory axon growth induced by laminin but not by the L 1 cell adhesion 
molecule. Mol Cell Neurosci 20, 2-12. 
-255-
Liu, R. Y. and Snider, W. D. (2001). Different signaling pathways mediate 
regenerative versus developmental sensory axon growth. J Neurosci 21, RC164. 
I 
Logan, A., Ahmed, Z., Baird, A., Gonzalez, A.M. and Berry, M. (2006). 
Neurotrophic factor synergy is required for neuronal survival and disinhibited axon 
regeneration after CNS injury. Brain 129, 490-502. 
Lu, B., Pang, P. T. and Woo, N.H. (2005). The yin and yang ofneurotrophin 
action. Nat Rev Neurosci 6, 603-14. 
Luckenbill-Edds, L. (1997). Laminin and the mechanism of neuronal outgrowth. 
Brain Res Brain Res Rev 23, 1-27. 
Luo, L. (2002). Actin cytoskeleton regulation in neuronal morphogenesis and 
structural plasticity. Annu Rev Cell Dev Bio/18, 601-35. 
Maeda, K., Murakami, H., Yoshida, R., Ichihara, M., Abe, A., Hirai, M., 
Murohara, T. and Takahashi, M. (2004). Biochemical and biological responses 
induced by coupling ofGab1 to phosphatidylinositol3-kinase in RET-expressing cells. 
Biochem Biophys Res Commun 323, 345-54. 
Mahadeo, D., Kaplan, L., Chao, M. V. and Hempstead, B. L. (1994). High 
affinity nerve growth factor binding displays a faster rate of association than p 140trk 
binding. Implications for multi-subunit polypeptide receptors. J Bioi Chern 269, 6884-91. 
Malinda, K. M. and Kleinman, H. K. (1996). The laminins. Int J Biochem Cell 
Bio/28, 957-9. 
Markus, A., Patel, T. D. and Snider, W. D. (2002a). Neurotrophic factors and 
axonal growth. Curr Opin Neurobio/12, 523-31. 
Markus, A., Zhong, J. and Snider, W. D. (2002b ). Raf and akt mediate distinct 
aspects of sensory axon growth. Neuron 35, 65-76. 
Marrs, J. and Newton, S. (2003). Updating your peripheral neuropathy "know-
how". Clin J Oncol Nurs 7, 299-303. 
-256-
Martin, G. R. and Timpl, R. (1987). Laminin and other basement membrane 
components. Annu Rev Cell Bio/3, 57-85. 
Martini, R. and Schachner, M. (1988). Immunoelectron microscopic 
localization of neural cell adhesion molecules (L1, N-CAM, and myelin-associated 
glycoprotein) in regenerating adult mouse sciatic nerve. J Cell Bio/106, 1735-46. 
Matesz, C., Modis, L., Halasi, G., Szigeti, Z. M., Felszeghy, S., Bacskai, T. 
and Szekely, G. (2005). Extracellular matrix molecules and their possible roles in the 
regeneration of frog nervous system. Brain Res Bull 66, 526-31. 
Matheson, C. R., Carnahan, J., Urich, J. L., Bocangel, D., Zhang, T. J. and 
Van, Q. (1997). Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophic 
factor for sensory neurons: comparison with the effects of the neurotrophins. J Neurobiol 
32,22-32. 
McDonald, N. Q. and Blundell, T. L. (1991). Crystallization and 
characterization of the high molecular weight form of nerve growth factor (7 S NGF). J 
Mol Bio/219, 595-601. 
McDonald, N. Q. and Chao, M. V. (1995). Structural determinants of 
neurotrophin action. J Bioi Chern 270, 19669-72. 
McDonald, N. Q., Lapatto, R., Murray-Rust, J. and Blundell, T. L. (1990). X-
ray crystallographic studies on murine nerve growth factor. J Cell Sci Supp/13, 19-30. 
McDonald, N. Q., Lapatto, R., Murray-Rust, J., Gunning, J., Wlodawer, A. 
and Blundell, T. L. (1991). New protein fold revealed by a 2.3-A resolution crystal 
structure of nerve growth factor. Nature 354, 411-4. 
McHugh, J. M. and McHugh, W. B. (2004). Diabetes and peripheral sensory 
neurons: what we don't know and how it can hurt us. AACN Clin Issues 15, 136-49. 
McKeon, R. J., Jurynec, M. J. and Buck, C. R. (1999). The chondroitin sulfate 
proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the 
chronic CNS glial scar. J Neurosci 19, 10778-88. 
-257-
McKeon, R. J., Schreiber, R. C., Rudge, J. S. and Silver, J. (1991). Reduction 
of neurite outgrowth in a model of glial scarring following CNS injury is correlated with 
the expression of inhibitory molecules on reactive astrocytes. J Neurosci 11, 3398-411. 
McKerracher, L., Chamoux, M. and Arregui, C. 0. (1996). Role of laminin 
and integrin interactions in growth cone guidance. 12, 95-116. 
McKerracher, L., David, S., Jackson, D. L., Kottis, V., Dunn, R. J. and 
Braun, P. E. (1994). Identification of myelin-associated glycoprotein as a major myelin-
derived inhibitor of neurite growth. Neuron 13, 805-11. 
McLean, W. G. (1997). The role of axonal cytoskeleton in diabetic neuropathy. 
Neurochem Res 22, 951-6. 
Mearow, K. M. (1998). The effects ofNGF and sensory nerve stimulation on 
collateral sprouting and gene expression in adult sensory neurons. Exp Neuro/151, 14-
25. 
Mearow, K. M. and Kril, Y. (1995). Anti-NGF treatment blocks the 
upregulation ofNGF receptor mRNA expression associated with collateral sprouting of 
rat dorsal root ganglion neurons. 184, 55-58. 
Mearow, K. M., Kril, Y., Gloster, A. and Diamond, J. (1994). Expression of 
NGF receptor and GAP-43 mRNA in DRG neurons during collateral sprouting and 
regeneration of dorsal cutaneous nerves. 25, 127-142. 
Meek, M. F. and Coert, J. H. (2002). Clinical use of nerve conduits in 
peripheral-nerve repair: review of the literature. J Reconstr Microsurg 18, 97-109. 
Meyer, G. and Feldman, E. L. (2002). Signaling mechanisms that regulate actin-
based motility processes in the nervous system. J Neurochem 83, 490-503. 
Meyer, M., Matsuoka, I., Wetmore, C., Olson, L. and Thoenen, H. (1992). 
Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: 
different mechanisms are responsible for the regulation of BDNF and NGF mRNA. J 
Cell Bio/119, 45-54. 
-258-
Mi, S., Lee, X.,' Shao, Z., Thill, G., Ji, B., Relton, J., Levesque, M., Allaire, N., 
Perrin, S., Sands, B. et al. (2004). LINGO-I is a component ofthe Nogo-66 
receptor/p75 signaling complex. Nat Neurosci 7, 221-8. 
Mills, J., Digicaylioglu, M., Legg, A. T., Young, C. E., Young, S. S., Barr, A. 
M., Fletcher, L., O'Connor, T. P. and Dedhar, S. (2003). Role ofintegrin-linked 
kinase in nerve growth factor-stimulated neurite outgrowth. J Neurosci 23, 1638-48. 
Molliver, D. C., Wright, D. E., Leitner, M. L., Parsadanian, A. S., Doster, K., 
Wen, D., Yan, Q. and Snider, W. D. (1997). IB4-binding DRG neurons switch from 
NGF to GDNF dependence in early postnatal life. Neuron 19, 849-61. 
Monnier, P. P., Sierra, A., Schwab, J. M., Henke-Fahle, S. and Mueller, B. K. 
(2003). The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated 
with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol Cell Neurosci 22, 
319-30. 
Mukhopadhyay, G., Doherty, P., Walsh, F. S., Crocker, P.R. and Filbin, M. 
T. (1994). A novel role for myelin-associated glycoprotein as an inhibitor of axonal 
regeneration. Neuron 13, 757-67. 
Muller, H. W. and Stoll, G. (1998). Nerve injury and regeneration: basic insights 
and therapeutic interventions. Curr Opin Neurolll, 557-62. 
Nakamura, T., Inada, Y., Fukuda, S., Yoshitani, M., Nakada, A., Itoi, S., 
Kanemaru, S., Endo, K. and Shimizu, Y. (2004). Experimental study on the 
regeneration of peripheral nerve gaps through a polyglycolic acid-collagen (PGA-
collagen) tube. Brain Res 1027, 18-29. 
Navissano, M., Malan, F., Carnino, R. and Battiston, B. (2005). Neurotube for 
facial nerve repair. Microsurgery 25, 268-71. 
Newton, C. D. and Nunamaker, D. M. (1985). Textbook of small animal 
orthopaedics. Philadelphia: Lippincott. 
Ng, J., Nardine, T., Harms, M., Tzu, J., Goldstein, A., Sun, Y., Dietzl, G., 
Dickson, B. J. and Luo, L. (2002). Rae GTPases control axon growth, guidance and 
branching. Nature 416,442-7. 
-259-
Noble, J., Munro, C. A., Prasad, V. S. and Midha, R. (1998). Analysis of upper 
and lower extremity peripheral nerve injuries in a population of patients with multiple 
injuries. J Trauma 45, 116-22. I 
Oguievetskaia, K., Cifuentes-Diaz, C., Girault, J. A. and Goutebroze, L. 
(2005). Cellular contacts in myelinated fibers of the peripheral nervous system. Med Sci 
(Paris) 21, 162-9. 
Oppenheim, R. W., Houenou, L. J., Johnson, J. E., Lin, L. F., Li, L., Lo, A. 
C., Newsome, A. L., Prevette, D. M. and Wang, S. (1995). Developing motor neurons 
rescued from programmed and axotomy-induced cell death by GDNF. Nature 373, 344-6. 
Paratcha, G., Ledda, F. and Ibanez, C. F. (2003). The neural cell adhesion 
molecule NCAM is an alternative signaling receptor for GDNF family ligands. Ce/1113, 
867-79. 
Park, J. I., Powers, J. F., Tischler, A. S., Strock, C. J., Ball, D. W. and Nelkin, 
B. D. (2005). GDNF-induced leukemia inhibitory factor can mediate differentiation via 
the MEK/ERK pathway in pheochromocytoma cells derived from nfl-heterozygous 
knockout mice. Exp Cell Res 303, 79-88. 
Park, S. Y., Avraham, H. and Avraham, S. (2000). Characterization ofthe 
tyrosine kinases RAFTK/Pyk2 and F AK in nerve growth factor-induced neuronal 
differentiation. J Bioi Chern 275, 19768-77. 
Paveliev, M., Airaksinen, M.S. and Saarma, M. (2004). GDNF family ligands 
activate multiple events during axonal growth in mature sensory neurons. Mol Cell 
Neurosci 25, 453-9. 
Petruska, J. C., Napaporn, J., Johnson, R. D., Gu, J. G. and Cooper, B. Y. 
(2000). Subclassified acutely dissociated cells of rat DRG: histochemistry and patterns of 
capsaicin-, proton-, and ATP-activated currents. J Neurophysiol84, 2365-79. 
Pierson, C. R., Zhang, W., Murakawa, Y. and Sima, A. A. (2002). Early gene 
responses of trophic factors in nerve regeneration differ in experimental type 1 and type 2 
diabetic polyneuropathies. J Neuropathol Exp Neurol61, 857-71. 
Pierson, C. R., Zhang, W., Murakawa, Y. and Sima, A. A. (2003). Insulin 
deficiency rather than hyperglycemia accounts for impaired neurotrophic responses and 
-260-
nerve fiber regeneration in type 1 diabetic neuropathy. J Neuropathol Exp Neural 62, 
260-71. 
Polydefkis, M., Griffin, J. W. and McArthur, J. (2003). New insights into 
diabetic polyneuropathy. Jama 290, 1371-6. 
Polydefkis, M., Hauer, P., Sheth, S., Sirdofsky, M., Griffin, J. W. and 
McArthur, J. C. (2004). The time course of epidermal nerve fibre regeneration: studies 
in normal controls and in people with diabetes, with and without neuropathy. Brain 127, 
1606-15. 
Previtali, S. C., Feltri, M. L., Archelos, J. J., Quattrini, A., Wrabetz, L. and 
Hartung, H. (2001). Role ofintegrins in the peripheral nervous system. Prog Neurobiol 
64, 35-49. 
Priestley, J. V., Michael, G. J., Averill, S., Liu, M. and Willmott, N. (2002a). 
Regulation of nociceptive neurons by nerve growth factor and glial cell line derived 
neurotrophic factor. Can J Physiol Pharmaco/80, 495-505. 
Priestley, J. V., Ramer, M.S., King, V. R., McMahon, S. B. and Brown, R. A. 
(2002b). Stimulating regeneration in the damaged spinal cord. J Physiol Paris 96, 123-
33. 
Prinjha, R., Moore, S. E., Vinson, M., Blake, S., Morrow, R., Christie, G., 
Michalovich, D., Simmons, D. L. and Walsh, F. S. (2000). Inhibitor of neurite 
outgrowth in humans. Nature 403, 383-4. 
Reo, X. D., Kiosses, W. B., Sieg, D. J., Otey, C. A., Schlaepfer, D. D. and 
Schwartz, M.A. (2000). Focal adhesion kinase suppresses Rho activity to promote focal 
adhesion turnover. J Cell Sci 113 (Pt 20), 3673-8. 
Ribotta, M. G., Menet, V. and Privat, A. (2004). Glial scar and axonal 
regeneration in the CNS: lessons from GF AP and vimentin transgenic mice. Acta 
Neurochir Supp/89, 87-92. 
Ruoslahti, E. (1996). RGD and other recognition sequences for integrins. Annu 
Rev Cell Dev Bio/12, 697-715. 
-261-
Saika, T., Senba, E., Noguchi, K., Sato, M., Kubo, T., Matsunaga, T. and 
Tohyama, M. (1991a). Changes in expression ofpeptides in rat facial motoneurons after 
facial nerve crushing and resectjlon. Brain Res Mol Brain Res 11, 187-96. 
Saika, T., Senba, E., Noguchi, K., Sato, M., Yoshida, S., Kubo, T., 
Matsunaga, T. and Tohyama, M. (1991b). Effects of nerve crush and transection on 
mRNA levels for nerve growth factor receptor in the rat facial motoneurons. Brain Res 
Mol Brain Res 9, 157-60. 
Sakai, Y., Ochi, M., Uchio, Y., Ryoke, K. and Yamamoto, S. (2005). 
Prevention and treatment of amputation neuroma by an atelocollagen tube in rat sciatic 
nerves. J Biomed Mater Res B Appl Biomater 73, 355-60. 
Salzer, J. L., Pedraza, L., Brown, M., Struyk, A., Afar, D. and Bell, J. (1990). 
Structure and function of the myelin-associated glycoproteins. Ann NY Acad Sci 605, 
302-12. 
Sandvig, A., Berry, M., Barrett, L. B., Butt, A. and Logan, A. (2004). Myelin-, 
reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor 
signaling, and correlation with axon regeneration. Glia 46, 225-51. 
Sango, K., Horie, H., Okamura, A., Inoue, S. and Takenaka, T. (1995). 
Diabetes impairs DRG neuronal attachment to extracellular matrix proteins in vitro. 
Brain Res Bull31, 533-7. 
Sariola, H. and Saarma, M. (2003). Novel functions and signalling pathways for 
GDNF. J Cell Sci 116,3855-62. 
Sarner, S., Kozma, R., Ahmed, S. and Lim, L. (2000). Phosphatidylinositol 3-
kinase, Cdc42, and Rac1 act downstream ofRas in integrin-dependent neurite outgrowth 
in NlE-115 neuroblastoma cells. Mol Cell Bio/20, 158-72. 
Sastry, S. K. and Burridge, K. (2000). Focal adhesions: a nexus for intracellular 
signaling and cytoskeletal dynamics. Exp Cell Res 261, 25-36. 
Sato, K., Otsuki, T., Kimoto, M., Kakumoto, M., Tokmakov, A. A., 
Watanabe, Y. and Fukami, Y. (1998). c-Src and phosphatidylinositol 3-kinase are 
involved in NGF-dependent tyrosine phosphorylation of She in PC12 cells. Biochem 
Biophys Res Commun 250, 223-8. 
-262-
Sa to, S. (200 1 )'. [Role of cell adhesion molecules in wound healing]. Nihon 
Rinsho Meneki Gakkai Kaishi 24, 98-111. 
Scarpini, E., Conti, G., Chianese, L., Baron, P., Pizzul, S., Basellini, A., 
Livraghi, S. and Scarlato, G. (1996). Induction ofp75NGFR in human diabetic 
neuropathy. J Neural Sci 135, 55-62. 
Schaller, M.D. and Parsons, J. T. (1994). Focal adhesion kinase and associated 
proteins. Curr Opin Cell Bio/6, 705-10. 
Schlaepfer, D. D. and Hunter, T. (1998). Integrin signalling and tyrosine 
phosphorylation: just the FAKs? Trends Cell Bio/8, 151-7. 
Schnell, L. and Schwab, M. E. (1990). Axonal regeneration in the rat spinal cord 
produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343, 
269-72. 
Schwartz, M. A. and Ginsberg, M. H. (2002). Networks and crosstalk: integrin 
signalling spreads. Nat Cell Bioi 4, E65-8. 
Schwartz, M.A., Schaller, M. D. and Ginsberg, M. H. (1995). Integrins: 
emerging paradigms of signal transduction. Annu Rev Cell Dev Biolll, 549-99. 
Schweigreiter, R. and Bandtlow, C. E. (2006). Nogo in the injured spinal cord. 
J Neurotrauma 23, 384-96. 
Schweigreiter, R., Walmsley, A. R., Niederost, B., Zimmermann, D. R., 
Oertle, T., Casademunt, E., Frentzel, S., Dechant, G., Mir, A. and Bandtlow, C. E. 
(2004). Versican V2 and the central inhibitory domain ofNogo-A inhibit neurite growth 
via p75NTR/NgR-independent pathways that converge at RhoA. Mol Cell Neurosci 27, 
163-74. 
Scott, J. N., Clark, A. W. and Zochodne, D. W. (1999). Neurofilament and 
tubulin gene expression in progressive experimental diabetes: failure of synthesis and 
export by sensory neurons. Brain 122 (Pt 11), 2109-18. 
Seddon, H. J. (1975). Surgical disorders ofthe peripheral nerves. Edinburgh, 
New York: Churchill Livingstone. 
-263-
Serini, G., Valdembri, D. and Bussolino, F. (2006). Integrins and angiogenesis: 
a sticky business. Exp Cell Res 312,651-8. 
I 
Skene, J. H. (1989). Axonal growth-associated proteins. Annu Rev Neurosci 12, 
127-56. 
Smith, D. S. and Skene, J. H. (1997). A transcription-dependent switch controls 
competence of adult neurons for distinct modes of axon growth. J Neurosci 17, 646-58. 
Snider, W. D. and McMahon, S. B. (1998). Tackling pain at the source: new 
ideas about nociceptors. Neuron 20, 629-32. 
Snider, W. D., Zhou, F. Q., Zhong, J. and Markus, A. (2002). Signaling the 
pathway to regeneration. Neuron 35, 13-6. 
Snow, D. M., Brown, E. M. and Letourneau, P. C. (1996). Growth cone 
behavior in the presence of soluble chondroitin sulfate proteoglycan (CSPG), compared 
to behavior on CSPG bound to larninin or fibronectin. Int J Dev Neurosci 14, 331-49. 
Soler, R. M., Dolcet, X., Encinas, M., Egea, J., Bayascas, J. R. and Comella, 
J. X. (1999). Receptors of the glial cell line-derived neurotrophic factor family of 
neurotrophic factors signal cell survival through the phosphatidylinositol 3-kinase 
pathway in spinal cord motoneurons. J Neurosci 19, 9160-9. 
Srinivasan, S., Anitha, M., Mwangi, S. and Heuckeroth, R. 0. (2005). Enteric 
neuroblasts require the phosphatidylinositol3-kinase/Akt/Forkhead pathway for GDNF-
stimulated survival. Mol Cell Neurosci 29, 107-19. 
Stoll, G., Jander, S. and Myers, R. R. (2002). Degeneration and regeneration of 
the peripheral nervous system: from Augustus Waller's observations to 
neuroinflammation. J Peripher Nerv Syst 7, 13-27. 
Strauch, B. (2000). Use of nerve conduits in peripheral nerve repair. Hand Clin 
16, 123-30. 
Sumner, C. J., Sheth, S., Griffin, J. W., Cornblath, D. R. and Polydefkis, M. 
(2003). The spectrum of neuropathy in diabetes and impaired glucose tolerance. 
Neurology 60, 108-11. 
-264-
Tarone, G., Hirsch, E., Brancaccio, M., De Acetis, M., Barberis, L., Balzac, 
F., Retta, S. F., Botta, C., Altruda, F. and Silengo, L. (2000). Integrin function and 
regulation in development. Int J Dev Bioi 44, 725-31. 
Thelen, K., Kedar, V., Panicker, A. K., Schmid, R. S., Midkiff, B. R. and 
Maness, P. F. (2002). The neural cell adhesion molecule L1 potentiates integrin-
dependent cell migration to extracellular matrix proteins. J Neurosci 22, 4918-31. 
Timpl, R., Rohde, H., Robey, P. G., Rennard, S. I., Foidart, J. M. and 
Martin, G. R. (1979). Laminin--a glycoprotein from basement membranes. J Bioi Chern 
254, 9933-7. 
Tomaselli, K. J., Doherty, P., Emmett, C. J., Damsky, C. H., Walsh, F. S. and 
Reichardt, L. F. (1993). Expression of beta 1 integrins in sensory neurons of the dorsal 
root ganglion and their functions in neurite outgrowth on two laminin isoforms. J 
Neurosci 13, 4880-8. 
Tomlinson, D. R., Fernyhough, P. and Diemel, L. T. (1997). Role of 
neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes 
46 Suppl2, S43-9. 
Tonge, D. A., Golding, J. P., Edbladh, M., Kroon, M., Ekstrom, P. E. and 
Edstrom, A. (1997). Effects of extracellular matrix components on axonal outgrowth 
from peripheral nerves of adult animals in vitro. 146, 81-90. 
Toyota, B., Carbonetto, S. and David, S. (1990). A duallaminin/collagen 
receptor acts in peripheral nerve regeneration. Proc Nat! Acad Sci US A 87, 1319-22. 
Travis, M.A., Humphries, J.D. and Humphries, M. J. (2003). An unraveling 
tale of how integrins are activated from within. Trends Pharmacol Sci 24, 192-7. 
Treanor, J. J., Goodman, L., de Sauvage, F., Stone, D. M., Poulsen, K. T., 
Beck, C. D., Gray, C., Armanini, M.P., Pollock, R. A., Hefti, F. et al. (1996). 
Characterization of a multicomponent receptor for GDNF. Nature 382, 80-3. 
Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A. S., Sieber, B. A., 
Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V. and Arumae, U. 
(1996). Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381, 
785-9. 
-265-
Trupp, M., Scott, R., Whittemore, S. R. and Ibanez, C. F. (1999). Ret-
dependent and -independent mechanisms of glial cell line-derived neurotrophic factor 
signaling in neuronal cells. J Bio~ Chern 274, 20885-94. 
Tsuruda, A., Suzuki, S., Maekawa, T. and Oka, S. (2004). Constitutively active 
Src facilitates NGF-induced phosphorylation ofTrkA and causes enhancement of the 
MAPK signaling in SK-N-MC cells. FEBS Lett 560,215-20. 
Tucker, B. A., Rahimtula, M. and Mearow, K. M. (2005a). Integrin activation 
and neurotrophin signaling cooperate to enhance neurite outgrowth in sensory neurons. J 
Cornp Neuro/486, 267-80. 
Tucker, B. A., Rahimtula, M. and Mearow, K. M. (2005b). A procedure for 
selecting and culturing subpopulations of neurons from rat dorsal root ganglia using 
magnetic beads. Brain Res Brain Res Protoc 16, 50-7. 
Unger, J. W., Klitzsch, T., Pera, S. and Reiter, R. (1998). Nerve growth factor 
(NGF) and diabetic neuropathy in the rat: morphological investigations of the sural nerve, 
dorsal root ganglion, and spinal cord. Exp Neuro/153, 23-34. 
van Weering, D. H. and Bos, J. L. (1997). Glial cell line-derived neurotrophic 
factor induces Ret-mediated lamellipodia formation. J Bioi Chern 272, 249-54. 
Verge, V. M., Tetzlaff, W., Richardson, P.M. and Bisby, M.A. (1990). 
Correlation between GAP43 and nerve growth factor receptors in rat sensory neurons. J 
Neurosci 10, 926-34. 
Vernadakis, A. J., Koch, H. and Mackinnon, S. E. (2003). Management of 
neuromas. Clin Plast Surg 30, 247-68, vii. 
Vogelezang, M.G., Liu, Z., Relvas, J. B., Raivich, G., Scherer, S. S. and 
ffrench-Constant, C. (200 1 ). Alpha4 integrin is expressed during peripheral nerve 
regeneration and enhances neurite outgrowth. J Neurosci 21, 6732-44. 
Vuori, K., Hirai, H., Aizawa, S. and Ruoslahti, E. (1996). Introduction of 
p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src 
family kinases. Mol Cell Bio/16, 2606-13. 
-266-
Wallquist, W.,' Zelano, J., Plantman, S., Kaufman, S. J., Cullheim, S. and 
Hammarberg, H. (2004). Dorsal root ganglion neurons up-regulate the expression of 
laminin-associated integrins after peripheral but not central axotomy. J Camp Neural 
480, 162-9. 
I 
Wang, G. Y., Hirai; K. and Shimada, H. (1992). The role oflaminin, a 
component of Schwarill cell basal lamina, in rat sciatic nerve regeneration within 
antiserum-treated nerve grafts. Brain Res 570, 116-25. 
Wang, K. C., Koprivica, V., Kim, J. A., Sivasankaran, R., Guo, Y., Neve, R. 
L. and He, Z. (2002). Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand 
that inhibits neurite outgrowth. Nature 417,941-4. 
Wary, K. K., Mainiero, F., Isakoff, S. J., Marcantonio, E. E. and Giancotti, F. 
G. ( 1996). The adaptor protein She couples a class of integrins to the control of cell cycle 
progression. Cel/87, 733-43. 
Wary, K. K., Mariotti, A., Zurzolo, C. and Giancotti, F. G. (1998). A 
requirement for caveolin-1 and associated kinase Fyn in integrin signaling and 
anchorage-dependent cell growth. Cel/94, 625-34. 
Weber, R. A., Breidenbach, W. C., Brown, R. E., Jabaley, M. E. and Mass, D. 
P. (2000). A randomized prospective study of polyglycolic acid conduits for digital nerve 
reconstruction in humans. Plast Reconstr Surg 106, 1 036-45; discussion 1046-8. 
Weber, R. V. and Mackinnon, S. E. (2005). Bridging the neural gap. Clin Plast 
Surg 32, 605-16, viii. 
Werner, A., Willem, M., Jones, L. L., Kreutzberg, G. W., Mayer, U. and 
Raivich, G. (2000). Impaired axonal regeneration in alpha? integrin-deficient mice. J 
Neurosci 20, 1822-30. 
Wiesner, S., Legate, K. R. and Fassler, R. (2005). Integrin-actin interactions. 
Cell Mol Life Sci 62, 1 081-99. 
Wiklund, P., Ekstrom, P. A., Edbladh, M., Tonge, D. and Edstrom, A. (1996). 
Protein kinase C and mouse sciatic nerve regeneration. Brain Res 715, 145-54. 
-267-
Williams, K. L., Rahimtula, M. and Mearow, K. M. (2005). Hsp27 and axonal 
growth in adult sensory neurons in vitro. BMC Neurosci 6, 24. 
Winton, M. J., Dubreuil, C. 1., Lasko, D., Leclerc, N. and McKerracher, L. 
(2002). Characterization of new cell permeable C3-like proteins that inactivate Rho and 
stimulate neurite outgrowth on inhibitory substrates. J Bioi Chern 277, 32820-9. 
Woodhall, B. (1951). The surgical repair of acute peripheral nerve injury. Surg 
Clin North Am, 1369-90. 
Woolf, C. J., Reynolds, M. L., Molander, C., O'Brien, C., Lindsay, R. M. and 
Benowitz, L. I. (1990). The growth-associated protein GAP-43 appears in dorsal root 
ganglion cells and in the dorsal hom of the rat spinal cord following peripheral nerve 
injury. Neuroscience 34,465-78. 
Wooten, M. W., Vandenplas, M. L., Seibenhener, M. L., Geetha, T. and Diaz-
Meco, M. T. (2001). Nerve growth factor stimulates multisite tyrosine phosphorylation 
and activation of the atypical protein kinase C's via a src kinase pathway. Mol Cell Bioi 
21, 8414-27. 
Xing, S., Furminger, T. L., Tong, Q. and Jhiang, S.M. (1998). Signal 
transduction pathways activated by RET oncoproteins in PC 12 pheochromocytoma cells. 
J Bioi Chern 273, 4909-14. 
Yagihashi, S., Kamijo, M. and Watanabe, K. (1990). Reduced myelinated fiber 
size correlates with loss of axonal neurofilaments in peripheral nerve of chronically 
streptozotocin diabetic rats. Am J Patho/136, 1365-73. 
Yamashita, T., Higuchi, H. and Tohyama, M. (2002). The p75 receptor . 
transduces the signal from myelin-associated glycoprotein to Rho. J Cell Biol157, 565-
70. 
Yanagida, H., Tanaka, J. and Maruo, S. (1999). Immunocytochemical 
localization of a cell adhesion molecule, integrin alpha5betal, in nerve growth cones. J 
Orthop Sci 4, 353-60. 
Yang, D., Bierman, J., Tarumi, Y. S., Zhong, Y. P., Rangwala, R., Proctor, T. 
M., Miyagoe-Suzuki, Y., Takeda, S., Miner, J. H., Sherman, L. S. et al. (2005). 
Coordinate control of axon defasciculation and myelination by laminin-2 and -8. J Cell 
Biol168, 655-66. 
-268-
Yano, H. and Chao, M. V. (2000). Neurotrophin receptor structure and 
interactions. Pharm Acta Helv 74, 253-60. 
Yasuda, H., Terada, M., Maeda, K., Kogawa, S., Sanada, M., Haneda, M., 
Kashiwagi, A. and Kikkawa, R. (2003). Diabetic neuropathy and nerve regeneration. 
Prog Neurobio/69, 229-85. 
Yoshida, S. and Matsuda, Y. (1979). Studies on sensory neurons of the mouse 
with intracellular-recording and horseradish peroxidase-injection techniques. J 
Neurophysio/42, 1134-45. 
Zhang, Y., Tohyama, K., Winterbottom, J. K., Haque, N. S., Schachner, M., 
Lieberman, A. R. and Anderson, P. N. (2001). Correlation between putative inhibitory 
molecules at the dorsal root entry zone and failure of dorsal root axonal regeneration. Mol 
Cell Neurosci 17, 444-59. 
Zhou, F. Q., Zhou, J., Dedhar, S., Wu, Y. H. and Snider, W. D. (2004). NGF-
induced axon growth is mediated by localized inactivation ofGSK-3beta and functions of 
the microtubule plus end binding protein APC. Neuron 42, 897-912. 
Zochodne, D. W. (1996). Is early diabetic neuropathy a disorder ofthe dorsal 
root ganglion? A hypothesis and critique of some current ideas on the etiology of diabetic 
neuropathy. J Peripher Nerv Syst 1, 119-30. 
Zochodne, D. W. (1999). Diabetic neuropathies: features and mechanisms. Brain 
Patho/9, 369-91. 
Zochodne, D. W., Verge, V. M., Cheng, C., Sun, H. and Johnston, J. (2001). 
Does diabetes target ganglion neurones? Progressive sensory neurone involvement in 
long-term experimental diabetes. Brain 124, 2319-34. 
-269-




